Strategies for mutation detection in sex-chromosome related disorders by Mohammed, Fawziah M.







Mohammed, Fawziah M. (1999) Strategies for mutation detection in sex-









Copyright and moral rights for this thesis are retained by the author 
 
A copy can be downloaded for personal non-commercial research or 
study, without prior permission or charge 
 
This thesis cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the Author 
 
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the Author 
 
When referring to this work, full bibliographic details including the 
author, title, awarding institution and date of the thesis must be given 
 
STRATEGIES FOR MUTATION 
DETECTION IN SEX-CHROMOSOME 
RELATED DISORDERS 
Fawziah M. Mohammed 
A Thesis Submitted to the Faculty of Medicine, University of 
Glasgow, for the Degree of Doctor of Philosophy 
Duncan Guthrie Institute of Medical Genetics, 
Yorkliill Hospitals MIS Trust 
Glasgow August 1999 
Declaration 
I certify that this thesis does not contain material previously published or written 
by any other person, except where referred to in the text. The results in this thesis 
have not been submitted for any other degree or diploma. 
Fawziah M. Mohammed 
Acknowledgments 
During this work, I have benefited greatly from the generous advice and 
help of many experts and friends. 
I would like to thank Professor J. M. Connor for the opportunity to pursue 
this course at the Duncan Guthrie Institute of Medical Genetics, University of 
Glasgow, and for his supervision and help through this work. I am equally 
indebted to my supervisors Dr. W. G. Lanyon and Dr. E. Boyd for their guidance 
and encouragement during the course of this study. I would also like to thank Dr. 
C. Chu for her help, valuable suggestions, and for providing samples. I am also 
thankful to Dr. A. Chandley for her generous gifts of probe MK5 and MK29. I 
would like to thank Dr. Ahmed Al-Ansari at male infertility clinic-Kuwait for his 
help in patient assessment and sampling. 
I am very thankful and grateful to Eqbal El-Rahmani, Mahbuba Hagig, 
Alaa Elshafey, Guity Ghaffari and Riza Davoodi for being devoted friends and 
allies and for their help, wisdom and criticism. I am especially grateful to all my 
friends Manal Bohaimed, Lubnah and Iman Al-Behnasawi, Sawsan Abulhasan, 
and Iman Abohamra who offered encouragement and moral support during my 
stay in Glasgow. 
My gratitude is also extended to Dr. Sadika Ali Al-Awadi Director of 
Kuwait Medical Genetics Center for support, guidance, and being very patience. 
I am equally thankful to Dr. Laila Bastaki Dr. Sayed Guoda, Dr. Rizk Al- 
Naggar and to all staff of Kuwait Medical Genetics Center for their moral support. 
Special thanks and appreciation to Dr. Kamal Naguib, Dr. Krishna 
Murthy, Dr. Dr. Shawki Tayel, Khaled Al-Nassafi, and Dr. Maha Mustafa Abo- 
Hendi at Kuwait Medical Genetics Center for their guidance and'patience during 
the preparation of this thesis. 
I am grateful to the post graduate research (PGR) laboratory group 
especially Morteza Bonyadi, Mojtaba Mohaddes, Hassan Acar, Munis Dundar, 
Huseyin Yuce and Eunice Stefanous. 
Many thanks to all staff at Duncan Guthrie Institute of Medical Genetics 
for being kind and for their help and valuable advice particularly Betty OHare, 
Am Theriault, Norma Morrison, Avril Morris, Sandy Cooke and Jim Colgan. 
And of course, I shall always be grateful and obliged to my parents for 
their love and support particularly during my long stay away from home. I am 
also very thankful and indebted to all my brothers and sisters for their faith, love, 
and encouragement and who have been there whenever I needed them. 
Finally I would like to thank all the patients who participated in the 
research. Without them the work would not have been possible. 
TABLE OF CONTENTS 
LIST OF FIGURES 
LIST OF TABLES 
LIST OF ABBREVIATIONS 
SUMMARY 
(1) INTRODUCTION 
1.1 Molecular path ology of single gen e disorder 
1 
1.2 Sex determination and sex differentiation 4 
1.2.1 Normal sex differentiation 4 
1.2.2 Role of chromosomes in sex determination 6 
1.3 Sew chromosome abnormalities and chromosomal intersex 10 
1.3.1 Turner Syndrome and variants 17 
1.3.2 Hermaphrodites or intersexes 19 
1.4 The mammalian sex-determining master regulator gene SRY 
(sew determining region on the Y chromosome) 20 
1.4.1 XX and XY sex reversal 22 
1.4.2 The search for the sex determination gene(s) 24 
1.4.3 The SRYgcne 24 
1.5 Androgen Receptor (AR) and Molecular Genetics ofAndrogen 
Insensitivity Syndrome (AIS) 31 
1.5.1 Androgen receptor (AR) structure and function 33 
1.5.2 AIS and genetic abnormalities of the AR gene 34 
1.5.3 AR gene mutations in other diseases 36 
1.6 Mak Infertility 37 
1.6.1 Spermatogenesis and its hormonal control 38 
1.6.2 Causes of male infertility 38 
1.6.3 The genetics of male infertility 39 
1.6.3.1 Chromosomal abnormalities as a cause of male infertility 42 
1.6.3.2 Deletion of the azoospermia factor (AZF) 42 
1.7 Mutation detection methods 48 
1.7.1 Screening for unknown mutations 48 
1.7.1.1 Detection of large gene alteration 50 
1.7.1.2 Detection of single base changes 58 
1.7.2 Methods to detect known sequences alteration 62 
1.8Aims of the present project 65 
(2) MATERIALS AND METHODS 67 
2.1 Patients 67 
Z2 Materials and solutions 68 
Z3 Cytogenetic studies 78 
2.3.1 Chromosomal preparation from stimulated peripheral blood 78 
2.3.2 Slide preparation 78 
2.3.3 Giemsa banding 79 
2.3.4 Late replication study of X-chromosome (LRX) 79 
2.4 Molecular cytogenetics: Fluorescence in situ hybridisation (FISH) 80 
2.4.1 Probe preparation 81 
2.4.2 Transformation and growth of the probe 85 
2.4.2.1 Growth of plasmid/cosmid probes 86 
2.4.2.2 Isolation of recombinant plasmid/cosmid 86 
2.4.3 Restriction enzyme digest to release probe insert 88 
2.4.4 Probe labelling 88 
2.4.5 Slide preparation 89 
2.4.6 Uni-colour fluorescence in situ hybridisation 90 
2.4.6.1 Probe mixture preparation and probe denaturation 90 
2.4.6.2 Cellular DNA denaturation and probe hybridisation 94 
2.4.6.3 Post hybridisation washes 94 
2.4.6.4 Amplification of hybridisation signals 94 
2.4.6.5 Chromosome counter staining 96 
2.4.7 Multi-colour FISH 96 
2.4.8 Detection and counter staining of multi-colour FISH 96 
2.4.9 Visualisation 98 
ZS Molecular Genetics study 100 
2.5.1 DNA extraction 100 
2.5.2 Agarose gel electrophoresis 100 
2.5.3 Oligonucleotide design and preparation 101 
2.5.4 Polymerase chain reaction (PCR) 102 
2.5.5 Multiplex PCR 102 
2.5.6 Gel analysis of multiplex PCR 104 
2.5.7 Southern blot analysis 104 
2.5.8 Single strand conformational, polymorphism (SSCP) analysis 107 
2.5.9 Heteroduplex analysis 108 
2.5.10 Silver staining 108 
2.5.11 Chemical cleavage of mismatches (CCM) 109 
2.5.12 Genomic Sequencing ill 
(3) RESULTS 113 
3.1 Cytogenetic and molecular cytogenetic studies: 113 
3.1.1 Establishment of FISH technique and optimisation of probes 113 
(1) Unicolour FISH using alpha satellite DNA probes 113 
(2) Dual and multi colour FISH 124 
3.1.2 Applications of FISH technique: 125 
(1) Patients 125 
(2) FISH studies of X and Y chromosomes aberrations 125 
(A) FISH studies of cases with X chromosome abnormalities 129 
(B) FISH studies of cases with Y chromosome abnormalities 164 
3.1.2 X-inactivation study 171 
3.2 Molecular studies 183 
3.2.1 Androgen Receptor gene (AR) 183 
3.2.1.1 PCR, amplification of the AR gene exons from genomic DNA 183 
3.2.1.2 Mutation detection strategy 183 
3.2.2 SRY-gene 192 
3.2.2.1 46, XY Females 192 
3.2.2.2 Study of the XX males 200 
FISH study of 46, XX males 200 
PCR study 201 
3.2.3 Mutation analysis of the azoospermia factor (AZF) region 205 
3.2.3.1 Patients' selection 205 
3.2.3.2 Screening for deletion in the Yq1 I region 206 
3.2.3.3 Mutation analysis of the RBMI gene 215 
3.2.3.4 Microdeletion screening of the DAZ gene 216 
CHAPTER 4 
(4) DISCUSSION 225 
4.1 Cytogenetic and molecular cytogenetic studies 225 
4.2 Molecular studies 239 
4.2.2 Mutational analysis of the AR gene 239 
4.2.2 Mutational analysis of SRY gene in sex reversed patients 244 
4.2.3. XY female 245 
4.2.4 XX males 249 
4.2.5 Mutational analysis of male infertility 254 
4.3 Conclusions and recommendations 266 
REFERENCE 272 
APPENDIXI 
List of Figures 
Figure 1.1 Diagrammatic representation of the G-banded Y and X 
chromosomes -------------------------------------------------------------- 8 
Figure 1.2 The human X and Y chromosome constitutions and the Barr 
bodies formed by the X chromosomes --------------------------------- 12 
Figure 1.3 Structural chromosomal abnormalities -------------------------------- 16 
Figure 1.4 A close-up view of the region of exchange between the X and Y 
chromosomes -------------------------------------------------------------- 23 
Figure 1.5 A hypothetical scheme for sex determination in mammals --------- 27 
Figure 1.6 A model of a target cell response to androgens ----------------------- 32 
Figure 1.7 Schematic representation of mutation detection strategies ---------- 49 
Figure 1.8 Strategies of FISH technique -------------------------------------------- 53 
Figure 3.1 FISH analysis using biotin-labelled DXZI (a) and 
PDP97 (b) probes --------------------------------------------------------- 115 
Figure 3.2 Panel of probes used for FISH study of the X chromosome -------- 116 
Figure 3.3 Hybridisation of OTI, cAL24, and cPT4 probes for the 
DMD locus ---------------------------------------------------------------- 117 
Figure 3.4 Digoxigenin-labelled DMD locus cosmid contig probe ------------- 118 
Figure 3.5 Hybridisation of KAL probe to the Kallman locus at Xp22 -------- 119 
Figure 3.6 Panel of probes used for FISH study of the Y chromosome -------- 121 
Figure 3.7 Separation of MK5 and MK29 inserts from the plasmid DNA---- 122 
Figure 3.8 Partial metaphase spreads hybridised to different Y chromosome 
specific probes ----------- - ----------------------------------------------- 123 
Figure 3.9 Dual colour hybridisation digoxigenin-labelled DXZI 
and PDP97 ------------------------------------------------- - -------------- 126 
Figure 3.10 Examples of FISH analysis of ring X chromosomes using DXZ1- 134 
Figure 3.11 FISH analysis using three different X specific probes (DMD, 
XIST, and DXZ4 on metaphase chromosomes from a Turner 
patient (C. B) --------------------------------------------------------------- 136 
Figure 3.12 FISH study on metaphase chromosomes from patient F. R. with a 137 
medium size ring X chromosome -------------------------------------- 
Figure 3.13 In situ hybridisation of X chromosome-specific probes to 
chromosomes from a patient (K. R. ) with a medium size ring ------ 138 
Figure 3.14 FISH analysis of a Turner patient (C. F. )with a medium 
size ring (X) --------------------------------------------------------------- 139 
Figure 3.15 FISH study on metaphase chromosomes from patient J. H. with a 
small ring X chromosome ----------------------------------------------- 140 
Figure 3.16 In situ hybridisation signals of DXZ1 and XIST loci observed 
over the normal and the ring X chromosomes from the 
Turner patient (W. H. ) ---------------------------------------------------- 141 
Figure 3.17 In situ hybridisation of metaphase chromosomes from 
Patient D. C ---------------------------------------------------------------- 142 
Figure 3.18 FISH investigation on metaphase spreads from 144 
a 46, XXq+ patient -------------------------------------------------------- 
Figure 3.19 FISH study using different X specific probes on metaphase 
spreads from a patient with a 45, X/46, XXq - ------------------------ 146 
Figure 3.20 G-banded X chromosomes of a patient with 46, X, i(Xp) ------------ 148 
Figure 3.21 G-banded X chromosomes of a patient with 45, X/46, X,? i(Xp)---- 150 
Figure 3.22 FISH study using DXZl, whole X chromosome library 
(paint) and chromosome arm paint (CAP) of the long 152 
arm of the chromosome -------------------------------------------------- 
Figure 3.23 FISH investigation of 46, XXp - ---------------------------------------- 154 
Figure 3.24 In situ hybridisation study of a Turner patient with a 
45, X/46, X, +mar ----------------------------------------------------------- 158 
Figure 3.25 FISH study of a patient with 46, XXp+ karyotype ------------------- 162 
Figure 3.26 Application of the Cytocell Multi probe Kit -------------------------- 163 
Figure 3.27 FISH analysis on metaphase spreads of a patient with a 
46, X, t(Xp; Yq) --- - -------------------------------- w ............... m ....... 165 
Figure 3.28 FISH study of a patient with a 46, X, i(Yq) karyotype --------------- 167 
Figure 3.29 FISH investigation of a patient with a 46, X? i(Yp) --- - ------------- 169 
Figure 3.30 Partial metaphase spreads of cytogenetically 
Reinvestigated case 4 22 ------------------------------------------------- 170 
Figure 3.31 Banding patterns of the early and late-replicating X 
chromosomes in a 48, XXXX control case ---------------------------- 172 
Figure 3.32 X-inactivation study in a Tumer patient (W. H. ) ---------------------- 173 
Figure 3.33 X-inactivation study in two cases with small rings (D. C. & J. H. )- 175 
Figure 3.34 BrdU-Iabelled replication study in a Turner patient (F. R. ) --------- 176 
Figure 3.35 X-inactivation study of a Turner syndrome case (C. B. ) ------------- 177 
Figure 3.36 The replication pattern of X chromosomes in case (C. F. ) ---------- 179 
Figure 3.37 Cells from case K. R., showing early (a, b) and late (c, d) 
synthesis r(X) ----------------------------------------- ------------------- 180 
Figure 3.38 Replication pattern of the X chromosomes in a case with 
X/16 translocation ------------------------------------------------------- 182 
Figure 3.39 The AR gene with locations and sizes (base pairs) 
of the PCR product ------------------------------------------------------- 184 
Figure 3.40 PCR products from exons 2 to 8 of the AR gene --------------------- 187 
Figure 3.41 ExamPles of SSCP screening of exons 3,5 and 6 of the AR gene- 188 
Figure 3.42 ExamPles of heteroduplex analysis of exons 1,2 and 7 of 
the AR gene --------------------------------------------------------------- 189 
Figure 3.43 Direct sequencing of the asymmetric PCR products from exon 8 
ofthe AR gene ---------------------------------------------------------- -- 190 
Figure 3.44 AluI restriction enzyme digestion of PCR products from exon 8 
of the AR gene ------------------------------------------------------------- 191 
Figure 3.45 FISH study using hocSRY and CMCYlO probes -------------------- 194 
Figure 3.46 PCR amplification products (710 bp) from the open reading 
frame of the SRYgene ---------------------------------------------------- 195 
Figure 3.47 SSCP analysis of the two segments that cover the HMG domain 
of the SR Y gene ----------------------------------------------------------- 196 
Figure 3.48 Chemical cleavage of mismatch (CCM) analysis of the whole 
open reading frame of the SRY gene ----------------------------------- 197 
Figure 3.49 Schematic representation of the SR Y gene indicating the 
positions of the primers used for PCR amplification and DNA 
sequencing ----------------------------------------------------------------- 198 
Figure 3.50 Examples of direct sequencing of the asymmetric PCR from 
overlapping regions covering the SR Y gene --------------------------- 199 
Figure 3.51 FISH analysis of 46, XX male patients using hocSRY and 
GMGY 10 probes --------------------------------------------------------- 202 
Figure 3.52 PCR amplification of DNA from the studied 46, XX males using 
four different Y-specific primers --------------------------------------- 204 
Figure 3.53 Pattern of multiplex PCR analysis of 28 Y-DNA loci ------ - 211 
Figure 3.54 Four multiplex PCR analysis of Y-DNA specific loci of the 
Yq 11 in 46, XY sterile males -------------------------------------------- 212 
Figure 3.55 Examples of false deletions upon the multiplex PCR screening of tD, 46, XY infertile males ---------------------------------------------------- 213 
Figure 3.56 PCR analysis of patient's DNA using RBMI and RBM2 
gene-specific primers ---------------------------------------------------- 214 
Figure 3.57 FISH study of male infertility ------------------------------------------- 217 
Figure 3.58 Southern blot analysis using MK5 cDNA probe and two different 
restriction enzymes (EcoRI and TaqI) --------------------------------- 218 
Figure3.59a PCR products from exon 2 of the RBMgene family (A, B, C, and 
D) and from the RBMI gene exons, 3,4,5 and 7 --------------------- 219 
Figure 3.59b PCR products from the RBMI gene exons 6, and 8-12 -------------- 220 
Figure 3.60 Examples of SSCP analysis of theRBMI gene exons 2 
(A, B, C, and D copies) -------------------------------------------------- 221 
Figure 3.61 Example of the heteroduplex analysis of the RBMI gene exon 
12 on IX MDE gel ------------------------------------------------------- 222 
Figure 3.62 Multiplex PCR analysis of infertile men DNA using two primer 
sets within the DAZ gene (sY254 and sY255) ------------------------ 223 
Figure 3.63 Deletion map of the DAZ region on human Y chromosome ------- 224 
List of Tables 
Table 1.1 Karyotype variations in Turner syndrome -------------------------------- 19 
Table 1.2 Genetic disorders of male infertility --------------------------------------- 40 
Table 2.1 Summary of cases investigated and techniques applied ---------------- 77 
Table 2.2 DNA probes specific for X chromosome used in this study ----------- 83 
Table 2.3 Y chromosome DNA/cDNA specific probes investigated ------------- 84 
Table 2.4 Preparation of hybridisation mixture of probes specific for X 
and Y chromosomes in the uni-colour fluorescence in situ 
hybridisation experiments --------------------------------------------------- 92 
Table 2.5 Commercial probes used in this study ------------------------------------- 93 
Table 2.6 Hybridisation mixture applied in the dual and in the combinatorial 
FISH studies ------------------------------------------------------------------ 97 
Table 2.7 Filters applied to visualize fluorochromes -------------------------------- 99 
Table 2.8 Primer start solutions for the multiplex PCR experiments ------------- 103 
Table 3.1 Details of patients investigated with known or suspected 
chromosomal abnormalities ------------------------------------------------ 127 
Table 3.2 Clinical and cytogenetic findings in nine patients with a ring X 
chromosome cell line -------------------------------------------------------- 132 
Table 3.3 Breakpoint analysis of ring X chromosome by FISH ------------------- 135 
Table 3.4 PCR amplification using Y-specific primer sets in 46, XX males 
and normal controls ---------------------------------------------------------- 203 
Table 3.5 Clinical, laboratory and cytogenetic findings in 56 infertile males--- 208 
Table 4.1 Type of mutations detected in the present study and other studies. 226 
Table 4.2 Methods for mutation detection 269 
LIST OF ABBREVIATIONS 
AIRS artificial introduction of restriction site 
AIS androgen insensitivity syndrome 
AR androgen receptor 
ARMS amplification refractory mutation system 
ASO allele specific oligonucleotide, 
AZF azoospermia factor 
Biotin- II dUTP biotin deoxyuracil Y-triphosphate 
bp base pair 
Brdu bromodeoxy uridine 
BRI, Bethesda Research Laboratory 
CAP chromosme arm paint 
cDNA complementary DNA 
CFTR cystic fibrosis transmembrane regulatory gene 
CISS chromosomal in situ suppression 
cm centimetre 
CCM chemical cleavage of mismaches 
cpm count per minute 
DAPI 4,6-diamino-2-phenl-iodole 
dATP deoxyadenosine F-triphosphate 
DAZ deleted in azoospermia 
dCTP 2'deoxycytidine F-triphosphate 
ddH20 double distilled water 
ddNTP dideoxyribonucleoside triphosphate 
DGGE denaturing gradient gel electrophoresis 
dGTP deoxyguanosine Y-triphosphate 
dH20 distilled water 
DMD duchenne muscular dystrophy 
DNA deoxyribonucleic acid 
dNTP deoxyribonucleoside triphosphate 
DSS dosage sensitive syndrome 
DTT dithiothreitol 
dTTP deoxythtmidine 5'-triphosphate 
EDTA cthylenediamine-tetra-acitic acid 
EMC enzyme mismatch cleavage 
FISH fluorescent in situ hybridisation 
FITC fluorescein isothiocyanate 
FRAX ftagile X 
FSH follicle stimulating hormone 
9 gravitional (centrifugal) force 
G-banding Giemsa banding 
GBY gonadoblastorna gene on Y chromosome 
gm gram 
HA heteroduplex analysis 
HMG high mobility group 
ISCN International System for Chromosomal Nomenclature 
ISH in situ hybridisation 
IU international units 
KAL Kallman 
kb kilobase 
kd kilo dalton 
I/L litre 




MIS Mullerian inhibiting substance 
ml inillilitre 
mm millimolar 
MRC Medical Research Council 
mRNA messenger ribonucleic acid 
Mn nanometer 
NOR nucleolar organizer region 
0C degree centigrade 
OD optical density 
ORF open reading frame 
P short arm of any chromosome 
32P 
radioactive phosphorus 
PAGE polyacrylamide gel electropgoresis 
PAR pseudo autosomal. region 
PBS phosphate buffered saline 
PCR polymerase chain reaction 
PHA phytohaemagglutinin 
pmol pico mole 
q long arm of any chromosome 
Q-banding quinicrine banding 
RBM RNA-binding motif 
RFLP restriction fragment length polymorphisms 
RNA ribonucleic acid 
rpm revolutions Per minute 
RPS4 ribosomal protein S4 
RT-PCR reverse transcription polymerase chain reaction 
SDS sodium dodecyl sulphate 
SMA spinal muscular atrophy 
SRY sex determining region on the Y 
SSC saline sodium citrate 
SSCP single strand confon-nation polymorphism 
STS sequence tagged site 
TAE tris-acetate ethylenediamine tetra-acitic acid 
Taq Thermus aquaticus 
TBE tris-borate ethylenediamine tetra-acitic acid 
TDF testis determining factor 
TE tris-ethylencdiamine tetra-acitic acid 
TEMED N, NN, N-tetramethylethylenediamine 
TGGE temperature gradient gel electrophoresis 
TM melting temperature 
TS Turners syndrome 
U unit 
UV ultraviolet 
WCP whole chromosome paint 
WT Wilm's tumor 
XIST X-inactivation specific transcript 
YRRM Y chromosome RNA recognition motif 
R microgram 
JA I microlitre 
gm micromolar 
PAR pseudoautosomal region 
ZFY zing finger on Y chromosome 
TSPY testis specific protein on Y chromosome 
SUMMARY 
The aims of the present study were to optimize and apply methods that could 
detect major or minor DNA sequence alterations in patients with sex chromosome 
aberrations, with sex determination/differentiation abnormalities and in patients with 
idiopathic male infertility. These strategies involved the application of cytogentic, 
molecular cytogenetic (FISH) and molecular genetic investigations. For each of the 
groups studied a different mutation strategy (or strategies) was chosen. A total of 93 
cases have been included. 
Unicolour, dual colour and multicolour FISH analyses were successfully 
optimised using different probe concentration, competitor DNA concentrations, 
hybridisation temperature, and detection methods. The optimal final concentration of 
the DNA mixture (probe and competitor DNA)/2 cm2 hybrdisation was found to be 
between 1-300 ng of the probe and 5-12 gg of the competitor DNA. The optimal 
hybridisation temperature was between 37-42 OC for 14-16 hours incubation time. A 
total of 21 probes were used, 15 were specific for chromosome X and six wre 
specific of the Y-chromosome. All probes used in this study were optimised to 
provide strong and well-defined signals on metaphase and interphase spreads. 
Among patients with sex chromosome aberrations, the optimised biotin- 
and/or digoxgenin-labelled X- and Y-chromosome specific DNA probes were 
applied to characterise the abnormalities in the sex chromosomes. Three general 
types of probes were used for FISH-based cytogenetic analysis; whole chromosome 
probes, chromosome specific repeats, and probes targeted to specific loci. They were 
used separately or in combination. Late replication (X-inactivation) study using 
BrdU was optimised and applied for structurally abnormal X chromosomes 
particularly ring X and X-autosome translocation. 
For patients with sex determination/differentiation abnormalities and with 
male infertility, conventional cytogenetics methods were applied. Optimised FISH 
and different molecular techniques including multiplex PCR, SSCP, heteroduplex 
analysis, CCM analysis, Southern blot and DNA sequencing were applied for the 
detection and full characterisation of mutation(s) in the androgen receptor (AR), SRY 
and RBMI genes. 
i 
Out of the 93 patients, 24 patients had sex chromosome aberrations diagnosed 
by conventional cytogenetics. Most of them were ascertained because they had 
Turner syndrome/variant phenotypes. Reassessment of the chromosomal constitution 
of those patients using fluorescent in situ hybridization technique revealed that in 20 
patients (83.3%) the FISH results were consistent with the cytogenetic findings. 
However, FISH analysis has confirmed the presence of mosaicism and/or structural 
abnormalities, delineated the breakpoints, and identified the origin of the marker 
chromosome among them. In addition, FISH investigation has detected cryptic 
rearrangements in four patients (16.7%). One patient diagnosed i(Xp) was found by 
FISH analysis to be t(Xp; Xq). A second patient with 46, XXp+ was precisely 
diagnosed as t(Xp; 16q). A third patient with marker chromosome was delineated as 
t(X; Y) and the fourth patient diagnosed by cytogenetics as mar(? der Y) has proved 
by FISH to be i(Yq), in addition to the detection of a third cell line in the form of 
r(Y). Late replication study using BrdU in cases of ring (X) showed active normal X 
while the ring (X) was either early replicating or late replicating within the same 
case. No genotype-phenotype correlation could be made in these cases in relation to 
the ring size or its replication pattern. In case of t(Xp; 16q), the derivative X was 
confirmed to be late replicating in all cells examined. However, the translocated 
segment of 16q demonstrated a differential replication pattern, which could be 
correlated with the patient phenotype. 
In the remaining patients, 13 had sex determination / differentiation 
abnormalities and 56 had infertility problems. 
The molecular screening methods used in this study included chemical 
cleavage mismatch analysis (CCM), single strand conformational analysis (SSCP), 
Multiplex PCR, Southern blotting and DNA sequencing. The strategy of using DNA 
as template for PCR and use of SSCP, heteroduplex and DNA sequencing analysis as 
the main screening methods has proved to be a useful screening strategy for detection 
of mutations within AR, SRY, and RBMI gene. Molecular genetic analysis for 
diagnostic purposes employing SSCP has proven to be a very useful approach for a 
variety of diseases. 
Among the 5 cases of androgen insensitivity syndrome (46, XY female), a 
point mutation in the steroid binding domain (exon 8) of the AR gene was detected 
by PCR-SSCP analysis in one patient with the complete fon-n of the disease. The 
ii 
substitution resulted from a point mutation at nucleotide 4109 G-+T causing 
replacement of Val 889 by Leu. 
Molecular analysis of the SRY ORF, promoter and the poly-A tail regions in 
4 patients with either complete or partial 46, XY gonadal dysgenesis has revealed no 
mutations in this region suggesting that these patients have a non-nal SRY gene. 
However, the failure to detect mutations in these unrelated cases does not exclude the 
existence of mutations. 
In the present study, cytogenetic analysis, FISH and molecular amplification 
have been used to detect the presence or absence of Y sequences and to characterise 
the transfer of Yp fragments to Xp22.3 in 4 XX males. FISH techniques using 
GMGY10 and hoSRY probes specific for the Ypl1.2 region were applied on the 
metaphase spreads and revealed the presence of the Yp 11.2 sequences on the short 
arm of the X chromosome in three patients while it was absent in the fourth one. 
DNA analysis of these 4 patients using SRY, ZFY, PAR and Yl/Y2 sequence 
amplification confirmed the existence of the SRY, AZF, and PAR sequences in three 
patients and its absence in the fourth patient. 
Fifty-six cases with male infertility were first analysed by routine 
cytogenetics. Abnormal karyotypes were found in 5 cases (8.9%). Four cases (7.1%) 
had 47, XXY and one case had 47, XYY. Out of the 50 men with idiopathic infertility 
only one azoospermic male (2%) was found to have aY chromosome microdeletion 
by multiplex PCR analysis. Six PCR products were absent in 4 out of 5 multiplex 
reactions. These deletions involved sYI53 (subinterval Q, sY147 and Y6HP52pr 
(subinterval D), sY 157 and sY 149 (subinterval E), and Frl5-I I pr (not determined) 
and the breakpoints in Yq II was estimated to be in subinterval MX-MXII of the Ma 
map between interval 6C and 6F, according to the Vollrath deletion map. PCR study 
using DAZ specific primers showed that all infertile patient and controls retained the 
DAZ gene, yet it was deleted in the patient with microdeletions. The father of the 
patient also retained DAZ gene. Therefore, the patient in this study has a de novo 
microdeltion in YqI I region, which spanned the DAZ gene region. Moreover, FISH 
analysis and Southern blot hybridisation to DNA from 50 infertile men and 50 
controls using cDNA encoding RBMI and RBM2 respectively revealed the multiple 
copies of the gene without any deletions or structural rearrangements. Accordingly, 
the possibility of the deletion or rearrangement of the RBM gene family was ruled 
out as a cause of the infertility in these cases. Finally, the DNA of 50 idiopathic 
iii 
patients with normal karyotypes was amplified with intronic primers specific for 
exons 1-12 of the RBMI genes. Single strand conformation polyinorphism (SSCP) 
analysis was optimised to screen exons 1-11 and heteroduplex analysis (HA) was 
optimised to screen exon 12 of the gene in all cohorts of the studied patients. No 
small deletions or structural rearrangements were detected in all cohorts, including 
the patient who showed microdeletion in YqlI upon multiplex PCR experiments. 
The possible reasons for these findings are, (1) the responsible gene (RB" may be 
unimportant in the process of spermatogenesis. (2) Point mutations may not be 
present, or not detectable, or in regions of the gene not yet analysed in these patients. 
(3) RBM is a multicopy family of genes and hence mosaicism is not easily shown. 
Finally, in this study no do novo point mutations were found which might have 






The genetic information is carried by discrete entities called 
"chromosomes", a characteristic number of which exist for each species. In man 
there are 46 chromosomes: 22 pairs (number 1-22) of autosomes and one pair of 
sex chromosomes (XX in females, XY in males). The fundamental dogma of 
molecular biology is that deoxyribonucleic acid (DNA) codes for ribonucleic acid 
(RNA) which in turn produces proteins. Thus the genetic information in the DNA 
specifying a particular function is converted into an RNA copy which is then 
translated into protein. The action of the protein then produces the phenotype. 
Phenotypic variation, both normal and abnonnal differences, can be considered in 
terms of several aetiologies: (1) Cytogenetic disorders, which result from changes 
in the chromosome number (deviation from the normal number) or structure 
(deviation in chromosomal morphology). The fomer arises by chromosome 
malsegregation and the later arise by either centromeric misdivision or 
chromosome breakage. (2) Mendelian disorders, which result from a mutation at a 
single genetic locus, causing an abnormal allele. (3) Polygenic (multifactorial) 
disorders which could result from (a) the cumulative effect of several different 
genes, (b) multiples allele at a single locus, or (c) a combination of genetic and 
environmental factors and (4) teratogenic agents (Weatheral, 1991; Connor and 
Ferguson-Smith, 1991). 
Id Molecular Dathology of single gene disorder 
Any trait caused by a single gene mutation is said to be Mendelian, or to 
have single gene inheritance. Such traits can be divided into autosomal dominant, 
autosomal recessive, sex linked and mitochondrial (Thompson et al, 199 1). A gene 
can be disrupted in many ways. Coding regions may be altered, promoter and other 
regulatory sequences may be disturbed, or processing signals such as splice sites 
may be modified. Alterations may vary from deletions or rearrangements 
(insertion, inversion, and duplication) that can remove an entire gene to individual 
nucleotide changes (single base-pair substitution). These various types of 
mutations have been detected and characterised in many human genes, thus 
enabling the study of the underlying mutational mechanisms. 
Nucleotide changes may or may not cause altered amino acid synthesis. 
Point mutations have been classified into silent, missense, nonsense and sense. In 
silent mutation, base substitution causes no change in the amino acid therefore it 
has no consequence at the phenotypic level. The protein product of the mutant will 
function just as well as that of the wild type. In missense mutation, a codon 
change results in coding of different amino acid. The effect of this mutation on 
protein function depends on its location in the protein molecules. In nonsense 
mutation, a stop codon (UAA, UAG, or UGA) is created, causing premature 
termination of protein. In sense mutation, a termination codon is changed to one 
that codes to amino acids and results in the translation of protein beyond the 
normal ten-nination signal until another termination codon is reached producing 
longer than normal protein (Weatherall, 199 1). 
Nucleotide substitutions are the most common type of mutations in coding 
DNA sequence. Nucleotide changes that involve the substitutions of one purine for 
another (A<->G) or one pyrimidine for the other (T+->C), called transition, are more 
frequent than transversion (substitution of pyrimidine by purine or vice versa). The 
excess of transition can be explained with finding that major form of DNA 
modification in the human genome involves methylation of cytosine residues to 
form 5'-methylcytosine, predominantly in CpG dinucleotides (Cooper and 
Krawczak, 1993). Spontaneous dearnination of 5'-methylcytosine to thymine in 
CpG dinucleotides gives rise to C -> T or G -* A transition. Since 35% of single 
base pair mutation occurred within CpG dinucleotides with transition substitution 
occurring with a frequency of over 90% (Cooper and Krawczak, 1991), the CpG 
dinucleotides appears to be a hotspots for mutation and contributes significantly to 
the molecular pathology of many disorders. 
One important aspect of RNA processing is the precise splicing out of 
introns to produce a mature mRNA ready for translation. Nearly all eukaryotic 
genes have a dinucleotide GT at the 5' starting point of the intron (the donor site) 
and a dinucleotide, AG at the 3' (the acceptor site). There are a wide variety of 
mutations in introns that affect normal RNA splicing (Krawczak et al, 1992). 
Naturally occurring mutations that affect mRNA splicing can be assumed to fall 
into three main categories: (1) mutations within a 5' or 3' splice site. Such lesions 
2 
usually reduce the amount of mature mRNA generated and/or activate so-called 
cryptic (i. e. alternative) splice sites resulting in the production of mRNA which 
either lacks a portion of the coding sequence (exon skipping) or which instead 
contain additional sequences of intronic origin (cryptic splice site situation). 
According to the definition model proposed by Robberson et al (1990), exons are 
recognised and defined as distinct units by the initial binding of protein factors to 
the 3' end of the intron followed by a search for a down stream 5' splice site. Thus 
an alternative consequence of splice site mutation could be for an exon to be no 
longer recognised as such, and as a result to be excluded from the mature mRNA 
transcript- a process termed exon skipping. (2) Mutations within an intron. This 
kind of mutation in the introns includes those that cause the activation of cryptic 
splice sites, by making a sequence to be more similar to an authentic consensus 
site or by creating new splice sites leading to the production of aberrant mRNA 
species. (3) Mutations within a branch-point sequence (Krawczak et al, 1992). 
Alterations of gene structure by deletion, insertion or duplications have 
been described in various inherited disorders and the frequency of such mutations 
differs greatly among different genetic diseases. Deletions may be the underlying 
cause of single gene Mendelian disorders. Deletions of multiple exons may 
remove a portion of the gene products, if newly juxtaposed exons are not in frame, 
a truncated product may result (Monaco AP, 1989). Gross gene deletions may 
arise either by homologous unequal recombination mediated by related gene 
sequences or repetitive sequences, or by non-homologous sequences involving 
DNA with minimal sequence homology (Krawczak and Cooper, 1991). Smaller 
deletions may remove specific amino acids from a protein if the deletion involves 
multiples of three bases. Other deletions result in frame shift that usually truncates 
the protein product. Direct repeats palindromes and symmetric elements could be 
potential mechanisms involved in gene deletions, 
Duplications involving part or all of a gene can cause genetic disorders 
because the inserted material disrupts the reading frame of a gene, leading to 
premature termination of translation. Gene duplications may also occur due to 
homologous or non-homologous recombination. For instance, homologous 
recombination may arise between repetitive sequences such as Alu elements 
however, non-homologous recombination may cause in duplication by random 
chromatid breakage and rejoining events. 
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Insertion of < 10 base pairs (bp) sequences into human genome coding 
region were also investigated by Cooper and Krawczak (1991). They stated that 
this event is not random and appears to be highly dependent on the local DNA 
sequence context. The majority of insertion can be explained either by (1) 
mispairing, or by (2) inverted repeats or by (3) symmetric elements (e. g. 
CTGAAGTC, GGACAGG) during DNA replication. 
1.2 Sex determination and sex di fferentiatiOll 
The existence of males and females is due to two processes: sex 
determination and sex differentiation. Sex determination is the process of choosing 
the male or female differentiation pathway (Goodfellow and Lovell-Badge, 1993). 
Sex determination and differentiation are sequential and complex processes 
starting with the establishment of genetic sex at conception, followed by gonadal 
determination in early ernbryogenesis and ends in puberty with complete sexual 
maturation and the ability to reproduce (Moore and Grumbach, 1992). The critical 
factor in this process is the differentiation of the bipotential genital ridge into 
either a testis or an ovary. Sex differentiation is governed by a pathway involving 
X-linked and autosomal genes and the pathway is initiated by a dominant inducer 
Y specific master gene called TDF (Testis-detennining factor), Male sex 
determination is dependent on the presence of a Y-chromosome and TDF (Page 
et at, 1987). Male gonadal sex or testis formation is subsequently thought to be 
determined by this gene and by other secondary pathways. The male gonad in turn 
normally produces hormones that regulate differentiation of the internal and 
external genital structures, thus determining phenotypic sex. In the absence of the 
Y chromosome (and TDF), the foetal gonads follow the ovarian pathway, with 
ensuing female development (Ford et at, 1959). When an abnormality develops in 
any of the above three processes complete or incomplete sex reversal individual 
results due to the discrepancy in genetic, gonadal and phenotypic sex (Gustafson 
et at, 1994). 
LZI Normal sex differentiation 
The early embryo has no sexual characteristics except for the chromosomal 
complement of its cells. In human embryos, the gonadal development begins 
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during the 4th and 5th weeks of gestation. The complete differentiation of normal 
gonads depends upon the arrival of sufficient numbers of viable primordial germ 
cells to the genital ridges of the dorsal mesentery. The germ cells arise 
extragonadally and therefore must migrate into the site of gonadal differentiation. 
Seeding of the ridges by primordial germ cells is an independent event not 
requiring Y chromosome and TDF (Moore and Grumbach, 1992). If they fail to 
arrive, gonads do not develop (gonadal agenesis) and only a fibrous streak will 
exist. At 6 weeks of foetal life, the indifferent gonad is bipotential, capable of 
forming either testis or ovary. 
Before gonadal differentiation, Wolffian ducts have already developed (by 
4 weeks). Mullerian ducts appear at about 7 weeks. In an XY embryo (normal 
male) the testis-determining switch commits the primitive gonads to testicular 
development, resulting first in Sertoli and later in Leydig cell differentiation. 
Sertoli cells envelope the primordial germ cells and form primitive cords 
(precursors of the seminiferous tubules), and inhibit germ cell meiosis, Their 
differentiation is predominantly cell autonomous and requires a Y-chromosome 
(Moore and Grumbach, 1992). The developing testis secretes two hormones that 
are important for the subsequent male differentiation. Mullerian-inhibiting 
substance (MIS) produced by Sertoli cells prevents formation of the uterus, 
fallopian tubes and upper part of the vagina (Mullerian structures) (Josso and 
Piccard, 1986). Leydig cell testosterone secretion is responsible for persistence of 
the Wolffian ducts and their differentiation into epididymis, vas deferens, seminal 
vesicles and ejaculatory ducts, and promotes the masculanisation of the external 
genitalia. The latter step requires conversion of testosterone to dihydrotestosterone 
(DHT) (Siiteri and Wilson, 1974) and the subsequent interaction of D11T with 
intracellular receptors (androgen receptors) (Migeon et al, 1981). DHT is 
responsible for fusion of labia, growth of the phallus and formation of scrotum. 
Wolffian development and masculanisation of the external genitalia begin at about 
10 weeks and are completed by 16-17 weeks (Marcantonio et a], 1994). 
In the XX (normal female) individual, without the active influence of aY 
chromosome, the bipotential gonad is committed to ovarian development. The 
gonad is silent until about 12 weeks when oocytes begin to differentiate and 
primordial follicles are present by 20 weeks. In the absence of Leydig cell 
testosterone, the Wolffian ducts virtually disappear completely, The Mullerian 
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system, in the absence of Sertoli cell MIS secretion, differentiates into upper 
vagina, uterus and falloPian tubes. 
LZ2 Role of chromosomes in sex determination 
It has been known for decades that sex determination in mammals is 
accomplished by a chromosomal mechanism. Females have two X chromosomes, 
and males have a single X and a small mainly heterochromatic Y chromosome. 
Analysis of individuals with unusual sex chromosome combination has shown that 
the presence of the Y chromosome is critical for male sex determination and 
absence of the Y chromosome results in female development. Ford et al (1959) 
showed that individuals with Turner syndrome had a single X chromosome and 
were females while patients with Klinefilter syndrome were shown to have two X 
chromosomes and a Y, and were males (Jacobs and Strung, 1959). These results 
implied that the Y chromosome carries a gene required for testis development. The 
concept that genes located on the Y chromosome play an essential role in human 
sex determination is stressed by the existence of various sex chromosomal 
aberrations. These conditions include the 46, XX male syndrome, true 
hermaphrodites, 46, XY gonadal dysgenesis, and various Y chromosomal 
aberrations that result in female development. From the analysis of Y chromosome 
rearrangements and their associated phenotypes, the testis determination factor 
(TDF) has been assigned to the short arm of the Y chromosome (Davis RM, 1981), 
and more precisely mapped to the most distal specific segment adjacent to the 
pseudoautosomal boundary (Affara et al, 1986; 1987, Vergnaud et al, 1986). 
There are two features that make sex chromosomes unique in mammalian 
genome. Most obviously, they determine sex. Also, they are morphologically and 
genetically different from each other, a difference that has accompanied the 
appearance of a sex determining role on the Y chromosome and a mechanism of 
dosage compensation for X-linked genes in females, mediated by random X 
inactivation (Graves JAM, 1995). 
The Y chromosome is composed of two parts with different proportion: 
the pseudo autosomal region (PAR), shared with the X chromosome, and the Y- 
specific region. At male meiosis the Y chromosome pairs with the X chromosome 
and the pairing occurs within the PAR region shared between the short arms of the 
6 
X and Y chromosomes (Burgoyne PS, 1986; Chandley et al, 1984). An obligate 
recombination event within the PAR is necessary to ensure correct meiotic 
segregation (Burgoyne PS, 1982). The Y-specific regions include the sex 
determining factor JDF) region containing the SR Y gene, located proximal to the 
PAR, the putative transcription factor ZFY (Zinc finger on Y), the gene for H-Y 
antigen (serological histocompatibility Y), genes necessary for spermatogenesis 
(Buhler EM, 1980; Goodfellow et al, 1985), anti-Turner gene (RPS4; ribosomal 
protein S4) (Fisher et al, 1990) and genes implicated in the development of 
gonadoblastorna (GBY) (Page D, 1987; Verp and Simpson, 1987; Barbosa et al., 
1995). On the distal portion of the long arm of the Y chromosome is the 
heterochromatic region, which is apparently not transcribed and varies in length 
(Fig 1.1). 
The X chromosome is currently the best characterised among all human 
chromosomes (McKusick VA, 1994). With the exception of genes located in the 
PAR (Ellis and Goodfellow, 1989), and a few other genes which have active 
copies on both the X and Y chromosomes, most genes on the X chromosome 
display a haploid status in males (Ballabio and Andria, 1992). The X chromosome 
is significantly larger than the Y chromosome but organised in a similar fashion, 
having a pseudo autosomal region matching that of the Y and an X-specific region 
(Fig 1.1). The X-specific region contains many genes including some genes crucial 
for male and female sexual differentiation and other genes that are essential for life 
(45, Y is lethal) (Moore and Grumbach, 1992). 
Because XX females have twice as many X-linked genes as XY males, a 
dosage compensation mechanism is achieved by X chromosome inactivation in 
order to avoid the aneuploidy effect that would stem from the presence of more 
than one X chromosome (Lyon M, 1961; Riggs and Pfeifer, 1992). The 
inactivation of one X chromosome is thought to be an essential part of female sex 
differentiation. X inactivation is associated with a switch in the timing of 
chromosomal replication, the inactive X chromosome being the last to initiate 
DNA synthesis (Lyon M, 1992). This late replicating chromosome is relatively 
condensed during the interphase and is visible cytologically as a Barr or sex 
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Figure 1.1: Diagrammatic representation of the G-banded Y and X chromosomes. 
Functional regions and loci involved in sex determination and differentiation are 
shown. (A) The Y chromosome: SRY= sex determining region; RPS4Y= ribosomal 
protein S4; ZFY= zinc finger protein. (B) The X chromosome: RPS4X= ribosomal 
protein S4; XIST= X-inactive specific transcript; XIC, = X-inactivation center. 
The X inactivation begins early in female embryological development and it 
occurs randomly with respect to parental origin of the chromosome. Once silenced 
the inactive X chromosome usually remains silent in all progeny cells (clonal 
inheritance). Although inactivation seems to affect the X chromosome as a whole 
(inactivating many loci), some loci on the inactivated human X chromosome are 
actually transcribed. These transcribed genes include not only those in the pseudo 
autosomal region (Xp22.3), but also some of the proximal short arm and the 
proximal long arm of the X chromosome such as zinc finger X (ZFX at Xp22.1) 
and ribosomal protein S4 (RPS4X at Xql3) (Fisher et al, 1990; Schnider et al, 
1989; Disteche et al, 1995). Furthermore, in female germ cells (oogonia) only one 
X chromosome is active but the inactive X is reactivated at about the time of entry 
into meiosis (Migeon and Jelalian, 1977; Monk and McLaren, 1981). Therefore 
both X chromosomes are thought to be active during oogenesis itself On the other 
hand, in spermatogenesis the single X chromosome is inactive (Monk and 
McLaren, 1981). 
The precise nature of the X inactivation, its control mechanism and 
sequence of imposition is still unclear. However, genetic evidence strongly 
suggests the existence of a specific locus required in Cis for X inactivation located 
within a segment of the X chromosome referred as the X-inactivation centre (XIC) 
(Borsani et at, 1991). This XIC region has been localised to the long arm of the X 
chromosome at Xq13 (Therman et at, 1990; Brown et at, 1991). Recently, a gene 
has been isolated and mapped to Xql3 and proposed to be a candidate for the 
inactivation centre. It is referred to as XIST (X-inactivation specific transcript) in 
human (Brown et at 199 1) and Xist in mouse (Borsani et at, 199 1; Brockdorff et at, 
1992) and is expressed from the inactive but not the active X chromosome. The 
complete cDNA sequences of the human (Brown et at, 1992) and mouse XIST 
(Brockdorff et at, 1992) have been determined and no substantial open reading 
frame has been found, and the RNA is confined to the nucleus, It has been 
suggested that the gene product is a structural RNA, which may act directly on 
chromosomal DNA by altering the conformation of the chromatin in the region 
(Brockdorff et at, 1992; Brown et at, 1992). Moreover, in human females whose 
karyotypes include tiny ring X chromosomes were found to be unable to inactivate 
the tiny rings which were thus thought to be responsible for their multiple 
phenotypic abnormalities and severe mental retardation (Migeon et at 1993). 
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The specific function of XIST in the inactivation process is unclear 
(Ferguson-Smith MA, 1991). XIST probably plays a role in the initiation of X 
inactivation, although it is not required for maintenance of the inactivation state. 
Maintenance of X inactivation through subsequent cell division is thought to result 
at least in part from epigenetic changes in the genes, including methylation of CpG 
islands of some X-linked genes (Cattanach BM, 1975; Riggs AD, 1990), absence 
of acetylated histone H4 (Rastan S, 1994), chromatin condensation and allocyclic 
replication (Lyon 1992; Migeon BR, 1994; Disteche CM, 1995). 
1.3 Sex chromosome abnormalities and chromosomal intersex 
Sex chromosome abnormalities can mean many things but commonly it 
refers to all abnormalities of sex chromosome number and structure, and usually, 
as well, to discrepancies between karyotype and phenotypic sex. Chromosomal 
errors may be divided into: (A) Numerical changes. (B) Structural changes. 
(A) Numerical chromosomal aberrations: 
If a haploid gamete or a diploid cell lacks the expected number of 
chromosomes (n or 2n respectively), aneuploidy exists. When the complement 
contains one addition of a whole chromosome (2n+l), trisomy exists. The term can 
be applied to sex chromosomal abnormalities (e. g. 47, XXX) but if an excess 
number of sex chromosomes are present it is customary to use the term polysomy. 
If one entire chromosome is missing (2n-1) monosomy exists (i. e. 45, X). 
Polyploidy happens when more than two haploid complements are present within a 
single cell. Triploidy (3n = 69 chromosomes) and tetraploidy (4n--92 
chromosomes) are the most common types of polyploidy. Both conditions are seen 
in spontaneous abortions and stillbirths and are essentially incompatible with life 
(Emery and Muller, 1992). 
Aneuploidy results from non-disjunction in either the meiotic divisions of 
the parents (during gametogenesis) or in the early cleavage division of the affected 
individual (during embryogenesis). Aneuploidy for more than one chromosome is 
the result of non-disjunction in both meiotic divisions, non-disjunction in the 
meiosis of both parents (which must be a rare coincidence), multiple non- 
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disjunction in the same mitosis or meiosis, or abnormalities in more than one 
mitosis (Therman and Susman, 1993). 
The sex chromosomes show a much wider range of viable aneuploidy than 
do the autosomes. Figurel. 2 summarises the non-mosaic numerical sex 
chromosome abnormalities found so far, their incidence in new bom of the same 
sex, and the number of Barr bodies (all but one X chromosome in a cell is 
inactivated, forming X chromatin bodies, in the interphase) (Therman and Susman, 
1993). 
The incidence of 45, X (Turner syndrome) individuals seems to be 
independent of maternal age. Experimental evidence has shown that 70 to 80% of 
patients with 45, X retain the maternal X chromosome (Lorda-Sanchez et al, 1992; 
Mathur et al, 1991). On the other hand, the incidence of 47, XXX and 47, XXY 
individuals increases with maternal age. In these cases, non-disjunction apparently 
occurs mainly in maternal meiosis. Individuals with three X chromosomes 
(47, XXX) do not seem to form a well-defined syndrome. They are often mentally 
retarded and are fertile (Polani PE, 1977). Females with more than three X 
chromosomes (e. g. 48, XXXX) suffer from severe mental retardation and several 
somatic anomalies, yet their sex development is usually normal (Nielsen et al, 
1977). In the group of sex chromosome abnormalities with a male phenotype, the 
47, XXY and 47, XYY conditions occur approximately equal at birth. Individuals 
with 47, XXY karyotype form a well-defined syndrome (Klinefelter syndrome). 
Klinefelter syndrome is a condition in which affected men are sterile, have very 
small testes, sometimes have gynecomastia and may be mentally retarded (Connor 
and Ferguson-Smith, 1991). Men with a 47, XYY sex chromosome constitution 
have been reported to be higher among penal institutions for the mentally 
abnormal (2/1000) and in mentally deficient adult males (3/1000) (Connor and 
Ferguson-Smith, 1991). Males with one Y chromosome and more than five X 
chromosomes are mentally retarded and display various other symptoms. 
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Figure 1.2: The human X and Y chromosome constitutions and the Barr bodies 
formed by the X chromosomes (Genotypes below the broken line show mental 
retardation and/or mentally illness: from Therman & Susman, 1993). 
(B) Structural chromosomal aberrations: 
Some structural variation exists in human somatic chromosomes without 
apparent phenotypic consequences. However, clearly abnormal variations are 
usually associated with phenotypic abnormalities. Aberrations may lead to genetic 
imbalance through deficiency or duplication of genetic information. In deficiency 
or duplications only portions of a given chromosome, not the entire chromosome, 
are involved. However, if the variation is large enough to be recognised by light 
microscopy, one can assume that many genes are duplicated or deleted. Phenotypic 
abnormalities might also result if the position of a gene with respect to its 
neighbouring gene(s) is altered (position effect). Structural chromosome 
aberrations result from chromosomal breakage. If only one chromosome is 
involved, the result may be a deletion (loss of genetic material) duplication (gain 
of genetic material) or inversion (rearrangement of genetic material) (Figl. 3). 
When both ends of a chromosome are deleted followed by joining of the sticky 
ends, a ring chromosome is formed (Figl. 3). If the centromere divides 
horizontally, rather than longitudinally, separating the two chromosome arms 
instead of sister chromatids in normal division, an isochromosome exists 
(Darlington DC, 1939). An isochromosome can be composed of identical long 
arms (i. e. 46, X, i(Yq) ), or short arms (i. e. 46, Xi(Yp)). If breakage involves more 
than one chromosome a translocation usually result (Figl. 3). In reciprocal 
translocations material distal to the breakage points is exchanged between 
homologous or non homologous chromosomes. In balanced translocation usually 
there is no net loss of genetic material and the individual may be perfectly normal 
(Brock DJH, 1993). 
Mosaicism and chimerism 
A mosaic individual has two or more genotypes (cell lines) that originate 
from a single zygote. Sex chromosome mosaicism is an important cause of 
abnormal sexual differentiation. Chromosomal mosaicism usually arises following 
mitotic non-disj unction, with the survival of at least two cell lines that contain 
different complement. 
An individual with sex chromosomal mosaicism might, but not invariably, 
differ phenotypically from non-mosaic individuals (Hassold et al, 1980). The 
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differences presumably reflect the distribution of various cell lines in different 
tissues. A great variety of mosaics have been described in man. For example, 
patients with Klinefelter's syndrome have been found with the following sex 
chromosomes constitutions: XX/XXXY, XY/XXY, XYIXXXY, XXXY/XXXXY, 
and XY/XXY/XXXY. The same variety has been reported in cases with Turner 
syndrome (X/XX, XfXXX, X/XX/XXX, X/XYY, X/XY). 
A chimeric individual has two or more genotypes each arising from a 
different zygote, which subsequently fuse. Dispermic chimeras are the result of 
fertilisation of two genetically different egg nuclei by two sperms and the resulting 
two diploid nuclei both contribute to the formation of the individual 
(46, XX/46, XY, true hermaphrodite). Blood chimeras on the other hand result from 
an exchange of cells between non-identical twins through the placenta while they 
are in the uterus (Emery and Muller, 1992). 
Numerical abnormalities of human sex chromosomes are common. They 
occur in approximately 2-3% of conceptions (Hassold et al, 1980), and are found 
in 1: 400 male and 1: 700 female live births (Hamerton et al, 1975). Correlation of 
the abnormalities with the phenotype led to the conclusion that the Y chromosome 
contains the male determinant (Jacobs and Strung, 1959). Furthermore mosaicism 
of X and XY leads to dysgenesis or mental subnormality often with 
hypogonadism. These patients with gonadal dysgenesis and X/XY mosaicism have 
a 20% risk of developing gonadoblastoma (Verp and Simpson, 1987). 
Short arm deletions of the X chromosome (Xp-) and long arm X 
isochromosome [i(Xq)] both involve loss of short arm material and both result in 
short stature, Turner stigmata, and gonadal dysgenesis (Ross et al, 1985; Therman 
and Susman, 1990). Patients with deletion of the long arm (Xq-), the critical region 
(Xql3-Xq26) or with short arm X isochromosomes [i(Xp)] both have loss of X 
chromosome long arm material and tend to have gonadal dysgenesis with normal 
stature and no somatic abnormalities associated with Turner syndrome (Therman 
and Susman, 1990; Ogata and Matuso, 1995). Other structural abnormalities such 
as fragments and ring X chromosome have been described (Cole et al 1980). These 
abnormalities are frequently associated with mosaicism including cells with X 
chromosome monosomy, and this makes correlation of the X chromosome 
constitution and phenotypic expression difficult. 
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X- autosome translocation has been associated with a wide range of 
phenotypic expression, including gonadal dysgcnesis (Sarto et al 1973). The 
correlation of phenotypic expression and clinical manifestation, with such X- 
autosome translocation depends on the segment of X chromosome lost and on the 
arm of X chromosome involved (Ballabio, and Andria, 1992; Therman et al, 1990). 
Since 22 pairs of normal autosomes and at least one normal X chromosome 
are essential for survival of the zygote, there are no phenotypic males with X 
chromosome monosomy or deletion of the short arm or long arm of an X 
chromosome. 
Structural abnormalities of the Y chromosome are rare but instructive with 
regard to functional segments, since Turner syndrome, intersex status, and 
maleness with infertility result from structural aberrations of the Y chromosome 
(Buhler EM, 1980; Davis RM, 1981). Short arm deletion involving the testis 
determining factor of the Y chromosome and Y long arm isochromosome [i(Yq)] 
both involve loss of the testis determining factor (Yp 11.2) resulting in sex reversal 
(Davis, 1981). XY translocations involving the TDF are found in sex reversal 
individuals (XX mates) or more rarely XY females (Petit et al 1987; 1990). 
Y: autosome translocation leading to loss of Yp also results in female phenotype. 
In the absence of a second X chromosome ambiguity of internal organs, streak 
gonads, or gonadoblastorna are often found (Munke et al, 1988). Structural Y 
chromosome abnormalities resulting in deletion of the fluorescent heterochromatin 
such as ring Y (Chandley, and Edmund, 1971), short arm dicenteric Y (Chandely 
et al 1986) and other cases of Yq deletion itself are documented in infertile men 
(Hartung et al, 1988; Chandley et al, 1989). With regard to structural abnormalities 
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Figure 1.3: Structural chromosome abnormalities. A, Formation of terminal and 
interstitial deletions. D, Formation of paracentric and pericentric inversions. Break 
points originate from same side and on opposite sides of centromere, respectively. C, 
Formation of ring chromosome, D, Formation of isocbromosome, E, Formation of 
reciprocal translocation. 
1.3.1 Turner Syndrome and variants 
Turner syndrome is a complex human disorder which is usually associated 
with a 45, X karyotype. It is the only monosomy compatible with life. It is a 
genetic disorder characterised by short stature, gonadal dysgenesis and various 
somatic stigmata (Zinn et al 1993). Overall the incidence of all abnormalities that 
include partial or complete monosomy X is about I in 2000-2500 live female birth 
(Nielsen and Wohlert, 1991). However, it is estimated that up to 99% of Turner 
conceptuses are spontaneously aborted, and conversely that 5-10% of 
spontaneously aborted foetuses have 45, X karyotype (Hassold TJ, 1986). In 
contrast, the mortality rate during pregnancy for foetuses with Turner mosaic 
karyotype is at least 13-fold lower than for non-mosaic 45, X and this has led to the 
hypothesis that most if not all livebom patients with 45, X are mosaic with a 
non-nal cell line present (Hassold et al 1988; Hook and Warburton 1983). About 
50-59% of patients with Turner syndrome have a 45, X complement. Structural 
abnormalities of the second X [usually 45, X/46, X i(Xq)] are seen in 25% of cases. 
45, X/46, XX mosaicism in 9.5%, 45, X/47, XXX in 3.5%, 45, X/46, XY in 5.5%, 
45, X/46, X + mar in 3%, and more complex karyotype in the rest (Table 1.1) 
(Magenis et al, 1980; Rooney and Czepulkowski, 1994). 
The somatic abnormalities can be classified into the following groups: (1) 
Anomalies attributable to lymphatic obstruction such as webbed neck, low 
posterior hair line, rotated auricle, puffy hands and feet, redundant skin, nail 
dysplasia, and whorl dominant finger pattern type (Zinn et al, 1944). (2) Skeletal 
anomalies, such as short neck, micrognathia, high arched palate, cubitus; valgus, 
geno valgus, short metacarpals and metatarsals, and scoliosis. (3) Cardio-vascular 
and renal abnormalities such as coarctation of the aorta and horseshoe kidney. (4) 
Miscellaneous anomalies, such as multiple pigmented nevi (Ogata and Matsuo, 
1995). The absence of secondary sexual characteristics is known to be caused by 
pre-pubertal ovarian failure and the consequent lack of ovarian sex steroid 
production. The ovaries initially develop normally, but at about six months of 
gestation massive oocyte loss occurs. Normal females also undergo oocyte loss in- 
utero, but to a lesser extent. Only small streaks of fibrous tissue remain in Turner 
Patients. Burgoyne and Baker (1984) proposed that incomplete chromosomal 
pairing in meiosis; might cause germ cell death. 
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Table 1.1: Karyotype variations III 'FLIHICI' SVII(II-0111C. 
Karyotype Incidence in 110 cases of TS with Percent 
chromosome abnormality* 
45, X 64 58.2 
45, X/46, XX or 47, XXX 
46, X, i(Xq) 
including mosaics 
45, X/46, X, r(X) 
45, X/46, XY or 47, XYY 
46, X, Xp- 










*From: Rooney and Czepulkowski, 1994. 
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The typical Turner phenotype is most frequently manifested by patients 
with 45, X karyotype. The full or partial Turner phenotype also exists in apparently 
non mosaic patients with various sex chromosome rearrangements (Ferguson- 
Smith, 1991; Grumbach and Conte, 1992). Short stature is a universal feature in 
45, X and 46, X, i(Xq) or mosaics; in contrast, normal stature occurred in 20% of 
45, X/46, XX; 50% of 45, X/47, XXX, and 63% of long arm deletion (Neely and 
Rosenfeld, 1994). 
Gonadal dysfunction varied in severity among different karyotypes 
45, X/46, X, i(Xq) , 46, X, idic(Xq), and 46, X, idic(Xp) were associated with severe 
gonadal dysfunction. In terminal X deletions, the degree of gonadal dysfunction 
was roughly correlated with the deleted size. Gonadal dysfunction appears to be 
mild in interstitial deletions of the X chromosome (Ogata and Matsuo 1995). 
Spontaneous pubertal development and menarche, which occurred in 8% of 
patients with X monosomy, were more likely in girls with 45, X/46, XX mosaicism, 
(21%) and deletions of the short arm (25%) (Neely and Rosenfeld, 1994). There is 
considerable diversity, however, in reports regarding the incidence of other 
anomalies. 
1.3.2 Hermaphrodites or intersexes 
Intersexuality can be defined as the "possession at birth of both male and 
female characteristics in the gonads and/or in the internal or external genitalia" 
(Jacobs PA, 1969). In the majority of forms of intersex, there is only one type of 
gonad present: a testis (male pseudohermaphroditism) or an ovary (female 
pseudohermaphroditism). An example of the former would be testicular 
ferninisation syndrome and for the latter, congenital adrenal hyperplasia. 
Patients identified as true hermaphrodites have both testicular and ovarian 
tissues, although the distribution of these two gonadal tissues between the left and 
right sides is variable. There may be any combination of the following; ovary, 
testis, and ovotestis. One might expect that true hermaphrodites would be due to 
mosaicism (XX/XY), some of cells having an XX sex chromosome complement 
and others having an XY sex constitution. In fact some hermaphrodites are 
XX/XY mosaicism (Josso et al, 1965; Jacobs PA, 1972), but for some reason 
which is still not clear the sex chromosome constitution of many of these patients 
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appears to be 46, XX (60%). 46, XY constitution has been found in 15% of these 
patients (Hunter RF, 1995). Of course hermaphroditism in the presence of an XX 
karyotype contradicts the requirement for aY chromosome (or TDF) to enable 
differentiation of testicular tissue. Possible explanations for the presence of 
testicular tissue in 46, YX hermaphrodites include: (1) undetected loss of aY 
chromosome after initiation of testicular development, or undetected chromosomal 
mosaicism such as X/XY or XX/XXY or XX/XY chimaerism. (2) The 
translocation of TDF from the Y to an X chromosome or to an autosome. (3) A 
single gene mutation (Eicher and Washburn, 1983). 
Since the availability of suitable cytogenetic techniques in the late 1950s a 
large variety of sex chromosomal abnormalities have been documented in man. 
Many but not all of these, have been shown to be associated with different degrees 
of abnormalities of primary and secondary sex character. The most frequently 
reported chromosome abnormality associated with intersexual. development is 
mosaicism, where one cell line has 45, X constitution and the other has 46, XY or 
45, X/47, XXY sex chromosome constitution (Jacobs PA, 1969). The phenotype of 
such individuals will depend on the time after fertilisation when the error giving 
rise to the two cell lines happened, and the frequency and distribution of the two 
types of cells in the embryonic gonad. In fact, almost every degree of intersexual 
development has been found to be associated with an X/XY constitution (Hunter 
RF, 1995). Another type of mosaicism expressed as intersex condition is when one 
cell line is that of a normal female while the other has aY chromosome (XX/XXY 
or XX/XY/XXY) (De La Chapell A, 1972). An intersex phenotype may also arise 
from an XX/XY chromosome complement (Jacobs PA, 1969; 1972). 
1.4 The mammalian sex-determining master -regulator ene 
SRY (sex 
determining region on tile y chromosome) 
1.4.1 XX and XY sex reversal 
One of the more elegant lines of evidence for testis determination being 
effected through the Y chromosome comes from analysis of sex reversal 
individuals, viz. 46, XX males, XX true hermaphrodites, and XY females. About I 
in 20,000 newborn males have a 46, XX karyotype and yet develop testes 
(McElreavey et al, 1993b). These individuals are sterile with small testes and 
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azoospermia. Two phenotypically distinct groups have been recognised among 
subjects with 46, XX sex reversal. 46, XX maleness is characterised by the presence 
of testes in a subject with a female karyotype. Most affected individuals have 
normal male external genitalia, but about 10% have hypospadias (De La Chapell, 
1972). 
46, XX true hermaphrodites are characteriscd by the development of 
ovarian and testicular tissue in the same individual, either in separate gonads or in 
one gonad (Ovotestis) [Van Niekerk and Retief, 1981; Torres et at, 1996). These 
patients usually present with ambiguous external genitalia whereas the 
development of Wolflian and Mullerian duct derivative depend on the type of 
gonad and extent of testicular development in each case (Berkovetz et at, 1992; 
Perez-Placios et at 1994). In 1966, Ferguson-Smith proposed that 46, XX maleness 
and 46, XX true hermaphrodites are generated by rare and illegitimate X: Y 
chromosomal interchange during paternal meiosis when the X and Y 
chromosomes pair, enabling Y-specific sequences to be transferred to the short 
arm of the paternal X (Figl. 4). The Y-specific transferred sequences were 
considered to include the testis determining factor (TDF) giving rise to either 
complete (XX male) or partial (XX true hermaphrodite) masculanization. Two 
lines of evidence confirmed this hypothesis. First, cytogenetic analysis of XX 
males revealed in some cases that the distal G-bands of the short arm of Y 
(Ypll. 3) are translocated onto the distal end of the short of the paternal X 
chromosome (Evans et at, 1979; Magenis et at, 1987). Second, molecular studies 
showed that about 80% of XX males and 10% of XX true hermaphrodites carry Y 
sequences on the tip of the short arm of their paternal-derived X chromosome 
(Abbas et at, 1990; McElreavey et at, 1992a). 
Human XY females with pure gondal dysgenesis (also known as Swyer 
syndrome) have a 46, XY karyotype and no sexual ambiguity. Approximately I in 
100,000 newborn females are XY females (Polani PE, 1981). This syndrome is 
defined by the presence of female genitalia, normal Mullerian structures, streak 
gonads and the absence of testes which result in lack of puberty, primary 
amenorrhea and high levels of gonadotropins (Marcantonio et al, 1994). The 
female phenotype together with an apparent absence of testicular tissue implies a 
mutation in the initial steps of male sex determining pathway. In contrast to XX 
males some XY females have deletions of portions of the Y chromosome. Since 
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the amount of Y material whether absent (XY female) or present (XX male) is 
variable, this allowed a precise genetic map of the Y chromosome to be 
constructed (Vergnaud et al, 1986) and led to precise mapping of TDF to the short 
segment of Y chromosome adjacent to the pseudo-autosomal. boundary (Affara et 
al, 1986; 1987; Vergnaud et al, 1986). 
1.4.2 The searchfor the sex determination gene(s) 
For more than 10 years, many investigators believed that the male-specific 
H-Y histocompatibility antigen was the product of TDF (Wachtel et al, 1975). 
However, the discovery of male mice failing to express H-Y excluded (in mouse) 
this gene as a possible candidate (McLaren et al, 1984). By chromosome walking 
between the break points present in an XX male and an XY female, Page et al 
(1987) have isolated a second candidate for TDF. They identified a zinc finger 
protein on the Y chromosome (ZFY) that resembles a group of transcription 
factors that bind to cis acting DNA elements and regulates gene transcription, 
which is compatible with regulatory switches such as TDF, and therefore ZFY was 
thought to be a candidate for TDF. However, its autosomal location in marsupials 
(Sinclair et al, 1988), its inappropriate expression in mouse tissue (Koopman et al, 
1989) and finally its location outside minimum sex determining region of the 
human Y (Palmer et al, 1989) excluded it from this function. 
Using the sarne strategy that identified ZFY, Sinclair et al (1990) and 
Gubby et al (1990) isolated SR Y (sex determining region on the Y chromosome), a 
single copy gene, which meets the criteria for TDF. It is located in the smallest Y 
chromosome region capable of causing sex reversal. It is expressed for a short time 
in the genital ridge (when testicular cords form) during embryonic development 
(Koopman et al, 1990) and is deleted or mutated in some cases of human XY 
females (Berta et al 1990; Jager et al 1990; Hawkin et al, 1992). Finally, this 
conclusion was confirmed by the male development of XX mice that were made 
transgenic for mouse Sry (Koopman et al, 199 1). 
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Figure 1.4: A close-up view of the region of exchange between the X and Y 
chromosomes. (1) Indicates the manner of normal exchange between the pseudo- 
autosomal regions [PAR] (P) as indicated in A-C. (2) Illustrates the manner of 
accidental interchange of testis-determining region or factor (TDF) outside the so- 
called pairing region from the Y to X chromosome enabling an X chromosome to 
carry SRY during errors in the paternal meiosis generating XX males (F-G). The 
deleted Y chromosome (SRY negative) generates XY females (E) (from Burgoyne, 
1992). 
1.4.3 The SRYgene 
The SRY gene as mentioned above, was identified by positional cloning 
within the region of the Y chromosome critical for male sexual development 
(Gubby et al 1990; Sinclair et al, 1990). It is an intronless gene potentially coding 
for a protein with 204 amino acids of which 79 show homology to the HMG (High 
Mobility Group) box, similar to nuclear chromosomal non histone protein HMGI 
and HMG2, which bind DNA (Su and Lau, 1993). The HMG-box is very 
conserved in a wide variety of mammals; conversely, the protein segments 
flanking the HMG-box are highly variable in sequence and length (Bianchi et al, 
1992; Grosschedl et al, 1994). Human SRY and mouse Sry proteins are 89% 
homologous in the HMG-box region but outside this diverge significantly (Tucker 
et al 1993; Whitfield et al 1993; Pontiggia et al 1995). The SRY cDNA sequences 
correspond to a direct copy of the genomic DNA with transcript size -1.1 kb on 
Northern blot (Sinclair 1990; Su and Lau, 1993) and 612 bp translated (Behlke et 
al, 1993). Sequencing a cDNA clone isolated ftom adult testis identified the 3' end 
of the transcript is mapping to position 747 from the first ATG (Methionine) codon 
of the open reading frame (ORF). The 5' end of SRY transcript is difficult to 
analysis and the results from different groups are contradictory. Vilain et al (1992) 
defined the transcription initiation site at 91 bp upstream ftom, the first Methionine, 
while Su and Lau (1993) defined two transcription start sites at position 78 bp and 
136 bp. The reason for these different results is not clear but it may be due to the 
different tissue tested (Goodfellow and Lovell-Badge, 1993). Moreover, the SRY 
transcriptional unit is immediately preceded by two small GC-rich segments 
covering part of the 5' untranslated region and sequence immediately 5' of the SRY 
gene. Several binding sites for the transcription factor SPI are identified among 
these GC-rich sequences. The 5' flanking region lacks an obvious TATA or CAAT 
box within the GC-rich sequences immediately upstream of the transcription start 
sites. However, several partial sequences (e. g. TATA, CATA, GATA, and TACA) 
homologous to the TATA box are present within this region, their exact role as 
promoter is unknown (Su and Lau, 1993). 
The function of SRY is still not completely clear. The SRY protein has been 
shown to bind specifically to DNA (Harley et al, 1992b) and the DNA binding 
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properties are entirely determined by the HMG-box (Bianchi et at, 1992; 
Grosschedl et at, 1994). Gieze et at (1992) showed the SRY protein binds to the 
minor groove of the double helix and recgonizes a higher affinity binding site 
defined by the nucleotide sequences 5'-CCATTGTTCT and produces a sharp 
bend, bringing distinct regions of the genome into juxtaposition and possibly 
enhancing protein-protein contact. Alternatively by bending the DNA, SRY could 
inhibit the binding of other transcription factors and therefore could play the role 
of a repressor, preventing the female sex determining genes, thereby effecting 
transcriptional control (Soullier et at, 1994). The HGM-box was found also to 
interact with high affinity to kinked DNA structures irrespective of their sequences 
(Ferrari et at, 1992). However, the importance of this binding for SRY function is 
not known. Furthermore, point mutations associated with sex reversal in XY 
human females fall within the HMG-box (Berta et at 1990; Hawkins et at 1992; 
Jager ct at 1992). And it was found that these mutations either affect the affinity of 
DNA or modify the geometry of the DNA- protein complex (Pontiggia et at, 1994; 
1995). 
In XY females with gonadal dysgenesis, mutations have been identified 
and so far some 23 different mutations are known, accounting for 10-20% of cases 
(Wolf et al, 1992; Scmitt-Ney et al, 1995). Thus in the majority of patients with 
XY gonadal dysgenesis (80%) the SRY does not appear to be affected and in some 
XX males the SRY gene is not present, pointing to the existence of other sex 
determining gene(s) (Goodfellow and Lovell-Badge, 1993; McElreavey et al, 
1993a, b; Poulat et al, 1994). 
The mutations within the SRY gene identified so far are with two 
exceptions clustered in the HMG-box region, indicating that this is the functional 
domain of the SRY protein. The exceptions are a case with a deletion 5' to the 
gene which may affect SRY expression (McElreavy et al, 1992b) and two sibs 
with an identical stop codon mutation 3' to the HMG-box (Tajima et al, 1994). 
Five of these mutations cause termination codons (causing truncated protein) and 
the others are small deletion or point mutations (Goodfellow and Lovell-Badge, 
1993; McElreavey et al, 1992b; Schmitt-Ney et al, 1995). Four familial cases of 
XY sex reversal have been described where the affected individuals share the same 
amino acid changes as their father and sometimes as other male relatives (Harley 
et al, 1992b; Jager et al, 1992; Vilian et al, 1992; Schmitt-Ney et al, 1995). 
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Familial mutations are considered to be conditional, their manifestations depend 
on the genetic background and epigenetic or environmental interaction. Thus it has 
been suggested that for SRY to fulfil its biological function bending of DNA at the 
site of its action must be geometrically precise (Pontiggia et al, 1994). 
In the XY sex-reversal females only the HMG-box regions have been 
analysed extensively for mutations therefore, it is possible that undetected 
mutations, lie elsewhere in the SRY 
1.4.4 Genes that interact with SRY 
The evidence that SRY is the master testis determining switch is 
compelling, but many observations show that sex determination is more 
complicated than a simple, single switch (Moore and Grumbach, 1992). SRY is 
assumed to act on transcription only indirectly by promoting the association of 
transcription factors, resulting in their activation. Therefore, there are likely to be 
many other genes involved in mammalian sex determination upstream and 
downstream of SRY. There is no evidence that any of these lie on the Y 
chromosome. Several autosomal or X-linked genes participating in the pathway 
have been proposed and reported (McElreavey et al, 1993a, b; Bogan and Pade, 
1994; Wolf U, 1995). 
SRY gene is thought to influence gonadal morphogenesis into male pattern 
of dispersed support cells surrounding germ cells in seminiferous tubules. It 
interacts with as yet unknown SRY intermediate factor(s) (SRYIF) to induce the 
MIS gene, which in turn causes regression of the female Mullerian duct 
derivatives. SRYIF may be one of several factors participating with SRY in the 
determining of gonadal sex. Sterogenic factor I (SF-1) is one of the SRYIF 
candidates that play a role in MIS regulation. SRY may also activate other target 
genes on autosomes such as SRA-1 (autosomal sex reversal factor). The dosage 
sensitive sex reversal locus (DSS) on the X chromosome may also act by 
repressing the SRY-induced male pathway or by activating expression of genes 
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Figure 1.5: A hypothetical scheme for sex determination in mammals. The male 
regulatory pathway is initiated by SRY. A factor or factors (SRYIFs) mediates 
induction of the MIS gene by SRY. SRYIF may interact directly with the MIS 
promoter, or indirectly through modification of the basal transcription machinery. 
MIS, in turn, plays a key role in male sexual development as a diffusible subsistence 
causing regression of the female Mullerian ducts derivatives: uterus, fallopian tubes, 
and vagina. SRY may activates other genes on autosomes such as SRAI. The DSS 
may represses the SRY-induced male pathway or by activating expression of genes 
required for formation of female strictures (modified from Haqq et al 1994). 
(A) Autosomal genes 
(1) Wilm's tumour gene (TVTI): 
In man, one of the genes frequently considered to be involved in gonadal 
development and differentiation is WTI, the Wilm's tumour suppressor gene at 
I lpl3 (Call et al, 1990; Van Heyningen and Hastie, 1992). Wilm's turnours are 
autosomal dominant childhood kidney cancers that affect I in 1000 children 
(Mastunga E, 1981). Some patients with Wilm"s tumour also have aniridia, 
genitourinary abnormalities and mental retardation (WAGR syndrome), and others 
have Denys-Drash syndrome (nephropathy, genital abnorinalities and 
predisposition to the development of Wilm's tumour). In both clinical conditions 
there is malformation of the gonads resulting in either ambiguous genitalia or 
complete sex reversal without genital ambiguities (MeElreavey et al, 1993b). The 
WTI gene encodes a zinc finger transcription factor expressed in tissues that 
develop into kidney and gonad (Pelletier et al, 1991; Pritchard-Jones et al, 1990). 
Heterozygous point mutations in the WTI gene have been observed in 
Denys-Drash syndrome. And the XY individuals who are heterozygous for certain 
mutations in WTI with Drash syndrome, the gonads showed varying degree of 
dysgenesis and the phenotypes ranged from normal female to a male with 
hypospadias with or without cryptorchidism (Pelletier et al, 1991; Baird et al, 
1992; Bruening et al, 1992). 
The role of WTI in normal gonad formation is still unclear. A mouse model 
for studying WTI function has been developed by introducing a mutation in the 
mouse WTI gene (Kreidberg et al, 1993). All foetuses homozygous for JFTI null 
allele showed a phenotype similar to Denys-Drash syndrome with streak gonads. 
Gonadal development is arrested at a very early stage, consistent with the earliest 
expression of WTI observed in wild-type animals at 9 dpc (days post coitum), 
which is before the time of primary gonad differentiation. Thus it is thought that 
WTI is required for early commitment of gonadal tissue and the establishment of 
the bipotential gonad (Kreidberg et al, 1993). Also it has been speculated that TFTI 
may act upstream of SRY and sex determination and that targets include genes 
other than SR Y (B ogan and Pade, 1994). 
(2) Mullerian inhibiling substances (AIIS): 
MIS is thought to be one of the candidate genes that operate down stream 
of the SRY gene (Bogan and Pade, 1994; Haqq et al, 1994). The MIS gene was 
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cloned in 1986 and mapped to the short arm of chromosome 19 (19pl3.3) (Picard 
et al, 1986; Cohen-Haguenauer et A 1987; Cate and Wilson, 1993). It belongs to a 
superfamily of growth factors important in cell growth, differentiation and 
regulation. The family includes transforming growth factor P, inhibin, activin and 
bone morphogenetic factors. Apart from SRY, MIS is the first biochemical marker 
of differentiation and is secreted by Sertoli cells. Even though MIS acts down 
stream of SRY in sex differentiation it is not obvious that MIS function in gonadal 
determination is strictly defined. In persistent Mullerian duct syndrome (PDMD), a 
form of male pseudohermaphroditism, patients have Mullerian duct structures and 
unilateral or bilateral undesended testes, but normal testicular differentiation. 
Certain individuals with PDMD syndrome harbour de novo mutations in MIS 
(Carre-Eusebe et al, 1992). The lack of effect of these mutations on testicular 
organogenesis is against MIS as a testicular differentiation factor (Bogan and Pade, 
1994). 
The early expression of MIS in testicular differentiation raises the 
possibility that the MIS gene is regulated by SRY directly. Several observations 
suggest that it is not. Evidence has recently been provided that MIS expression 
occurs by interaction of SF-I with the promoter region of MIS gene, and indeed in 
Sertoli's cells the spatiotemporal expression of MIS and SF-l is concordant during 
embryonic development (Shen et al, 1994). In situ hybridisation experiment in 
mice first detected Mis expression at 12.5 dpc in Sertoli cells, approximately 48 
hours after the onset of Sry transcription (Munsterbeg and Lovell-Badge, 1991). 
This observation (delayed onset of Mis expression) raises the possibility that other 
steps are involved. In vitro studies of MIS expression demonstrated that MIS 
transcription could be induced by SR Y even if the binding of SR Y to MIS promoter 
is abolished by mutation (Haqq et al, 1994). Therefore, MIS induction by SRY is 
thought to be indirect and intervening SRY-induced factors (SRYIF) are proposed 
which transduce the SRY signal to the MIS promoter. A candidate for such factor 
is SF-1. SF-I can bind to a MIS regulatory element (MIS-RE-1) and in the 
presence of SRY, the transcription of SF-I is upregulated, while in its absence (in 
female) SF-I transcription decreases (Shen et al, 1994). Moreover, SFI has been 
shown either alone or combined with SR Y to decrease the MIS expression (Haqq et 
al, 1994), indicating that SF-I acts as a transcriptional repressor. The interaction of 
SF- I with the MIS gene seems to be established. However, its interaction with SR Y 
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appears to be more indirect because of the temporal difference in peak expression 
of SRY and SF- I during testis differentiation (Wolf U, 1995). 
(3) A utosomal sex reversal: 
An autosomal XY sex reversal locus SRAI associated with campornelic 
dysplasia has been mapped to the distal long arm of chromosome 17 at 17q24.3- 
q25.1 (Tommerup et al, 1993). An SRY-related gene SOX9 (SRY-related HMG 
box) was isolated and found to encode a transcription factor expressed in many 
adult tissues, in foetal testes and skeletal tissues (Foster et al 1994; Wagner et al, 
1994). Furthermore, mutations in SOX9 gene demonstrated that this gene is 
responsible for both campornelic dysplasia (severe skeletal abnormalities in both 
XX and XY individuals) and varying degrees of sex reversal in XY individuals 
only, including intersexual and female phenotype, and gonadal dysgenesis or even 
ovarian like histology (Houston et al, 1983; Foster et al, 1994; Wagner et al, 
1994). From the pleiotropic effect it has been speculated that SOX9 has a function 
in both skeletal and gonadal development (Foster et al, 1994). The gonadal 
phenotype in campornelic dysplasia could result from mutation of a gene involved 
in forming the bipotential gonad (like WT) or involved in gonadal sex 
determination (like SRY) (Bogan and Pade, 1994). 
(B) X-linked genes 
There are two genes on the X chromosome which if mutated suppress male 
development of XY foetuses: the androgen receptor (AR) and dosage sensitive 
(DSS) loci. 
Dosage Sensitive Sex reversal locus (DSS): 
The existence of an X-specific gene involved in human sex determination 
was postulated after observations of families with apparent X- linked modes of 
inheritance of 46, XY gonadal dysgcnesis (Fechner et al, 1993). Furthermore, 
evidence was provided by the identification of sex reversal patients carrying 
duplications of portions of the Xp. The fact that two active copies of chromosomal 
region Xp2l. 1-22.1 can cause sex reversal was initially reported by Am et al 
(1994) and was referred to the sex reversal X locus (SRVX). Shortly after, Bardoni 
and colleagues (1994) confined the sex reversal region to Xp2l and named it the 
dosage sensitive sex reversal (DSS) locus (Bajalica et al, 1995). To date twenty 
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cases with partial duplications of the X short arm and an intact SRY gene has been 
described (Bajalica et al, 1995). XY individuals with an X carrying the duplication 
show various forms of intersexuality and sex reversal ranging from incomplete 
testicular differentiation to streak gonads. On the other hand XY individuals with 
deletions of the DSS region develop as male, while females are not affected by 
heterozygous duplications within this region. Therefore, Bardoni et al (1994) 
concluded that the DSS gene is not involved in testicular differentiation, but a 
double dose of DSS protein interferes with this process. They speculated that DSS 
plays a part in the ovarian pathway and that in the presence of SR Ya single dosage 
of DSS can be overcome, but not a double dosage of it (Bardoni et al, 1994; Wolf 
U, 1995). Thus it is thought that it may act either by repressing the SRY-induced 
male pathway or by activating the expression of genes required for formation of 
female structure (Haqq et al, 1994). 
1.5 Androgen Recel2tor (AR) and Molecular Genetics of Androgen 
Insensitivity Syndrome (AIS) 
Androgens [testosterone (T) and 5 a-dihydrotestosterone (DHT)] are 
essential for sexual differentiation of the male embryo and for the regulation of 
virilization in the adult. Androgens, secreted by foetal testes are responsible for the 
initial growth and differentiation of the male reproductive tract, including the 
Wolfflan ducts, the urogenital sinus, and the primordial of the external genitalia 
(Fig 1.6). During puberty, androgens promote the appearance of secondary male 
sex characteristics, including growth of the external genitalia, development of the 
prostate and seminal vesicles, male distribution of body hair, and increase in total 
muscle mass. These hormones are essential for initiation and maintenance of 
spermatogenesis and they have a negative feed back control on the secretion of 
gonadotropins by the hypothalamic-pituitary axis (Brown TR, 1995). 
Testosterone, secreted by the testes, is responsible for virilization of the 
Wolffian ducts. Development of the prostate and external genitalia are dependent 
upon the tissue-specific conversion of testosterone to its more biologically potent 
DHT by 5 oc-reductase (Griffin JE, 1992). Testosterone and DIIT mediate their 
function through the intracellular androgen receptor (AR) which belongs to the 
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Figure 1.6: A model of a target cell response to androgens, the major actions of 
which are listed to the right of the cell. Testosterone enters the cell and binds either to 
the androgen receptor in the nucleus or is first converted enzymatically to 
dihydrotestosterone: action of testosterone is indicated by continuos arrows, that of 
dihydrotestosterone by broken arrows (From Wilson, 1992). 
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L5.1 Androgen receptor (AR) structure andfunction 
The AR gene locus spans over 90 kb and has been mapped to the long arm 
of the X chromosome qI 1- 12 region (Brown et at, 1989; Kuiper et at, 1989). The 
human AR gene is a single copy gene consists of 8 exons (Lubahn et at, 1989). 
The 5' untranslated region (5'UTR) encoded by exon 1, is 1.1 kb in length and 
contains one major and one minor site of transcription initiation in a 13 bp region. 
The promoter lacks TATA and CCAAT like elements, but has GC rich sequences 
including a putative SP-1 binding motif at -50 and -60 (Tilley ct at, 1990; Faber et 
at, 1991). The 3'UTR, encoded by exon 8, is 6.8 kb long, and is postulated to play 
a role in the stability and/or translation of AR rnRNA (Mizokami and Chang, 
1994). There are two poly (A)+ signals. Northern blot analysis of RNA showed the 
presence of a predominant 10 or II kb mRNA, with a less abundant, alternatively 
processed 7 or 8 kb mRNA (Faber et at, 199 1). The I 10- 114 kb receptor protein 
contains 910-919 amino acids encoded by a 2.75 kb open reading frame (Chang et, 
at, 1988; Tilley et at, 1989). Studies of the steroid receptors including human AR, 
have revealed the presence of three conserved functional domains (Evans RM, 
1988). 
(i) The transactivating N-terminal domain: 
The amino terminus is the least conserved region with the greater variation 
in length among steroid receptors, but is important for transcriptional activation of 
target gene by the human AR (Jenster et al, 1991). It contains 529-539 amino acids 
and is encoded by exon 1. A distinguishing feature of the DNA sequence encoding 
the N-terminal domain is the presence of two polymorphic trimcric repeats of 
(GGN)n and (CAG)n (Trifiro et al 1994). The GGN repeats (16-27 mer) encoding 
glycine stretch, start at codon 449 and the (CAG)n repeats (IS -3 1 mer ) encoding a 
polyglutamine stretch, start at codon 189 (Jenster et al, 1991). The polymorphic 
variation within these segments accounts for the variable number of amino acids 
(910-919) in the human AR protein between individuals. 
0i) The DNA-binding domain: 
The central domain, encoded by exons 2 and 3, contains 66 amino acids. 
This cystein-rich region is the most highly conserved region within the steroid 
receptor and is important for DNA-binding to target DNA (Lubahn et al, 1989). It 
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shares approximately 80% homology with the same domain of the glucocorticoid 
(GR) and progesterone (PR) receptors. By structural analogy to GR (Hard et al, 
1990; Luisi et al, 1991), the DNA-binding domain consists of two zinc fingers 
which each of them being teterahedrically co-ordinated to four cystein (Evans RM, 
1988; Sultan et al, 1993). Crystallography studies on the GR have indicated that 
the first zinc-finger (N-terminal) specifies DNA recognition of the receptor, while 
the second finger is mainly responsible for dimerisation of two receptor molecules 
during their association of DNA (Fawell et al, 1990; Guiocho-Mantel et al, 1989). 
This DNA-binding domain interacts with cis-acting elements of the regulated 
genes [androgen responsive element (ARE)], which are 15-nucleotide-long 
palindromic sequences located in the flanking region of the gene (Sultan et al, 
1993; Ham et al, 1988). 
iii) The steroid-binding domain: 
The carboxy terminus (C-terminal) of AR (250 amino acids) is encoded by 
exons 4-8 and is responsible for ligand (steroid) binding affinity and specificity 
(Jenster et al, 1991) and in the interaction with heat-shock proteins such as HSP90 
(Veldscholte et al, 1992). The binding of the two physiologically active androgens 
(Testosterone and DHT) to the receptor coincides with the dissociation of heat 
shock proteins and conformational activation of the hormone-receptor complex 
(Brown TR, 1995). 
The actions of androgens on target cells occur via the classical steroid 
receptor pathway. The action is initiated by the interaction of the steroid with the 
androgen expressed in target tissue. Androgen binding induces a process of 
receptor activation involving dissociation from receptor-associated proteins (Smith 
and Toft, 1993). The activated receptor binds as a dimer (Wong et al, 1993) to a 
specific DNA sequences (ARE) in the promoter regions of target genes and 
modulates transcription of those genes (De Bellis et al, 1994). 
I. S. 2AIS andgenctic abnormalities of theAR gene 
Androgen insensitivity syndrome is a rare-X linked disorder (1/60,000 
male birth) caused by an inability to express the androgen effect in 46, XY 
individuals with testes able to synthesise androgen. This impaired response to 
androgen result from the inability or reduced ability of the androgen receptor (AR) 
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to transactivate androgen responsive genes in target cells, and leads to abnormal 
differentiation and development of internal and external genitalia in male, and thus 
leads to male pseudohermaphroditism (Griffin JE, 1992). Depending on the extent 
of AR defect, the phenotype varies and usually the complete form [Complete AIS] 
(CAIS)] is distinguishable from the partial ones [partial AIS (PAIS)]. In CAIS, 
primarily referred to as testicular ferninisation, affected individuals are genetic 
males presenting with female external genitalia, without ambiguity, however, the 
vagina is short and blind. They are usually diagnosed in the neonatal period 
because of inguinal hernia, or at puberty because of primary amenorrhea 
associated with normal breast development and absent axillary and pubic hair. 
Female internal genital structures are usually absent and testicular histology show 
spermatogenesis, to be incomplete or absent, although Leydig cells are abundant. 
Plasma testosterone concentrations are within normal to elevated as a result of the 
increased stimulation by luteinising hormone (1,11). In contrast, PAIS is 
heterogeneous and associated with a wide spectrum of clinical disorder from males 
with severe ambiguous genitalia (i. e. Cryptorchidism, micropenis and 
hypospadias) to a phenotypic male with severe hypospadias (Reifenstein 
syndrome) (Pinsky et al, 1992; Ris-Stalpers et al, 1994), to unexplained male 
infertility (Aiman and Griffin, 1982). 
The clinical heterogeneity of AIS is matched by a diversity of biochemical 
abnon-nalities of the AR receptor. The first indication that the AR itself is defective 
in AIS came from androgen studies on genital skin fibroblast cell line from AIS 
patient (Keenan et al, 1974; Hughes et al, 1986). These defects can be grouped into 
four broad categories: (a) Negative binding (AR-), (b) qualitative defects in 
receptor function (thermal instability of the protein), (c) deficient amount of 
apparently normal receptor (AR), and (d) receptor-binding positive (AR+), a 
category in which the endocrine, phenotype, and genetic features are compatible 
with a receptor abnormalities but no functional abnormalities been identified 
(McPhaul et al, 1991; McPhaul et al, 1993). The majority of CAIS patients are 
receptor negative. In contrast, no clear cut relationship between clinical phenotype 
and AR binding exist in PAIS patients; the majority of cases show normal receptor 
binding, although a small group show qualitative abnormalities in the AR binding. 
Recently, cloning of the AR gene led to molecular genetic studies to 
identify lesions in the AR gene. When binding is negative or qualitatively 
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abnormal, mutations are identified in the exons encoding the ligand binding 
domain of the AR gene, whereas normal AR binding in CAIS is associated with 
mutations affecting the DNA binding region (Griffin and Wilson, 1992; McPhaul 
et al, 1993). A number of mutations of the AR gene have now been reported in 
both CAIS and PAIS. Complete or partial AR gene deletions have been found in 5- 
10% of all AR gene mutation causing AIS (Trifiro et al, 1991; Quigley et al, 
1992a, b; Brown TR, 1995). Deletions involving multiple (4-8, or 3-8, and 6-7) 
and single exon (2,3, or 5) have been reported for families with CAIS (Brown et 
al, 1994). Deletion of part of intron 2 and 3 were reported in only one case with 
PAIS (Ris-Stalpers et al, 1992) and deletion of exon 4 was detected in a patient 
with only azoospermia (Aiken et al, 199 1). 
The vast majority of mutation in both CAIS and PAIS are point mutations 
in the coding region of the AR gene causing amino acid substitutions (Brown et al, 
1990; Maracelli et al, 199 1; McPhaul et al, 199 1), or premature termination (Sai et 
al, 1990; Trifiro et al, 1991; De Bellis et al, 1992), or aberrant mRNA splicing 
(Ris-Stalpers et al, 1990; Brown TR, 1995). Most of these substitutions were 
localised in three regions of the AR: the DNA binding domain and 2 segments of 
the ligand binding domain. Two hot spots for mutations are present in the AR gene 
namely exon 5 and exon 7 (McPhaul et al, 1993; Sultan et al, 1993). 
The evidence to date indicates that mutation of the AR gene is responsible 
for most cases of CAIS. In contrast, many patients with PAIS demonstrate no 
defect in androgen binding and no AR gene mutation can be identified (Batch et al, 
1992; McPhaul et al, 1993) Moreover, an attempt to assign a phenotype to a 
particular mutation have failed (Griffin JE, 1992; McPhaul et al, 1993). The same 
mutation has been reported to result in different phenotypes (McPhaul et al, 1991; 
McPhaul et al, 1993). The reasons for such discrepancies between patients 
exhibiting the same molecular defect are still poorly understood. 
1.5.3 AR gene mulations in other diseases 
It is interesting to note that AR gene mutation is also involved in other 
diseases. In a study of 26 patients with prostate cancer, only one somatic point 
mutation in the ligand-binding domain (exon 5) has been described in a patient 
with early stage cancer (Newmark et al, 1992). The authors postulated that this 
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mutation might be involved in the development or progression of prostate cancer. 
Moreover, Wooster et al (1992) reported a germ line mutation responsible for an 
Arg-Gln substitution at position 607 in two bothers with breast cancer and PAIS. 
Lobaccaro et al (1993) reported a substitution of position 608 in one out of 13 
male patients with breast cancer. Both mutations occurred in the DNA binding 
domain (in exon 3). Lobaccaro et al (1993) postulated two hypotheses that may 
explain the development of breast cancer linked to AR mutations. One possible 
explanation is that the mutated AR gained an ability to bind to oestrogen 
responsive element (ERE), thus activating oestrogen regulated gene. Although this 
region of the binding was never shown to be involved in the binding specificity to 
the response elements, yet the authors claimed a 'tri-dimensional' structure 
modification might play a role. The second hypothesis is loss of the protective 
effect of the androgen. Thomas et al (1992) suggested that the breast cancer in men 
develop in response to androgen deficiency and under conditions associated with 
excess oestrogen. Lastly, La Spada et al (1992) showed that spinal bulbar muscle 
atrophy (SBMA or Kennedy syndrome) is due to the expansion of the normal 
polyglutarnine tract (Tandem CAG repeat) from 15-31 to 40-50. This adult onset 
neurodegenerative disorder is often associated with mild androgen insensitivity 
(gynecomastia, testicular atrophy, and infertility). SMA has never been reported in 
AIS with any other AR mutation. It was postulated that this expansion of the 
polyglutarnine region could cause structural constraint of the N-terminal domain 
resulting in modification of transcription initiation complexes on target genes 
(Brown TR, 1995). 
6 Male Infertilily 
The end process of sex determination and differentiation is the ability to 
reproduce. Approximately 15-20% of couples have difficulty or are unable to 
conceive (Purvis and Christiansen, 1992; Bhasin et al, 1994) and in one-third of 
cases it is the male who is considered the predominant reason for the infertility 
(Bhasin et al, 1994). Most authorities define these patients as prematurely infertile 
if they have been unable to achieve a pregnancy after twelve months of regular 
intercourse without contraception (Greenhall and Vessy, 1990; te Velde and Beets, 
1992). 
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1.6.1 Spermatogenesis and its hormonal control 
Spermatogenesis is a complex developmental process. The progression 
from spermatogonial stem cells to mature spermatozoa requires 65 days and 
involves elaborate succession of distinct cell types. The process is carried out by at 
least three mitotic and two meiotic divisions (Reijo et al, 1995). The primitive cells 
(spermatogonia), either divide to reproduce themselves for stem cells renewal or 
they divide to produce daughter cells that will later become spermatocytes. The 
spermatocytes then divide and give rise to mature cell lines that eventually give 
rise to spermatids. The spermatids then undergo a transformation into spermatozoa 
(Dym M, 1994). Spermatogenesis begins at puberty and continues throughout 
adult-life. A human male may produce 1012 to 1013 gametes during his life time 
(Reijo et al, 1995). 
Spermatogenesis requires the stimulatory effects of follicle-stimulating 
hormone (FSH), luteinzing hon-none (LH), and adequate testosterone (T) 
concentrations (Matsumoto and Bremner, 1989). FSH is enough to be required for 
maturation of spermatids but its role in maintenance of spermatogenesis is less 
clear (Soham et al, 1994). Luteinizing hormone is thought to have effect on 
initiation and maintenance of spermatogenesis indirectly in that it stimulates 
androgenous testosterone production (Purvis and Hansson, 1978). 
1.6.2 Causes of inale infertility 
Male infertility can result from a number of different changes within the male 
genital tract but generally infertile men can be divided into five major diagnostic 
categories (Cummins et al, 1994). (1) Disorders related to motility or function of 
the sperm such as congenital defect of the sperm tail, sperm maturation defects and 
immunologic defect (sperm antibodies) (Purvis and Christiansen, 1992; Cummins 
et at, 1994). (2) Disorders related to obstructive lesions (obstructive defect) which 
most commonly affect the excrine ducts of the testes but may also involve the 
more distal duct system such as the ejaculatory ducts themselves (Cummin et al, 
1994). Around 7-15% of all patients attending infertility clinic was shown to have 
obstructive lesions (Dubin and Amelar, 1971). (3) Disorders related to 
spermatogenetic failure as a result of lesion in the testis itself has been reported to 
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be present in -30% of infertile men (Jaquier and Holmes, 1993). (4) Sexual 
dysfunction disorders of erection and ejaculation. (5) Endocrine dysfunction. 
Patients with endocrinopathy such as hypogonadotropic hypogonadisim, are rarely 
seen in the infertility clinic, with an incidence of approximately 3% (Purvis and 
Christiansen, 1992). 
Environmental factors, genetic factors or a combination of both may cause 
defects in male reproductive function. Environmental factors with known effects 
on reproductive function include nutrition (obesity or undernutrition), infection, 
excessive physical exercise, toxic substances, radiation, smoking and excessive 
consumption of coffee or alcohol (Negro-Vilar A, 1993; Fauser and Hsueh, 1995). 
Recent studies have begun to focus on genetic defects underlying disturbed human 
male reproductive function. 
1.6.3 The genetics of male infertility 
The genetic disorders related to male infertility can be divided into three 
categories: (i) pre-testicular, (ii) testicular and (iii) post-testicular causes of male 
infertility (Mak and Jarvi, 1996). These genetic defects are responsible for a 
variety of clinical presentations of male infertility, from gonadotropin-releasing 
hormone deficiency such as congenital hypogonadotropic syndromes (Kallmann's, 
Prader-Willi and Bardit-Biedl syndromes), to spermatogenic failure such as 
chromosomal abnormalities (Klinefelter, XX males and deletion of the 
azoospermia factor gene), to obstructive azoospermia such as mutation in the 
cystic fibrosis transmembrane regulatory gene (CFTR) (Table 1.2). 
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Table 1.2: Summoa of ggnetic disorders related to male Lnferlift 
i) Pre-testicular: 




Cerebellar ataxia with 
Hypogonadotropic 
hypogonadism 
Sickle cell anemia 
P-Thalassemia 
ii) Testicular : 
Klinefelter's syndrome 
XYY 
Deletion of azoospermia 
factor gene 
46, XX male 
Noonan's syndrome 
Myotonic dystrophy 
Anosmia, Craniofacial asymmetry, 
cleft palate, delayed puberty, small 
testes 
Obesity, mental retardation, 
hypotonia; small hands and 
feet 
Obesity, mental retardation, 
Retinitis pigmentosa, 
polydactyly 
Speech delay, gait, lack of 
secondary sexual 
characteristics, eunuchoidism, 
decreased libido, small firm 
testes 
Anemia, sickling of 
erythrocytes at low oxygen 
tension 




hypogonadism, small firm 
testes, diminished secondary 
sexual characterisitics. 




Small finn testes 
Short stature, hypertelorism, 
webbed neckjow set ears, 
cubutus vulgus, ptosis, 
pulmonary stenosis, cardiac 
anomalies, cryptorchidism, 
testicular atriphy 
Myotonia, muscle wasting, 
cataract, frontal balding, 
electrocardiographic changes, 
testicular atrophy 
X-linked recessive, variable 
inheritance; defect in 
KALIG- I gene on Xp22.3 
chromosome 
Often due to interstitial 
deletion of chromosome 
15qI2 (paternally inherited) 
Autosomal recessive; gene 
mapped to chromosome 
16q2l 




inheritance, defect in gene for 
P-globin chain of hemoglobin 
Autosomal dominant 
inheritance, defect in gene for 
P-globin chain of hemoglobin 
90% of cases 47, XXY 
karyotype. Remainder are 
mosaicis for polysomy for X 
or Y chromosome 
Karyotype 47, XYY 
De novo deletion of 
azoospemia factor gene 
mapped to Yq 11.22-23 
chromosome 
46, XX, SRY gene present, 
azoospermia factor gene 
absent 
46, XY, autosomal dominant 
inheritance 
Autosomal dominant 
inheritance, with variable 
pcnetrance, expanded number 
of CTG sequcnccrepeats in 
gene mapped to l9ql3.3 
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iii) Post-testicular : 
DISORDER CLINICAL FEATURES GENETIC MECHANISM 
Cystic fibrosis 
Congenital bilateral 




Polycystic kidney disease 




insufficiency, elevated sweat 
chloride, wolfflan duct 
derivatives atrophic or absent. 
Wolfflan duct derivative 







Multiple cysts in kidney, 
liver, spleen, pancreas, lung, 
ovary, testes, epididymis, 
seminal vesicle, cerebral 
aneurysms, mitral valve 
prolapse, colonic 
diverticulosis 





ventral urethral groove, blind 
vaginal pouch, female habitus 
without breast development 
Autosomal recessive 
inheritance, defect in CFTR 
gene on chromosome 7q3 1.1 
Autosornal. recessive 
inheritance, defect in CFTR 
gene in patients without 
concomitant renal anomalies 
Defect in CFTR gene 
implicated 
Autosornal recessive 
inheritance, defect in CFTR 
gene implicated 
Autosomal. dominant 
inheritance, 2 genes 
implicated (PKD I on 16p 13.3 






inheritance, gene encoding 
5-ce-reductase iso-enzymes I 
and 2 located on chromosome 
5p 15 and 2p23 
Androgen Insensitivity Complete /incomplete 46, XY, X-linked recessive 
syndrome testicular feminization, inheritance, defect in 
Reifenstein's syndrome, androgen receptor gene 
infertile male syndrome located on Xq 11-12 
chromosome 
*Modified from: Mak and Jarvi, 1996. 
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1.6.3.1 Chromosomal abnormalities as a cause of male infertility: 
(1) Numerical chromosome abnormalities: 
Klinefelter syndrome is a genetic disorder due to the presence of an extra X 
chromosome in the male, the common karyotype is either 47, XXY (classic form) 
in 90% of cases or 46, XY/47, XXY (the mosaic form) in 10% of cases. This 
disorder is a common genetic cause of male infertility, with an incidence of 1/1000 
male births (Connor and Ferguson-Smith, 1991). More than 30 karyotypic 
varieties of Klinefelter syndrome has been described such as, XXYY, XXXY, 
XXXXY, and various mosaicisms of X chromosome with or without associated 
structural abnormalities of the X chromosome (Griffin and Wilson, 1992). 
Characteristically, these individuals have small, firm testes, delayed sexual 
maturation, azoospermia and gynecomastia. Testicular biopsy often reveals 
sclerosis and hyalinization of the seminiferous tubules, absence of 
spermatogenesis and increased Leydig cells. LH and FSH levels are 
characteristically elevated. Testosterone levels can range from normal to low and 
decrease with age. 
The mosaic variant of Klinefelter syndrome (46, XY/47, XXY) is usually 
not as severe as the classic form and fertility has been documented in some 
patients with mosaicism (Foss et al, 1971). The testes may be normal in size and 
gynecomastia and azoospermia are less common. The frequency of the mosaic 
form may be underestimated, since chromosomal mosaicism may occur only in the 
testes while karyotypes on peripheral leukocytes may be normal (Griffin and 
Wilson, 1992). 
The incidence of the XYY syndrome (1per 1000 male birth) (Connor and 
Furguson-Smith, 1991) is the same as that of Klinefelter syndrome but its 
phenotype expression is more variable. These patients are excessively tall and I- 
2% has anti-social behaviour. Semen from these patients may vary from 
azoospermia to normal. Testicular biopsy specimens show maturation arrest to 
complete genninal aplasia. Most have a normal L11 and testosterone level with the 
FSH level dependent on the extent of germ cell damage. 
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(2) Structural chromosome abnormalities: Structural Y chromosome disorders 
include 46, XX male karyotype and deletion of the azoosPermia factor gene. 
XX disorder or sex reversal syndrome: it is a variant of Klinefelter syndrome. 
Male individuals with this disorder are phenotypically masculine but have a 46, XX 
karyotype. The signs are similar except for the average height which is less than 
normal, hypospadias is common and decreased incidence of mental deficiency. 
These patients have a 46, XX chromosome complement with an incidence of 
1/20000 males (McElearvey et al 1992a). It is postulated that in these patients, the 
sex determining region of the Y chromosome (SRY gene), which encodes the 
putative testis determining factor, is present, however the azoospermia factor 
(AZF) is missing in the genome. The mechanism of this disorder thought to be due 
to aberrant X-Y interchange at paternal meiosis which may occur because of the 
proximity of TDF (SRY) to the pseudo-autosomal region where recombination 
between X and Y chromosomes normally occurs (Page et al, 1987). 
1.6.3.2 Deletion of the azoospermia factor (AZF) 
Several genes are likely to be involved in the complex process of 
spermatogenesis. There is increasing evidences for the presence of such gene(s) in 
the distal long arm of the Y chromosome. Cytogenetic studies in sterile men with 
deletions of the long arm and other structural abnormalities of the Y chromosome 
have been observed in men with azoospermia and suggested the localisation of a 
gene controlling spermatogenesis, named azoospermia factor (AZF), resides in 
Yql 1.23 (Tieplo and Zuffardi, 1976; Chandley et al, 1989). Molecular mapping 
localised AZF to interval 6 of the Y chromosome (Anderson et al, 1988) as defined 
by Vergnaud et al (1986). As a first step towards the molecular isolation of AZF, 
its gene structure in Yql I has been mapped using two interstitial deletions in the 
proximal and distal part of Yq1 I (Ma et al, 1992; Vogt et al, 1992a, b) and a 
detailed map of interval 6 was constructed (Ma et al 1992). Based on these non 
overlapping deletions, Vogt et al (1992a) postulated that there may be two 
spermatogenesis genes in distal Yq1 1, AZFA and AFZB, or a very large gene 
similar to the Y fertility gene of Drosophila. Deletion of the azoospermia factor 
accounts for 10% of 46, XY men with non-obstructive azoospermia (Johnson et al, 
1989; Vogt et al, 1992a, b; Nagafuchi et al, 1993). It was estimated that at least 
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1/10,000 male newborn carry a de novo deletion of the AZF (Vogt et al 1992a). 
Histological studies of testicular biopsies from azoospermic men with deletion in 
AZF region exhibited a wide spectrum of spermatogenetic defects from complete 
absence of germ cells (Sertoli-cell-only syndrome) to maturation arrest with 
occasional production of mature, condensed spen-natids (Tiepolo and Zuffardi, 
1976; Chandley et al, 1986; Chandley et al, 1989; Vogt et al, 1992a, b). 
In 1993, the finding of overlapping interstitial Yq deletion in 3 
azoospermic men led to identification of YRRMI and YRRM2 (Y chromosome 
ribonucleic acid recognition motif), now renamed as RBM1 and RBM2 (RNA 
binding motif) (Chandley and Cooke, 1994). It was proposed that absence of these 
closely related genes might be the cause of azoospermia (Ma et al, 1993). 
1.6.3, Z2 Isolation QfRRMggue-f, 7m 
The RBM (YRRM gene family were originally cloned, on the basis of its 
position, with probes deleted in a small number of infertile men with phenotypes 
ranging from oligospermia to a complete absence of genn cells (Ma et al, 1993). 
Two RBM gene copies were isolated as cDNA clones (MK5, MK29). The 1878 bp 
MK5 cDNA shows the AUG starting codon is present at 118 bp, followed by an 
open reading frame of 1491 bp which predicts a novel peptide of 469 residue. The 
1874 bp MK29 cDNA displays 7 nucleotide substitution and a5 bp deletion 
relative to MK5 causes a translation frame shift that truncates the MK29 open 
reading frame, giving a predicted peptide of 419 residue. Both clones contain a 
consensus poly-adenylation signal, and MK29 contains a short poly (A)+ tail (Ma 
et al, 1993). 
L-6.3, Z3 RHAtl2rolein-contalits an RNA-binding--related mol 
The predicted peptide sequence showed 5' homology to a super family of 
RNA binding protein (HnRNPs) that contains a 90 amino acids RNA recognition 
motifs (RRM), often in a tandernly repeated array (Kenan et al, 1991; Ma et al, 
1993). The RBM genes were found to have similarity (60% amino acid 
conservation) to HnRNPG (human glycosylated nuclear RNA-binding protein) 
(Chandley and Cooke, 1994). The majority of the genes code for protein which 
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have two copies of an RNA binding domain (RRM) but a subset has been found 
whose members, like RBM genes and HnRNPG, have only a single domain. A 
feature of the RRM domain is a pair of very highly conserved motifs, an 
octapeptide RNPI and a hexapeptide RNP2. These parts of the protein probably 
form the beta sheet, which contact the RNA directly (Ma et al, 1993; Chandley and 
Cooke, 1994). Because of the RNA recognition motif and because of their Y 
chromosome localisation these genes were called RBMI (MK5) and RBM2 
(MK29). These RRM motifs showed the highest similarities to the third RRM 
repeat in mouse polyadenylate-binding protein (PABP) (Adam et al, 1986; Sach et 
al, 1986). Adjacent to RRM domain is a 139 residue followed by four repeats of a 
37 residue (111 bp), all of which showed high conservation at both the nucleotide 
and predicted protein level. The repeated domain is rich in serine, argenine, 
glycine, and tyrosine content, with no aliphatic leucine, isoleucine, and methionine 
and valine residue. Adjacent to the tetrapeptide SRGY box (Serine-Arginine- 
Glycine-Tyrosine) is a carboxyl tail of 122 amino acid in RBMI and 45 amino 
acid in the RBM2 gene due to the deletion that is present beyond the SRGY box 
(Ma et al, 1993). 
Expression studies showed that RBM sequences are confined to germ cells 
(testis specific) and the genes showed a male-specific conservation of expression 
in DNA from several other mammals (Ma et al, 1993; Chandley and Cooke, 1994). 
Moreover, interphase in situ hybridisation and Southern blot studies showed that 
the RBM sequences compose a multigene family clustered in 1-2 Mb regions of 
the Y chromosome with majority of the genes in intervals 5 and 6 of YqI 1.23. The 
RBM gene family has approximately 30 genes and pseudogenes, one or some of 
which encode HnRNPG-like protein expressed in adult testis (Prosser et al, 1996). 
The HnRNPG proteins are widely expressed proteins and these proteins are 
abundant in the nucleolus as histones (Soulard et al, 1993). Ma et al (1993) have 
reported that the RBM gene family may be involved in RNA trafficking between 
nucleus and cytoplasm and implicated in RNA process. Therefore, they have 
suggested that the RBM gene family may have a role in spermatogenesis and are 
candidates for AZF. Transcription of the RBM genes has not been detected outside 
the testis, distinguishing them from HnRNPG (Chandley and Coole, 1994). 
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1.6.3. Z4RBM deletions in oligo- a nd azoog ermicIzatients 
Ma et al (1993) detected deletion of RBM (YRRM sequences in two 
infertile (oligo and azoospermic) patients with no previous deleted mutations. 
Moreover, Kaboyashi et al (1994) analysed DNA from 63 Japanese men with 
either azoospermia or severe ofigoospermia whose Y chromosomes were 
cytogenetically normal. They examined 15 loci included RBMI locus on the long 
arm of the Y chromosome. They detected microdeletion in 10 of the infertile men. 
The RBM1 gene was involved in only 3 of them. They proposed that the RBMI 
(YRRMI) is not the only gene essential for spermatogenesis. 
6-3. Z 5 RBMI ggne structurg 
Recently Prosser et al (1996) characterised the exon/intron boundaries of 
the RBM1 gene. Twelve exons were defined. Exons I-II consist of 100 bp each 
(88-117 bp) and the 12th was slightly larger (<600 bp). Introns in the repeated 
SRGY box region of the 3' half of the gene are equal in size (450 bp) and each 
repeat is in a separate exon (Exon 7-11). The remaining introns, 1-6 and II varied 
from about 400 bp to 3 kb in length. The RRM motif extends from exon 2-4, with 
the highly conserved sequences RBPl and RBP2 in exons 3 and 2 respectively. 
The 1.8 kb RBMI transcript covers a genomic region of 15kb. 
1.6.3. Z6 New candidate Ugne efA 
Using 84 sequence-tagged-site (STS) markers covering the 30-megabase 
euchromatic region, Reijo et al (1995) looked for Y chromosome deletions in 89 
azoospermic males who had no signs of any physical obstruction and showed that 
the RBM1 and RBM2 genes were present in all infertile men studied, including 12 
patients with interstitial Yq deletion of the azoospermia factor region. In 12 of 
these patients (13%), they found overlapping de novo deletions spanning a 
common region of about 500 kb in the distal segment of the Y long arm. They 
identified a novel gene within this region, which they named "deleted in 
azoospermia" (DAZ). Like RBM, DAZ is expressed specifically in the testis and 
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contains an RNA recognition motif, however, unlike RBM, DAZ is a single- copy 
gene in humans and chimpanzees. These results suggest that DAZ is the candidate 
gene for AZF and not RBM1 and RBM2. 
At least three different AZF genes are present on the long arm of the 
human Y chromosome in YqI 1. They are named AZFa, AZFb, AZFc (Vogt P, 
1995; Vogt et al, 1995). The positions of these genes were marked according to the 
results of the search for microdeletion in Yql 1 (Henegariu et al, 1994). They 
appeared as de novo mutations in males with severe oligoospermia and 
azoospermia (Vogt et al, 1995). Deletions in AZFa or AZFb disrupt the germ cell 
development in males before the proliferation phase of spermatogonia or at 
meiosis, respectively, while deletion in'AZFc region disrupts the germ cells 
development during the maturation phase of spermatids or spermatozoa. Patients 
with AZFc deletion can display different amount of mature sperm cell (Vogt P, 
1995; Vogt et al, 1995). Candidate genes for expression of AZFb are copies of the 
RBM gene family. Candidate genes for expression of AZFc are DAZ and SPGYI 
(spermatogensis gene on the Y). Candidate genes for expression of AZFa are not 
yet known (Vogt et al, 1996). 
A variety of other chromosome abnormalities involving the sex 
chromosome and/or autosomes associated with male sterility have been 
documented (Chandley and Edmund, 1971; Gabriel-Robez et al, 1987; Speed and 
Chandley, 1990; Mohandas et al, 1992). Although definitive proof of a causal 
relationship between these chromosomal abnormalities and spermatogenctic 
abnormalities till now is lacking, however, these reports suggest that genes within 
such chromosomal regions may have a role in spermatogenesis. At least three 
different mechanisms resulting in abnormal spermatogenesis have been postulated 
(Maraschio et al, 1994). (1) Microdeletions that could affect azoospermia factor 
involved in spermatogenesis (Ma et al, 1992). (2) Alteration of the correct 
sequence order of the Y chromosome interfering with the steric organisation of the 
sex vesicle (Gonzales et al, 1981; Rivera and Diaz-Castanos, 1992) and 3) 
Autosomal interference with the X-Y bivalent (Chandley AC, 1981) through 
interference with X-inactivation at meiotic prophase (Forjt J, 1982), a prerequisite 
for normal spermatogenesis (Lifschytz and Lindsley, 1972). 
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LTMutation detection methods 
A wide variety of techniques are available for detecting disease-causing 
mutation within human genes. These methods are used to determine whether a 
candidate gene is causally related to a phenotype and also to identify new alleles at 
a known locus for diagnostic, population genetics and structural function studies. 
The spectrum of disease causing mutation ranges from cytogenetically 
visible chromosome rearrangements (such as large deletion, insertion, inversion, or 
duplication) to microdeletion, duplication and insertion and finally single base 
changes. Some candidate genes, such as Dystrophin are prone to deletions 
(Chamberlain et al, 1989) while others such as CTTR gene in cystic fibrosis 
patients are associated with hundreds of point mutations (Tsui LC, 1992). Some 
genes can be as complex in structure as dystrophin, with a 14 kilobase (kb) peptide 
coding region and 80 exons (Koenig et al, 1988) or as simple as the SRY (Sinclair 
et al, 1990) locus with only one large exon. Moreover, many genes of interest may 
not be expressed in easily accessible samples such as blood, as in male infertility 
RBM gene family (Ma et al, 1993), leaving analysis of genomic DNA as the only 
option. Therefore, the most applicable screening method is influenced by the 
expected nature of the mutation, size and structure of the gene in question, 
availability of mRNA, degree of sensitivity required and resources available 
(Grompe M, 1993). 
In general, the methods for mutation detection can be divided into two 
distinct groups. The first consists of techniques, which identify human disease 
alleles, and the second group consists of methods of screening for unknown 
mutations (Figure 1.7). 
1.7.1 Screeningfor unknown mutations 
Techniques have been devised to permit rapid screening for mutations in cases 
where the common mutations are not known. Each technique has its advantages 
and disadvantages for a given situation. 
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Figure 1.7: Schematic representation of mutation detection strategies. 
1.7.1.1 Detection of large gene alteration 
Methods for identifying mutations that grossly alter a gene (>500 bp 
portion) are well established. Standard and specialised cytogenetic techniques can 
really identify mutations that significantly disturb chromosome structure. 
Techniques that assess genomic organisation, including pulsed-field gel 
electrophoresis, Southern blot hybridisation and multiplex polymerase chain 
reaction (PCR) can be used to identify large deletions, insertions, inversions, or 
duplications. 
(A) Cytogenetic techniques 
Cytogenetic analysis is one of the most common approaches to genetic 
testing. It is the study of genetic material at the cellular level. Routine laboratory 
human cytogenetics is concerned with light microscope studies of chromosomes. 
Almost all human ctyogenetic studies involve the examination of a dividing cell 
population requiring preliminary cell culture followed by blocking cell division at 
metaphase, with an inhibitor of spindle formation. 
There are many different staining techniques. The Giemsa (G) banding 
method is the most widely used for routine karyotyping (Seabright M, 1971; 
Sumner et al, 1971). This can resolve 400-500 bands (alternating light and dark 
bands) per haploid karyotype. At this level of resolution, deletion of the order of 
5-10 Mb can be visualised using routine G-banding. Using high resolution level of 
banding (prometaphase) deletions as small as 2-5 Mb can be detected (Yunis J, 
1976). This technique has led to the identification of an increasing number of 
small deletions causing specific syndromes such as del (I Ip 13) for aniridia/Wilms 
tumour, del (15ql3) for Prader-Willi and Angelman syndromes and others 
(Ballabio A, 1991). The chromosome banding pattern obtained is thought to reflect 
both the structural and functional composition of the chromosomes (Holmquist et 
al, 1982). Dark bands contain adenine and thymine (A+T) rich DNA, appear to 
contain relatively few active genes and generally replicate their DNA late in S- 
phase (Sumner AT, 1982). A similar banding pattern can be obtained by staining 
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with quinacrine (Q) and visualising with fluorescent microscope (Caspersson et al, 
1970). Polymorphic variations in: (1) the centromeric region of chromosomes 1,9, 
16, (2) the satellites region of the acrocentric chromosomes, (3) and variation of 
the heterochromatic region of the Y chromosome (Yqh) can often be recognised 
using the Q-banding method. Reverse banding in which the bands stain in opposite 
pattern from the G-bands is used routinely in some laboratories. This technique 
may be useful if the telomeres are involved in aberration (Dutrillaux et al, 1973). 
Special techniques for staining the highly repetitive DNA in heterochromatin at the 
centromeres especially of chromosomes 1,9, and 16 and at the distal region of the 
long arm of the Y chromosome (C-banding) (Arrighi and Hsu, 1971) are usually 
applied to investigate chromosome rearrangement near centromeres and to confirm 
polymorphism. On the other hand, the nucleolar organiser region (NOR) using the 
silver stain, can be applied to selectively identify chromosome containing genes 
for ribosomal RNA (rRNA) which are located on the short arm of acrocentrics 
chromosomes (13,14,15,21,22) (Bloom and Goodpasture, 1976). Furthermore, 
the differential replication staining, produced by incorporation 5-bromodeoxy 
uridine (BrdU) into chromosomes, is applied to the detection of different cycles of 
replication within a single cell cycle (Rooney and Czepulkowski, 1992). Initially 
the main technique for such studies involved feeding cells with a radioactive 
chromosome constituent and the results were analysed with autoradiography 
(Taylor JH, 1958). Recent methods however, are based on the introduction 
methods that detect the incorporation of Brdu (thymidine analogue) into the 
chromosome. Chromosomes and chromatids that have incorporated Brdu, instead 
of thymidine, have a different structure and consequently different staining 
preparation form those containing thymidine. Substitution with Brdu has also been 
successfully demonstrated in the late-labelling X chromosome (late replicating X 
chromosome) and other individual chromosomes and segments that replicate in the 
later part of the S period (Latt SA, 1973; 1974). 
(B) MoIccular cytogenctic (Fluorescme in sint hybridisation) 
Recently, the power of cytogenetic analysis has been enhanced by the use 
of fluorescence in situ hybridisation (FISH) (McNeil et al, 1991; Tkachunk et al, 
1991; Lichter and Cremer, 1992). It has been used as an adjunct to routine 
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cytogenetics to achieve a higher sensitivity and better resolution of chromosome 
aberrations as compared to banding analysis. Although chromosome analysis by 
conventional methods is very precise and gives a comprehensive view of the 23 
pairs of chromosomes, it is time consuming and requires highly skilled 
cytogeneticists. 
FISH has become a powerful tool both of basic science and diagnostic 
applications. In basic science, FISH has strongly enhanced gene and genome 
analysis enabling rapid mapping of genes (Lawrence et al, 1988; Heng et al, 1992; 
Ried et al, 1993) and large genomic clones using the competition principles as well 
as chromosome painting (Lengauer et al, 1990; Lichter et al, 1990). 
Diagnostically, FISH allows identification of pathological chromosome 
abnonnalities in oncology (Cremer et al, 1988; Lichter et al, 1988, Ried et al, 
1992a) congenital malformation (Callen et al, 1995) and single gene disorder 
(Ried et al 1990). This is attributable to recent technical improvements with 
respect to sensitivity, multiplicity, and resolution. 
In the late 1980s, non-radioactive methods of detecting genes and 
chromosomes were developed, resulting in techniques which make chromosomes 
look colorful (Langer et al, 198 1). The most widely used and popular technique is 
"Fluorescence In situ Hybridisation" (FISH). In principle the FISH technique is 
based on molecular biology. In brief, complementary DNA complex present in 
chromosomes or interphase nuclei is denatured into single strands, Specific 
sequences of DNA (or probes) representing genes or chromosomal regions are 
tagged with one or more hapten molecules or fluorochrome conjugated 
nucleotides. These are then mixed with the single strand target DNA under 
appropriate conditions, for complementary binding (hybridisation) to take place. 
The hybridised labelled DNA sequences are visualised as fluorescent signals on 
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The technique can be easily applied to both dividing and non-dividing 
fixed cells (interphase cells), as well as tissue sections (Klinger et al, 1992; 
Lawrence et al, 1990). FISH has become one of the most widely adopted 
techniques, because of its sensitivity, cost-effectiveness and rapid reporting 
turnaround time of 24-48 hours. However, it is mostly used as an adjunct to 
routine high resolution cytogenetics methods. The application of FISH in 
detecting mutations or abnormalities depends upon the availability of probes, for a 
particular chromosome locus. A variety of FISH probes are currently made 
available commercially, which are extensively used in detecting numerical and 
structural chromosomal abnormalities (deletion, duplications) more accurately 
than routine cytogenetic method. DNA probes as small as I kb can be visualised 
on metaphase chromosome (Lawrence et al, 1990; Reid et al, 1993) and interphase 
chromatin (Lawrence et al, 1988). Protocols for Alu-polymerase chain reaction 
(ALU-PCR) of yeast artificial chromosome (YAC) clones provide a better tool of 
interphase diagnosis, with a detection efficiency up to 99% (Lenguer et al, 1992 a, 
b; Lenguer et al, 1993)'. The probes are available in four different categories based 
on their property of binding, (a) centromeric probes (cc-sat), (b) whole 
chromosome paints (WCP), {c) unique DNA-sequences, and (d) telomeric 
probes. 
Chromosome-specific centromeric probes 
These probes hybridise to repeated alphoid DNA sequences located at the 
centromeric/peri-centromeric region of specific human chromosomes (Moyzis et 
al, 1988). The centromeric probes are routinely utilised in detecting ploidy, 
detection of aneuploidy for specific chromosomes (21,18,13 or X and Y), in 
metaphase chromosomes, interphase nuclei (uncultured fixed cells) specimens or 
tumours, gametes as well as in in vitro fertilisation (Ried et al, 1992c). X and Y 
probes are widely used in the determination of sex in fetuses or in case of 
ambiguous genitalia (Guyot et al, 1988). Centromeric probes have also been 
applied in identifying marker chromosomes (Callen et al, 1990). However, 
centromeric probes are not suitable to detect structural unbalanced chromosomes 
rearrangements, as the FISH signals observed cannot be differentiated between 
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normal and abnormal chromosomes. Furthermore, the introduction of the primed 
in situ labelling (PRINS) technique (Koch et al, 1991) provides another way for 
direct detection of repeated sequences in chromosome (Gosden et al, 1991; 
Gosden and Lawson, 1995). It is based on the annealing of specific 
oligonucleotide primers and subsequent primer extension by Taq DNA polymerase 
in the presence of labelled nucleotide. 
Whole chromosome paintprobes 
These are either biotin or digoxigenin-labelled DNA segments 
complementary to unique DNA segments covering the length of the target 
chromosome. Hybridisation of these probes produces complete fluorescent signals 
(appearing as paint) over the whole chromosome. Whole chromosome paints 
(WCP) are useful in detecting complete or partial duplication of a specific 
chromosome, resulting from numerical or structural rearrangements (translocation 
or deletion), as well as to resolve unidentified additional chromosomal segments or 
marker chromosomes (Cremer et al, 1988; Pinkel et al, 1988). However, 
chromosome paints can not be used in interphase nuclei or gametes. WCP are not 
useful in detecting structural rearrangements other than translocations and 
deletions. Whole chromosome paints are available for short or long arms of 
specific chromosomes, known as chromosome arm paints (CAPS) (Guan et al, 
1996). 
Unique DNA sequence probes (single copy probes) 
These are composed of specific DNA sequences, which can be targeted 
against a specific 'locus' on a chromosome (chromosome band) in metaphase 
spreads, or interphase nuclei. The probe has its application in the precise diagnosis 
of submicroscopic deletions (microdeletions) or duplications not detectable by 
routine high resolution banding techniques. The single copy probe also is useful in 
detecting translocations, oncogenes, and amplified genes in malignancies in 
particular turnour suppressor genes (Albertson et al, 1989; Cherif et al, 1989). 
Unique copy probe are premixed or tagged with control probe (chromosome 
specific) as positive controls. 
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Telomericprobes 
Telomeric probes are more recent, helpful in identifying subtle, terminal 
deletions and tandem duplications. They are composed of unique DNA sequences 
which hybridize to complementary sequences present at, or near the 'telomeres' 
[tandem repeats (TTAGGG)n] (Moyzis et al, 1988). They are specific for either 
short arm (p) or long arm (q), of a chromosome. The telomeres are mostly G-band 
negative. 
Multiplex FISH 
Recent advances in FISH technology supported by sophisticated computer 
software (Smart Capture), filters sets and digital mapping devices such as charge 
coupled device (CCD) cameras increased the sensitivity of FISH. Multiple 
haptenisation and detection protocols, and combinatorial labelling approaches 
allow the simultaneous visualisation of several target regions in metaphase 
chromosomes and interphase nuclei (Nederlof et al, 1990; Ried et al, 1992b; 
Dauwcrse et al, 1992; Wiegant J, 1993; Tocharoentanaphol et al, 1994). 
Finally, the application of FISH technology in routine cytogenetic analysis 
has helped in the precise diagnosis of several cases of mosaicism, structural 
rearrangements, in particular, microdeletions and marker chromosomes, 
particularly the X and Y chromosomes (Callen et al, 1995; Hatchwell et al, 1996; 
Bettio et al, 1997; Henegariu et al, 1997). FISH has tremendous applications in 
cancer cytogenetics. However, FISH does not replace banding, but it aids in the 
detection of aberrations precisely. 
(C) Southern blot hybridisation: 
Another technique with wide application is Southern blot method. 
Essentially, the test DNA is digested with one or more restriction enzymes, size- 
fragmented by agarose gel electrophoresis, denatured, and transferred to a 
membrane for hybridisation (Southern et al, 1975). The main advantage of the 
technique is that no detailed knowledge of the sequence and the structure of a gene 
is required and a preliminary screen can be done with a probe of interest 
immediately after its isolation (Grompe M, 1993). Large deletions, duplications, 
and insertions can be detected by this method. In X-linked disorders such as 
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Duchenne muscular dystrophy (DMD), deletions result in complete absence of a 
sequence in an affected male. This is readily detected on a southern blot with a 
cDNA probe, because a DNA fragment will be absent or have a different length 
(Koenig et al, 1987). For autosomal genes and for female carrier of X-linked 
disorders deletion detection is more difficult. Quantitative Southern analysis can 
be done, but such approach can be laborious and subject to error (Abbs et al, 
199 1). Occasionally, the deletion results injunction fragment which can be helpful 
in heterozygotes detection. In some, a mutation creates or destroys a restriction 
enzyme recognition site which may be detected by southern analysis, Finally, 
Southern analysis has been used successfully to detect large trinucleotide repeat 
expansion in patients with FRAXA and myotonic dystrophy (Fu et al, 1991; 
Harley et al, 1992a). 
(D) PCR-based detection methods: 
Since the advent of PCR technology using a thermostable DNA 
polymerase, which allow the in vitro production of large amount of a target DNA 
sequence, various PCR-based methodologies have been developed for rapid 
detection of genetic variation (Grompe M, 1993; Cotton R, 1993). Both, genomic, 
DNA and mRNA can be used as templates for the PCR-based mutation strategies. 
The advantage of using mRNA which is reverse transcribed to cDNA as template, 
is that only the coding region will be analysed, leading to the rapid detection of 
gross deletions or alterations, minor alterations, or splicing errors, 
Multiplex PCR for the detection of deletion: 
Because 60% of dystrophin gene mutations are deletions, a rapid and 
efficient method of screening for deletions was introduced by Chamberlain et al 
(1989) to analyse six frequently deleted exons simultaneously in a multiplex 
amplification. The multiplex reaction efficiently detected 80-98% of all dystrophin 
gene deletions (Chamberlain et al, 1989; Abbs et al, 1991). Recently, Tuffery et al 
(1998) developed a multiplex PCR to analyse 17 exons of the dystrophin gene in 
one reaction. Therefore, this method has found wide use in the diagnosis of DMD 
disorder. The deletions in homozygotes are indicated by the absence of some of 
the bands in the multiplex pattern, while in heterozygote, the deletions are seen as 
50% reduction of band intensities in a quantitative analysis of the multiplex 
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reaction (Abbs and Bobrow, 1992). Since then the multiplex PCR applied to loci 
of known sequences prone to deletions and had been employed with other genes 
such as the 8-fragment multiplex PCR reaction of the human hypoxanthine 
guanine phosphoribosyl, transferase (HPR7) gene (Gibbs et al, 1990; Grompe M, 
1993). 
1.7.1.2 Detection of single base changes and small sequence alterations 
Single base alterations are the most common type of mutation of most loci. 
Changes of a single base can result in the insertion of incorrect amino acid or can 
change an amino acid to a stop codon. Some changes are conservative, substituting 
an amino acid with similar properties that may not affect the function of the 
protein, and represent polymorphisms and common genetic variants. In other 
instances, non-conservative changes result in an alteration of protein function or 
changes of an amino acid codon to a stop codon, causing premature termination of 
protein synthesis. Point mutation can also occur within an intron, where they may 
affect the fidelity of splicing (Krawczak et al, 1992). 
The detection of point mutation and small sequence alterations in a DNA 
sequence represent technical obstacles for the genetic analysis of human inherited 
disease. To face this problem many methods have been developed, particularly 
after the introduction of PCR (Grompe M, 1993; Cotton R, 1993). Mutations can 
be detected by: (1) analysis of single strand conformational polymorphisms 
(SSCP; Orita et al, 1989), (2) heteroduplex analysis (HA; White et al, 1992), (3) 
denaturing gradient gel electrophoresis (DGGE; Fischer and Lerman, 1983; Myers 
et al 1987) (4) chemical cleavage mismatch (CCM; Cotton et al, 1988) or RNase 
cleavage (Myers et al, 1985a). 
(A) Single strand conformation polynsorphism (SSCP) analysis: 
Owing to its simplicity and sensitivity SSCP is one of the most widely used 
method for the detection of point mutation. It is based on the fact that single- 
stranded DNA has a tendency to fold up and form complex structures stabilised by 
weak intramolecular bonds, and the electrophoretic mobility of such structure on 
non-denaturing gel will depend not only on their chain length but also on their 
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conformation, which in turn depends on its nucleotide sequence (Orita et al, 1989). 
With this method, PCR products are partially denatured to allow the formation of 
single stranded secondary structures and then electrophoresed in a non-denaturing 
polyacrylamide gel. A test DNA sample that differs by a single base from a 
standard DNA sample can be detected as a comparative mobility shift during 
electrophoresis if the base results in a change of conformation. There are however, 
discrepancies in the reported sensitivity of this technique (Hayashi K, 1992; Sarkar 
et al, 1992 a, b; Hayahi and Yandell, 1993). Detection rates reported varies from 
79% to 96% when PCR product of 200 bp or less and rapidly falls to <50% when 
the size is more than 400 bp (Hayashi K, 1991; Grompe M, 1993; Sarkar et al, 
1992 a, b). Several technical factors that might affect sensitivity, including the type 
of gel matrix, electrophoresis condition, the dimension of the gel, overloading the 
gel, and the isotope used (Dianzani et al, 1993). The sensitivity of SSCP is 
improved when the analysis is carried out on an RNA copy of the sequence, since 
the secondary structure of RNA is more suited to SSCP (Dianzani et al, 1993). 
(BIR) Heteroduplew analysis: I 
Heteroduplex analysis (HA) takes advantages of the formation of 
heteroduplexes between mutant and wild type sequences. Heteroduplex molecules 
containing single base pair mismatches can be accurately separated from related 
nonhomoduplex on nondenaturing gel (Keen et al, 1991; White et al, 1992). This 
phenomenon is thought to be caused by sequence dependent conformation changes 
in the double strand DNA induced by mismatch. Although IIA is as simple as 
SSCP, its application has not been so widespread, because of its later description 
and because of the need for Hydrolink gels in the initial description (Keen et al, 
1991). Recently, new gel matrices (Hydrolink and MDE from AT Biochem) 
(Grompe M, 1993) have become available, which markedly enhances the ability to 
detect mutation induced mobility shifts in heteroduplex molecules. fleteroduplex 
analysis on Hydrolink gel has been successfully applied to mutation screening in 
several genetic diseases. This simple technique was reported to be able to identify 
different types of genetic alteration including point mutation and minor deletion or 
insertion in PCR fragments of different sizes from about 200 up to 1400 bp 
(Tassabehji et al, 1992). The main disadvantage of IIA is the lack of 100% 
detection as in SSCP analysis (80-901/6) and the sensitivity increase with 
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decreasing the size of the DNA fragment (optimal <300 bp) (Perry et al, 1992; 
White et al, 1992). Both isotopic and non-isotopic methods have been used (Perry 
et al, 1992; White et al, 1992; Yap and McGee, 1992). 
(C) Denaturing Gradient Gel Electrophoresis (DGGE): 
This method of mutation detection is developed by Myers et al (1985a, b), 
compares homoduplexes with heteroduplexes of wild type and mutant DNA 
strands in terms of their electrophoretic mobility. In principle, when a double 
stranded DNA (dsDNA) fragment is subjected to electrophoresis through a 
gradient increasing concentration of a denaturing agent it will reach a certain point 
in the gradient where its lowest melting temperature domain melt to create a 
branch molecule which effectively does not move any further through the gel 
matrix. The melting behaviour is sequence dependent. Strand separation at a 
domain in a DNA fragment is detected as a reduction in the mobility of the 
fragments. Two dsDNA fragments of the same sizes but differing in sequences, 
melting at different points in a DGGE and can be distinguished by differential 
migration. 
A major draw back of DGGE technique initially was its insensitivity to 
mutations in regions of the DNA which melt last in the gradient of denaturant, 
because at this point the strands separate and the resolution is lost. To observe the 
effect of mismatches in the highest melting domain, a modification was designed 
that involved the addition of a GC-rich fragment (Myers et al, 1985b; Myers et al, 
1985c). Detection is usually carried out by a non-radioactive means (Fodde et al, 
1994). DGGE can detect mutations with 95% accuracy in PCR products of up to 
600 bp in length (Grompe M, 1993). 
(D) Chemical Cleavage Mismatch Detection: 
The cleavage methods of mutation detection are also based on the principle 
of detecting differences between wild type and mutant single-stranded molecules 
when a heteroduplex is formed between the two. In RNase cleavage (Myers et al, 
1985a) a ribonucleic acid probe hybridised to RNA or DNA containing. one base 
difference can be cut at the mismatch by ribonuclease (RNase A). Mutation can 
then be detected and located after analysis of the cleavage products by gel 
electrophoresis (Dianzani et al, 1993). However, the method is not very sensitive, 
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it detects only one third to two third of point mutations (Dianzani et al, 1993; 
Myers et al, 1985a). Given the limitation of the enzymatic cleavage methods of 
mutation detection, Cotton et al (1988) developed an assay for detection of 
heteroduplex mismatches using Maxam and Gilbert cleavage chemistry (Maxam 
and Gilbert, 1980). The mutation screening by chemical cleavage mismatch 
method (CCM) is based on the fact that mismatched cytosine (C) and thymidine 
(T) are much more reactive with the compounds, hydroxylamine and osmium 
tetroxide, respectively, than are the matched pair C and T. Double strand DNA 
treated in this way can then be cleaved opposite the modified bases by piperidine 
and the fragments separated by gel electrophoresis. The main advantages of CCM 
are high detection rate (79-100%; Forrest et al 1991) and the ability to screen 
kilobase lengths of DNA or RNA (up to 1.7 kb; Grompe M, 1993). Moreover, 
CCM gives in the approximate location of the mutation by estimating the size of 
the cleavage product as well as the type of base change from the cleaving reagent. 
While all of these methods have been used successfully for identification of 
alleles, which cause disease, SSCP (because of simplicity) and DGGE (because of 
its near 100% sensitivity) are the favoured techniques. A draw back of SSCP is 
that two or three different gel conditions are required to detect all mutation in 
fragments and DGGE suffers from the need for special equipment and more 
expensive GC-clamps (Dean M, 1995). Moreover, some methods are not suitable 
for screening large numbers of individuals, because of their complexity. This is the 
case for RNase cleavage and CCM methods. 
("' Direct sequencing: ILV 
The ultimate molecular characterisation of a mutation is at the level of the 
nucleotide sequence and with the availability of the PCR technique, sequence 
information has become readily available, Sequencing can be used either as a 
screening or a diagnostic method. Direct sequencing of PCR products has been 
used as the primary mutation screening method to detect mutation in parts of large 
genes (Higuchi et al, 1990) or by sequencing an entire coding sequences (Mogne 
et al, 1992). 
The methods of Sanger (1977), Maxam, and Gilbert (1980) for rapid DNA 
sequence determination have formed the corner stone of the sequencing technique 
used today. Of the two methods, Sanger's one is most widely used. The Maxam 
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Gilbert technique for sequencing DNA is based on a chemical procedure that 
breaks a terminally labelled DNA molecule partially at each repetition of a base. 
The lengths of the labelled fragments then identify the position of that base. They 
described a reaction that cleaves DNA preferentially at guanine, adenines and 
guanines equally, at cytosine and thymines equally, and at cytosine alone. When 
the products of these four reactions are separated by high resolution denaturing 
polyacrylamide gel electrophoresis, the DNA sequence can be read from the 
pattern of radioactive bands. 
The Sanger's method also known as dideoxy sequencing or chain 
termination is an enzyme-based method. In this approach the usual first step is to 
prepare a single-stranded DNA from the DNA to be sequenced. A chemically 
synthesised oligonucleotide primer is annealed to its complementary sequence on a 
single stranded DNA template. The primer/template duplex is then used as a 
substrate of chain extension from the 3' end of the primer by DNA polymerase. 
Four separate synthesis reactions are carried out. Each include all four nucleotide 
dATP, dCTP, dGTP, and dTTP, one of which carries a radioactive isotope, 
together with one of the four dideoxy nucleotide (ddNTP) analogue, ddATP, 
ddCTP, ddGTP, and ddTTP. Incorporation of ddNTPs causes chain termination 
since they lack a Y-hydroxyl group, Random low level incorporation of a specific 
ddNTP, in competition with the normal dNTP analogue, will result in mixture of 
different length chains, all starting at the 5' end of the primer and ending at every 
possible position where the specific ddNTP can be incorporated in place of the 
dNTP. The average length of the resulting chain can be altered by changing the 
ddNTP/dNTP ratio within the reaction mixture. For example increasing relative 
concentration of ddNTP will result in a short average chain length. These four sets 
of reactions are then fractionated alongsidc each other by denaturing 
polyacrylamide gel electrophoresis. On conventional sequencing gels about 200- 
400 nucleotides can be determined from a single DNA sample. 
1.7.2 Methods to detect knows sequences alteration (diagnostic techniques) 
Once a particular disease causing mutation has been identified in a family, 
diagnostic techniques are called into use. The genetic screening programmes of the 
general population are aimed at preventing common genetic diseases. There are 
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several approaches for conducting genetic screening which dependent on the target 
population and the type of the disease (Caskey T, 1993). Genetic screening is 
offered to populations at high risk of autosomal recessive disorders such as Tay- 
Sach disease (Kaback M, 1981), hemoglobinopathesis (sickle cell anemia or 
thalassemia) and lately for cystic fibrosis (Scriver and Fuiwara, 1992). These 
techniques are generally simpler than those used in the original identification of 
mutation. This can be achieved by the following methods; (1) allele specific 
oligonucleotide hybridisation (ASO) (Wallace et al, 1979), (2) allele specific PCR 
amplification or by an amplification refractory system (ASA/ARMS) (Wu et al, 
1989; Newton et al, 1989a), (3) restriction enzyme digestion (if a site has been 
created or abolished), (4) artificial introduction of a restriction site (AIRS)(Cohen 
and levinson, 1988), or (5) SSCP or HA. Direct sequencing of PCR products may 
also be the method of choice. 
(1) Allele-spcciflic oligonticleotide (ASO) hybridisation 
A point mutation, which does not produce a restriction site change, may 
still be detected using allele-specific oligonucleotide (ASO) probes. 
Oligonucleotide probes can therefore be designed to hybridise to specific alleles of 
a gene, which differ by a single nucleotide at a diagnostic site. Two probes are 
made, one has the normal sequence, while the other is identical except for a single 
altered base corresponding to a particular mutation (Wallace et al, 1979). ASO 
probes are typically 15-20 nucleotides long and are normally employed under 
stringent hybridisation conditions at which the DNA duplex between probe and 
target is only stable if there is perfect base complementarity between them. ASOs 
can be used in conventional Southern blot hybridisation, it is more convenient to 
use them in dot-blot assays. Both radiolabelled and fluorescently labelled probes 
have been used. In reverse blot (Saiki et al 1989) different probes were spotted 
onto the membrane and the biotin-labelled target sample applied. The probes 
forming duplexes without mismatches and retaining the target became stained with 
HRP avidin. The approach is feasible if the DNA sequence causing a genetic 
disease is known and if the number of disease-causing mutations is limited (such 
as sickle cell disease and cystic fibrosis). DNA from normal individuals will 
hybridise only to the wfld-type oligonucleotides, heterozygotes, will hybridise to 
both, and individual homozygote for the mutation will hybridise to only to the 
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mutant oligonucleotide. Multiple mutations can be detected in a single reaction by 
mixing several hybridisation probes (Saiki et al. 1986). 
(2) Amplification refractory mutation system (ARMS) 
The PCR depends on elongation from the 3' end, by Taq polymerase, of a 
double-stranded template to the target DNA. Naturally, if the template is 
mismatched at the 3' end, the PCR will proceed less efficiently and, over 20 or 30 
cycles, this will have a significant effect. In the amplification refractory mutation 
system (ARMS) two sets of primers are used, each set designed in such a way that 
amplifies only either the normal or the mutant allele. Primers that are mismatched 
with either target sequence by only single nucleotide at their 3' ends will not 
amplify the DNA to which they anneal. Two parallel reactions are ran; one will 
prime with oligonucleotides corresponding to the wild type sequence, and a second 
corresponding to a known mutation. The former will amplify normal copy of the 
gene, while the later will amplify the mutant copy (Newton et al, 1989a). DNA 
from heterozygote individual will amplify with both primers. A second pair of 
primers, producing a different size of product, is normally introduced in the same 
reaction as a positive control. ARMS have found wide spread use in the diagnostic 
laboratory and are routinely used for diagnosis of thalassemia (Old et al, 1990) and 
cystic fibrosis (Newton et al, 1989b). 
(3) Artiflcial introduction restriction sites (AIRS) 
Many mutations, but not all, naturally create or remove restriction enzyme 
sites. The artificial introduction of restriction site system (AIRS) provides an 
alternative way of making restriction enzyme detection of sequence changes, 
which is more universally applicable (Cohen and Levinson, 1988). A mismatch is 
deliberately introduced, by a primer that has one base mismatched near to the site 
of mutation, to create an artificial restriction enzyme site in the PCR product, 
either in the normal or mutant cases. Therefore, presence of the mutation will 
make the proper recognition site for a specific restriction endonuclease. Digestion 
of the PCR products using this enzyme followed by gel electrophoresis will enable 
the identification of the presence or absence of the mutation in the sample. AIRS 
have been used successfully to screen for common mutations in different genes 
such as Duchenne muscular dystrophy (Yau et al, 1993) and phenylketonuria 
(Eiken et al, 199 1). 
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1.8 Aims of the present project 
The overall aims of the present project are to optimise and apply methods 
that detect large or small sequence DNA alterations in patients with sex 
chromosome aberrations and sex determination / differentiation abnormalities. 
These patients were chosen because of the differences with regard to known 
molecular pathology, available gene information and the availability of studying 
material (DNA or chromosomal fixed materials). The spectrum of the mutations 
ranges from cytogenetically visible chromosome abnormalities to microdeletions, 
and finally to single base alterations. This will involve the application of 
cytogenetic, molecular cytogenetic and molecular genetic investigations. The 
specific targets are summarised as follows: 
I) Cytogenetic and molecular c togenetic studies Y 
i) To optimise the FISH technique using different probes such as the repeated 
sequences (e. g. the alpha satellite centromeric probes of X and Y 
chromosomes), whole chromosome libraries specific for both the X and Y 
chromosomes (chromosome painting), and X and Y-specific probes. 
b) To optimise multi-colour FISH using the optimised probes in the uni-colour 
FISH experiments. 
iii) To apply FISH to diagnostic problems in clinical cytogenetics in patients with 
sex chromosome abnormalities. 
iv) To analyse the X-inactivation pattern using BrdU labelling (late replication) 
methods of structurally abnormal X chromosomes particularly ring X 
chromosomes and to correlate it with the phenotype if it is possible. 
II) Molecular Genetic studies: 
To detect and fully characterise mutations in the androgen receptor gene (AR) 
in patients with androgen insensitivity syndrome (AIS). 
ii) To detect mutations in the sex determining (SRI) gene in patients with sex 
reversal (46, XY female). 
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iii) To detect Y sequences, particularly of the SRY gene in males with female 
karyotypes (46, XX male). 
iv) To develop diagnostic screening methods for mutation detection in male 
patients with non-obstructive infertility. The screening programme is based on: 
(1) microdeletion detection in azoospen-nia factor (AZF) region(s) by 
optimising and applying multiplex PCR using 28 different pairs of primer sets. 
2) To detect microdeletions of the RBM gene family by applying FISH and 
Southern blotting techniques using MK5 and Mk29 cDNA probes (specific for 
RBM gene family) as a first step of the screening method. 3) To carry out a 
comprehensive search for mutations in the RBMI gene by designing primers 
spanning the entire essential sequence of the gene to enable PCR-based 





(2) MATERIALS AND METHODS 
2.1 Patients 
A total of 93 patients with known or with possible sex chromosome 
abnormalities were investigated. Table 2.1 summarises the patient categories and 
the techniques applied for studying each category. 
Twenty four patients were referred from Duncan Guthrie Institute (DGI) 
and from Kuwait Medical Genetic Centre with known or suspected X and Y 
chromosomes abnormalities. These patients were studied at cytogenetic and 
molecular cytogenetic level. Out of these seven patients with Turner phenotype 
carrying ring chromosomes and one patient with 46, XXp+ karyotype were studied 
for late X replication. 
Thirteen of the investigated patients were referred due to sex disorders. 
Four male patients with 46, XX karyotypes were investigated by cytogenetics, 
molecular cytogenetics and by molecular genetics for the presence or absence of Y 
chromosome material. Five females with 46, XY karyotype were clinically 
suspected to have androgen insensitivity syndrome, while 4 females with 46, XY 
karyotype were clinically classified as gonadal dysgenesis syndrome. 
Blood samples were collected from two different male infertility clinics in 
Kuwait from a total of 56 males with azoospermia (sperm number of zero) or 
severe oligoospermia (sperm count <2 million/ml). 
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2.2 materials and Solutions: 
Supplemented RPMI 1640 
To 100 ml. of RPMI 1640 the following were added: 
Material Final concentration 
PHA 2% 
Fetal calf serum 
L-Glutamin 
Penicillin/Streptomycin 
(5000 Unit/ml/5000 gg/ml) 
Stored at 4T. 
Ix Iscoves Medium 




Material Final concentration 




The media was stored at 4T. 
1% 
Hypotonic Solution (0.0 75 Mpotassium chloride) 
For every 100 ml deionized water 0.5 6 gm of KCI added and stored at room 
temperature for up to two weeks. 
Carnoys Fixative 
3 parts methanol to I part glacial acetic acid prepared fresh each harvest. 
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NormalSaline 
0.09% NaCI (sodium chloride) 
Sorensens Buffer pH 6.8 
(a) 10 X anhydrous potassium phosphate monobasic (KH2P04) Wl 5 
9.09 gm KH2P04 dissolved in 100 ml distilled H20. Stored at 4"C. 
(b) 10 X Anhydrous Sodium phosphate dibasic W15 
11.88 gm Na2HP04 dissolved in 100 ml distilled H20. Stored at 4T, 
Working buffer was prepared by mixing 5 ml of K2HP04 and 5 ml of NaH2PO4 in 
90 ml distilled water. Adjusted PH to 6.8 and stored at room temperature. 
10yo stock trypsin solution 
200 mg trypsin 1: 250 (Difco) reconstituted with 20 ml sterile normal saline. 
Aliquoted in 1.0 ml lots and frozen. 
0.02 % working trypsin solution 
I ml 10% stock trypsin diluted in 49 ml normal saline. Prepared fresh each 
harvest. 
Gienisa Stainhig solution 
Two gm of Giemsa powder dissolved in 132 ml of glycerol. Incubated in water 
bath for 2 hours at 56*C, cooled and then 132 ml of methanol was added. The 
mixture was then shaken well and kept in a dark place for seven days. The stain 
was then filtered through Whatman IMM paper and stored in brown bottles for 
use. 
211o Giemsa solution 
ml Giernsa added to So ml (PH 6.8) working Sorensens, buffer solution. 
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Leishman staining 
3 gm of Leishmans powder dissolved in 2000 ml of methanol, filtered through 
Whatman I MM paper and used 
Fluorodeoxy uridin e (MR) stock solution (4 x 10'4 M 
To 50 ml distilled water added 5 mg FUdR stored frozen in dark vials. 
Uridine stock solution (3 x 10 AD 
To 10 ml distilled was added 10 mg uridine and stored frozen as small aliquots. 
BrdU solution (1.5 mglml. - working solution) 
To 17 ml distilled water added 30 mg BrdU, 2 ml uridine stock solution, I ml 
FUdR stock solution. Filter sterilised and stored frozen in dark vials. This solution 
can be used over a period of 2 weeks. 
Hoechst 33258 solution (150, ugr1ml) 
To 100 ml distilled water added 15 mg Hoechst 33258. Stored frozen in dark 
vials. 
Phosphate Buffer PH 6.8 
Buffer consisted of 0.025 M KH2P04 (3.4 grn/L) titrated to PH 6.8 with 50% 
NaOH (sodium hydroxide). 
2XSSCsolution 




I part Leishmans stain, 3 parts phosphate buffer 
Luria-Broth Media (LB) 
To 450 ml of deionised water the following were added: 
Bacto-tryptone 5.0 gm 
Bacto-yeast extract 2.5 gm 
NaCl 5.0 gm 
Adjusted PH to 7.0 with concentrated NaOH. The volume was adjusted to 500 ml 
with deionised water and then sterilised by autoclaving at 121"C for 20 minutes. 
The medium was cooled and then an appropriate antibiotic with final 
concentration of 60-100 [ig/ml was added under sterile conditions and kept at VC 
until used. 
SOC Media (1.020 litre) 10 gm bactotrypton 
5 gm bacto yeast extract 
5 gm NaCl 
PH 7.5, adjusted by 5M NaOH. 
Sodium citrate (]AD 
29.4 gm of sodium citrate was dissolved in 90 ml of ddH20. The PH was adjusted 
to 5.8 and then the volume was adjusted to 100 ml with d1120, 
ED TA (0.1 M) 
3.2 gm of EDTA was dissolved in 90 ml of d1120. The p1l was adjusted to 8 and 
then the volume was adjusted to 100 ml with d1120. 
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SM Potassium Acetate 
4.9 gm of potassium acetate was dissolved in 10 ml. H20. 
T. E. buffer 
10 mM Tris-HCI was mixed with I mM EDTA, PH 8.6. The obtained solution 
was filter sterilised and stored at room temperature. 
IOx TAE buffer 
The following were added: 
Tris base 108 gm 
Boric acid 55 gm 
EDTA 9.3 gm 
To 800 ml of dH20 and dissolved. The pH was adjusted to 8.1-8.2 with IN 
NaOH. The volume was adjusted to I litre by dH20 and stored at room 
temperature. 
T. A. E buffer SOX 
Tris base 242 gm 
Glacial acetic acid 57.1 ml 
0.5M EDTA, PH 8.0 100 ml 
dH20 UP tO I litre 
6 XAgarose gel loading Mix 
Bromophenol blue 0.25 gin 
Sucrose 40% (w/v) 
Dissolved in IX TBE buffer 
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Salmon Sperm DNA (20 mglml) 
200 mg salmon sperm DNA dissolved in 10 ml of distilled water and incubated in 
a 701C water bath for 10 minutes. The solution then sheered by repeatedly passing 
through a needle (21G) attached to a 10 ml syringe. The tube then sonicated for 
3x4 minutes at 4 volts. The fragment size of sonicated DNA was checked by gel 
electrophoresis in 0.8% agarose gel and stored at 40C. 
IOOXDenhardt's solution 
BSA (bovine serum albumin) 2% (w/v) 
Ficoll 2% (w/v) 
Plyvinylpyrrolidone (PVP) 2% (w/v) 
Hyrhridisation buffer] 
5 ml Formamide (Fluka) 50% (v/v) 
2 ml 50% dextran sulphate 10% (W/V) 
0.5 ml 20 X SSC Ix ssc 
2.5 ml sterile water 
Aliquoted and stored at -200C 
Hybridisation buffer 2 
Two gm of dextran sulphate was dissolved in 4 ml of deionised water and then the 
following were added: 
Formamide (Fluka) 
20 x SSC 
10 ml 
2.0 ml 
Salmon Sperm DNA (10 mg1ml) 200 ptl 
The contents were mixed very well, aliquoted in Iml volumes in eppendorf tubes 
and stored at -20*C until used. 
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20XSSC 
Tri-sodiurn citrate 44.1 g 
Sodium chloride 87.6 g 
Dissolved in dH20, adjusting the volume to 500 ml and stored at room 
temperature. 
4XSSC, Tween-20 
100 ml of 20 X SSC diluted in 400 ml dH20 then 250 ýtl of tween-20 was added. 
The solution was mixed and stored at room temperature. 
Wash A solution 
20 X SSC 100 ml 
Tween-20 
Dried skimmed milk 
250 [d 
25 gm 
The volume was adjusted to 500 ml with dH20, mixed well and then spun at 200 
rpm for 15 minutes. The solution was freshly prepared for every experiment. 
DAN (4,6-diamidino-2-phcnyl-indole)- working solution (40 ýLg/ml) 
I gl of DAPI (mg/ml) was diluted in 24 gl of distilled water, mixed and stored in 
dark at 4 OC until used. 
Propidiuns iodide - working solution (20 gg/ ml) 
2 gI of propidium iodide (10 mg/ml) was diluted in 988 gl of distilled water, 
mixed and stored in dark at 4 OC. 
TojE buffer I OmM Tris-HCI, PH 7.4 
0.1 mM EDTA 
74 
20X TTE 
CIR CLEPREP Kit BIO 101: Cat. No. CP-1 00) 
216 g Tris base 
72 g taurine 
4gEDTA 
distilled water yp to I litre 
The kit contains the following: 
* Pre-lysis buffer. (Tris/EDTA/ glucose solution) 
* Alkaline lysis reagent (0.2 NNaOH and 1% SDS). 
Neutralising solution (3M Potassium acetate) 
Lithium Chloride solution (near saturated solution) 
* Circleprep Glass milk 
9 Binding buffer (KBrNaI/Tris mixture) 
& Wash solution 
9 Sieve material 
BRL Nick Translation Kit (GIBCO BRL, Cat. No. 8160SB) 
The kit supplied the following reagents and solutions: 
e Solution A4: 0.2mM nucleotides C, G and A in 500 mM Tris-HCL (PH 
7.8), 50 mM Magnesium Chloride. 
Solution C: 0.4 units/gl DNA polymerase 1,40 pg/gl DNA Pol I/DNase I, 
50 mM Tris-HCI, pH 7.5,5 mM Magnesium acetate, mM 2-mercaptoethanol, 
0.1 mM phenylmethylsulphonyl fluoride, 50% glycerol and 100 gg/gl bovine 
serum albumin). 
Solution D: 300mM disodium EDTA, pH 8. 
Solution E: dH20. 
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Digoxigenin DNA labelling Kit (Boeshringer Mannheim Biochemica'CatBo 
1175033) 
The kit contains the following: 
" Unlabelled control-DNA 1: One vial with 20 ýil pBR328 DNA, 100 pg/ml. 
" Unlabelled control-DNA 2: One vial with 20 41 pBR328,200 ýig/rnl, 
linearised with BamH 1. 
" DNA dilution buffer: Two vials with I ml of 50 4g/mI herring sperm DNA 
in 10 nmol/1 Tris-HCl and I mmol/l EDTA, pH 8.0 each. 
" Labelled control DNA: One vial with 50 41 linearised pBR328 DNA, 
labelled with digoxigenin. 
" Hexanucleotieide Mixture: One vial with 80 ýtl 10 X concentrated 
hexanucleotide reaction mixture. 
" dNTP Labelling Mixture: One vial with 80 41 of 10 X concentrated dNTP 
labeling mixture containing dATP, I mmol/l; dGTP, 1 mMol/l; dTTP, 0.65 
mmol/l; Dig-dIT[, 0.35 mMol/l; pH 7.5. 
" Klenow EnMe, labeling grades: One vial with 40 41 Klenow enzyme 
labelling grade, 2 Units/ýtl. 
Slide cleaning 
Slides are cleaned in absolute alcohol before use to facilitate uniformity of 
spreading and to increase metaphase quality and banding quality. Slides are 
soaked briefly in ethanol, wiped with a tissue or gauze, and then dipped back into 
the absolute alcohol before dipping in distilled water. Alternatively slides are 
soaked in detergent (100% Decon 90: Decon Laboratories Limited) then slides 
were rinsed thoroughly under running tap water in order to clean them completely 
from the detergent. Slides then stored in 70% alcohol till use. On the day of using 
the slides, slides were rinsed with tap water completely to get rid of alcohol. 
76 
Table 2.1: Summary of cases investigated and techniques applied. 
Subjects No. of Remarks/Ref. Techniques 
Cases Diagnosis AP-Plie4 
....... - -- -- 
Al Known or suspected 24* 
chromosomal abnormalities 
BI Sex-reversal 
i) 46, XX males =3 
ii) 46, XX inale =I 
iii) 46, XY females =5 
iv) XY gonadal 
clysgenesis =4 




(a) Turner phenotype = 16 FISH 
(b) Primary amenorrhea =2 
(c) Failure to thrive; 
developmental delay =2 
(d) MCA= 2 
(e) Ambiguous genitalia= I 
(f) Short stature =I 
Infiertility Cytogenetic 
FISH 
Hypogonmhsm; Undescended Molecular 
testes 
CAIS=3 Cytogowtic 
PAIS =2 Molecular 
Pure gonadal dysgenesis =2 Cytogenetic 
Inconiplete gonadal dysgenesis =2 F'ISI I 
Molecular 
Cytogenetic 
a) Azoospermia = 32 FISI I 
b) Severe oligoospermia = 24 Molecular 
Total 93 
Refer to Table 3.1 for detailed description of chromosomal abnormalities. 
** Refer to Table 3.5 for detailed description. 
CAIS = Complete androgen insensitivity syndrome; PAIS = Partial androgen insensitivity 
syndrome. MCA = Multiple congenital anomalies 
2.3 Cytoffenetic studie 
2.3.1 Chromosomal preparation from stimulated Derinheral blood 
In principle, blood is cultured for 72 hours in media containing mitogen 
[usually phytohemagglutinin (PHA)] which is added to stimulate 
lymphoproliferation. Before harvesting the culture is treated with colcimid to 
arrest the cell cycle in metaphase. The culture is then treated with a hypotonic 
solution to swell the lymphocytes and is subsequently fixed in a methanol: acetic 
acid solution. 
10 ml of peripheral blood sample was collected in a sterile 10 ml lithium 
heparin tube and gently mixed to prevent clotting. 0.1 ml of blood was added to 10 
ml complete RPM 1 1640 supplemented media or I ml of blood cultured in 10 ml 
Ix Iscoves medium and the cultures were incubated at 37'C for 72 hours. 0.1 ml 
of colcimid (10 ýLg/ml) was added to each 10 ml culture and incubation at 37"C 
was continued for an additional 30-60 minutes. The culture tubes were then 
centrifuged at 1200 rpm (400g) for 8 minutes using Beckman GH-3.7 rotor in GS- 
6 centrifuge (Beckman, California). Carefully the supernatant was removed and 
discarded into 1/10 volume Chloros and the pellet were resuspended in 10 ml of 
0.075 M KCI. The tubes were incubated for 15-20 minutes at 37"C and then 
centrifuged at 1200 rpm (400g) for 8 minutes. The pellets were resuspended in 10 
ml of fresh fixative by flicking, pipetting or vortexing and the tubes left to stand at 
room temperature for 30-60 minutes. The tubes were then centrifuged at 1200 rpm 
for 8 minutes and the pellets washed in fresh fixative. This step was repeated 2-3 
times before the cells were resuspended in 10 ml fixative and stored at 4"C or at - 
20T until needed. 
2.3.2 Slide jDreparation 
Chromosome pellets removed from 4"C or -2011C storage and allowed to 
come to room temperature. The tubes were centrifuged at 1200 rpm for 8 minutes 
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resuspended in 2-3 ml fresh fixative until the solution was just slightly hazy. A 
few drops (3-5 drops) of cell suspension were dropped onto wet cold slides from 
approximately 15 cin distance and slides allowed to air dry. The slides were 
viewed under phase contrast (10x objective) to evaluate mitotic index, metaphase 
quality and chromosome morphology. 
2.3.3 Giemsa banding 
Giemsa banding (G-banding) has become the most widely used technique 
for the routine staining of mammalian chromosomes. The most common methods 
to obtain this banding pattern are to treat slide with a proteolytic enzyme such as 
trypsin (Seabright, M, 1971) or to incubate the slides in hot saline citrate (Sumner 
et al, 1971), although a variety of other methods have been used. 
In this study G-banding was produced on freshly made metaphase spreads 
by a modification of Seabright 1971 method. In general, slides for G-banding 
should be aged 3-5 days at room temperature or overnight (16-18 hrs) at 56-60"C 
for optimal results. To get optimal result of G-banding slides were aged overnight 
at 56-60*C. Slides were then treated for 20-40 seconds in 0.02% working trypsin 
solution (10% stock solution). Slides then rinsed thoroughly with normal saline 
stained for 5 minutes in 2% Giemsa solution, rinsed in distilled water, and then air 
dried. 50 cells were counted and 5 cells were analysed for full karyotyping for all 
cases using Axioplan Carl-Zeis light microscope. 
2.3.4 Late replication study of X-chromosome LRX [Reverse bandina using 
5-BromodeoxvuridineJ BrdU) and Giemsa (RBG)] 
Chromosomes and their segments replicate at different times during the S 
phase. This phenomenon has been extensively studied both itself and for its 
implications for chromosomes structure and function. 
This technique can be achieved for example by growing lymphocytes in 
thyrnidine-containing-medium and then a medium with BrdU. The late replicating 
chromosomes including inactive X chromosome are darkly fluorescent with 
quinicrine and faintly stain with Giemsa. Yet the inactive X is not completed 
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inactive, there are several segments escaping inactivation especially the pseudo 
autosomal. segment Xp22.3 and the postulated inactivation centre at Xq13.1 
(Rooney and Czepulkowski, 1992). 
Differential replication studies were conducted using IH of peripheral 
blood in 9 ml Ix Iscoves culture medium containing PHA. Cultures were then 
incubated at 37'C for 63 hours. 0.2 ml BrdU solution (1.5 mg/ml) was added to 
each culture and incubated in the dark (using aluminium. foil) for a finther 6 hours 
at 3711C. Then cultures incubated with 0.1 ml of colcimid in dark at 3711C for a 
further 45 minutes. Cultures then harvested as normal as described previously 
taking care not to expose cultures to light in order to prevent photodegradation of 
BrdU. The incorporation of BrdU was detected using Hoechst/Giemsa staining 
procedure with some modification according to Latt (Latt SA 1973). To each 
prepared slide few drops of Hoechst 3358 solution (150 jig/ml) were added, 
covered with a cover slip (22X 50 mm) and allowed to stand for 15 minutes in the 
dark at room temperature. The cover slips were carefully removed by forceps 
taking care not to scratch the slide. Slides were then rinsed in distilled water and 
allowed to air dry. The slides were mounted in 2x SSC with cover slips and' 
exposed to ultraviolet (long wave) at a distance of 20-25 cm for 2 hours. Slides 
then rinsed in distilled water and air-dried. The slides then stained in freshly 
prepared Leishmans stain for 2 minutes, mounted in Histoclear and were viewed 
with a Zeiss Axioskop microscope. 
2.4 Molecular cylopenetics: Fluorescence in-situ hybridisation 
(FISH) 
Fluorescence in situ hybridisation. (FISH) involves hybridisation of biotin 
or digoxigenin- labelled DNA probes to denatured metaphase chromosomes and 
interphase nuclei and visualisation of those probes with fluorochrome conjugated 
reagents. Minor variations in hybridisation and washing conditions permit 
successful visualisation of single-copy probe, whole arm paint (CAP), whole 
chromosome paint probes and repetitive-element probes. 
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2.4.1 Probe preparation 
Different types of X and Y chromosome specific probes were used in this 
study (Table 2.2). Some of the probes were prepared in this department and some 
were commercially obtained. Probes used in this study consisted of single-copy 
probes, repetitive element probes, whole arm paints (CAP), and whole 
chromosome paints. 
Fourteen different probes specific for the X-chromosome were used. A set 
of three overlapping cosmids CPT4, CAL24 and CPTI, mapping to Xp2l. 1-21.3 
were used. These cosmids cover 80 Kb of the distal half of intron 44, exon 45 and 
10 kb of the 5' end intron 45 of the dystrophin gene (Blonden et al, 1989). 
Another set of three cosmids 141R, G9L and VK21, mapping to Xq27-28 of the 
FRAX-A/E gene (fragile site) were used. These cosmids correspond to the loci 
G9L (G9LB, I CRFC 104DO8104), 14 1R (EZI 65, ICRFC 100132165) and VK21 
(G3/1) respectively (Hirst et al, 1991, Flynn et al, 1993). The G9L locus lies 
approximately 70 Kb proximal, 14 1R 120 Kb distal and VK21 up to 650 Kb distal 
to the FMRI CpG island (Flynn et al, 1993). 
The commercial probes that were used in this study were DXZI, KAL, 
DXZ4, XIST and X-chromosome paint. The DXZI (Oncor) is a 2.0 Kb BamH1 
fragment which hybridises to highly repeated alphoid DNA located at the 
centromere of the X-chromosome (Waye and Willard, 1985). Both biotin and 
digoxigenin labelled DXZI were used. The Kallman (KAL and DXZ1 
commercially combined probes from Oncor) allows the identification of deletion 
in the region of the KAL gene at Xp22.3 region (Ballabio et al, 1989). The DXZI 
control probe is included to facilitate chromosome identification. The DXZ4 
(Oncor) is a human X chromosome microsatellite probe which detects satellite 
DNA at a locus near band Xq24. The Oncor probe (XIST) for the X-inactivation 
locus was also used in the study for identifying the specific human sequences in 
the XIST (Xi-specific transcript) gene in either metaphase chromosomes or 
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the XIST (Xi-specific transcript) gene in either metaphase chromosomes or 
interphase nuclei. This probe is assigned to XqI 3.2 (Brown et al, 199 1). Whole 
chromosome paint of X chromosome was purchased from Oncor or Cambio and 
was either biotin or digoxigenin-labelled. Whole arm paints specific for the short 
arm and long arm of the X chromosome were purchased from Biomedical 
Research Corp (Arlington, VA, USA). 
Y specific probes used in this study were PDP97, hocSRY cosmid probe 
two cDNA probes for AZF region (MK5 and MK29), PHY2.1, GMGIO and whole 
Y chromosome library (Y-paint) probe. The PDP97 probe is a sub-clone derived 
from cosmid Y97 (Wolfe et al, 1985) which at high stringency detects a repeated 
Y-specific EcoRI fragment (DYZ3), a marker for the centromere of the Y 
chromosome. 
The hocSRY cosmid probe contains a 36 Kb DNA insert from human 
Ypi I which allows the identification of sex determination region SRY gene (Su 
and Lau, 1993). The MK5 and MK29 are 1.9 Kb cDNA cosmid probes assigned to 
human Yq1 1.2, a region specific for azoospermia factor in male. (Ma et al, 
1993). The GMG-10 probes are 6 Kb HindIII fragments which hybridise to 
repetitive DNA sequences at Yp 11.1 - 11.2 (Affara et al, 1986). The PHY2.1 probe 
is a 2.45 Kb HacIII fragment that hybridises to highly repetitive DNA sequences 
(in -2000 copies) at the heterochrornatic Yq region. Whole chromosome paints 
specific for chromosome Y (biotinylated) were purchased from Cambio for use in 
this study (Table 2.3). All cosmid and plasmid probes were amplified by growing 
in appropriate culture media containing the appropriate antibiotic (100 ýIg/ml 
ampicilin or 60 gg/ml kanamycin) and then were used for DNA isolation. 
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Table 2.2: DNA probes specific for X chromosome used in this study. 
PROBE I VECTOR INFORMATION MAPLOC, 4770N REFERENCE 
cPTI Cosmid C2RB BamHI site; Xp2l. 1-21.3 Blonden et a] 1989 
100gg Ampicillin DMD locus 
cAL24 Cosmid C2RB Bam HI site; Xp2l. 1-21.3 Blonden et al 1989 
100ýtg Ampicillin DMD locus 
cPT4 Cosmid C2RB Bam HI site; Xp2l. 1-21.3 Blonden et al 1989 
100ýLg Ampicillin DMD locus 
141R Cosmid EZ I 65. ICRFC Xq27-28 Hirst et al 1991 
I OOE2165; 60gg Kanamycin DXS296 Flynn at al 1993 
FRAX-A/E 
VK21 Cosmid G3/1; 60gg Xq27-28 Hirst et a] 1991 
Kanamycin DXS296 Flynn at a] 1993 
FRAX-A/E 
G9L Cosmid G9LB ICRFC 140D8104: Xq27-28 Hirst et al 1991 
601ig Kanamycin DXS296 Flynn at al 1993 
FRAX-A/E 
Table 2.3: Y chromosome DNA/cDNA specific probes investigated in this study. 
Probe Vector Insert size Map location Reference 
hocSRY Cosmid Lorist 5 36Kb 0.9Kb Ypil. 1 Su and Lau 1993 
60 ýLg HincII or 12.6Kb SRY locus 
Kanarnycin EcoR I or 2. lKb 
Hind II 
MK5 Cosmid A517 1.9 EcoR I Yq 11.2 Ma et a) 1993 
CDNA loogg RBM1 locus 
Ampicillin 
MK29 Cosmid A5F 1.9 EcoR I Yq 11.2 Ma et at 1993 
CDNA I 00ýig RBM1 locus 
Ampicillin 
GMGY1O Chorion 21 6Kb Hind III Ypl 1.1-11.2 Affara et at 1989 
HindIII 
I 00jig ampicillin 
PHY2.1 Plasmid 2.4Kb Hae III Yq I 2-qter Cooke et at 1982 
PSP65SmaI DYZ2 
I 00jig Ampicillin 
PDP 97 Cosmid Yq7 5.5Kb EcoR I Centromere Wolfe et at 1985 
60gg Ampicillin DYZ3 
2.4.2 Transformation and growth of the probe and glycerol stock preparation 
Probes hocSRy specific for SRY gene were kindly provided by Dr. Lu and 
MK5, MK29 cDNA probes were generously provided by Dr Ann Chandley. These 
cosmids were transferred to DH5aTM E. Coli competent cells (Gibco BRQ 
according to the manufacturers protocol with slight modification, The competent 
cells were removed from -70*C and thawed on ice. The cells were gently mixed 
using chilled sterile pipette tips and 50 41 of cell mix transferred to ice chilled 
sterile 1.5 ml eppendorf tubes. 10 pI of the cosmid DNA (10 ng) were added to all 
tubes containing the competent cells except one tube used as a negative control. 
Tubes were gently shaken for 5 seconds and then incubated on ice for 30 minutes. 
The cells were then subjected to heat shock in a 42*C water bath for 2 minutes 
without shaking and rapidly placed on ice for a further 2 minutes. After adding 
800 IA of SOC media to all tubes, the cultures were incubated at 37*C with 
shaking (100 rpm) for one hour. 200 ý1 of the transformed cell culture were spread 
into LB agar plates containing the appropriate antibiotics and left to stand at room 
temperature until the excess moisture had been absorbed. The plates then were 
incubated at 37*C for 12-16 hours and transferred to 4'C for up to one month. 
Single colonies were observed in all plates except the negative control. Once 
transformation occurred, a single colony of each probe was picked by sterile loop 
and cultured in 5 ml of LB media with the appropriate antibiotic and grown for 16 
hours at 37"C with shaking at 225 rpm. The overnight culture was then used for 
DNA isolation and glycerol stock formation. Glycerol stock was made by mixing 
0.7 ml of the bacterial growth with 0.3 ml sterile glycerol, and was then stored at - 
70'C till use. 
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Z4. Zl Growth ofplasmidlcosniidprobes 
Glycerol stocks of transformed bacterial cells containing the probes used in 
this study were grown to amplify the required DNA probe. 
50 ýLl of bacterial stock was cultured in 50 ml LB media containing the 
appropriate antibiotic at 3711C with vigorous shaking at 225 rpm for 16 hours. The 
cultu res then were used for the extraction of recombinant plasmid/cosmid, DNA. 
2.4.2.2 Isolation of recombinant plasmidlcosmid DNA using the 
CIRCLEPREP kit 
Probe isolation was performed according to Circle prep protocol with 
slight modification. On the day following the culture, the cells were transferred to 
50 ml centrifuge tubes and centrifuged at 10,000 rpm (1 2,000g) for 5 minutes at 
4'C in Beckman XL-90 centrifuge using JA-20 rotor (Beckman, California). The 
supernatant was discarded and the tubes were drained for 1-2 minutes. Then cell 
pellets were resuspended and mixed well in 4ml prelysis buffer to obtain 
homogeneous suspension. 4 ml of alkaline lysis reagent was added and mixed for 
2 minutes until all the cells were lysed and cell suspension became viscous. Then 
4 ml of neutralising solution was added and mixed thoroughly for 1-5 minutes 
until the solution showed two phases, consisting of a white precipitate suspended 
in clear liquid of water-like viscosity. The mixture was centrifuged 12,000 rpm 
(I 7,000g) for 5 minutes at 4"C. Carefully the supernatant was transferred throu& 
a sieve to a new centrifuge tube. Equal volume of isopropanol (approximately 12 
ml) was added, mixed well until a fine precipitate formed and then centrifuged at 
12,000 rpm (I 7,000g) for 5 minutes at 4*C. The supernatant was removed and the 
pellet was drained. The cell pellet was dissolved in 0.5 ml sterile water and the 
cleared supernatant was transferred to a microcentrifuge tube. At this stage the 
supernatant could be stored at 4"C or frozen. This cleared supernatant consisted of 
RNA, cosmid/plasmid DNA and some cellular chromosomal DNA. 
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To denature the linear cellular DNA without nicking supercoiled 
plasmid/cosmid DNA, the cloned supernatant was incubated in a boiling water 
bath for 5 minutes and then the tube quenched immediately on ice water bath for 
one minute. 300 gI of LiCl (Lithium chloride) was added to the tube, mixed well 
and allowed to stand at room temperature for 5 minutes. The mixture then was 
centrifuged for 30 seconds at 14,000 rpm (12,000g) in Beckman microfuge E 
(Beckman, California) to pellet down the ribosomal RNA (rRNA) and single- 
strand DNA (ssDNA). The supernatant was transferred to a new microcentrifuge 
tube, 600 gl of isopropanol was added, mixed thoroughly and then centrifuged at 
full speed for I minute. The aqueous phase was discarded, the pellet was drained 
and then dissolved in 0.5 ml sterile distilled water. Then 300 PI of LiCl was added 
and mixed well. To the mixture 75 gl of circle prep Glass milk was added and 
then incubated for 5 minutes at room temperature with occasional mixing. The 
mixture was centrifuged for a few seconds to pellet down circle prep Glass 
milk/DNA complex, the supernatant was removed and the pellet was washed 
twice with I ml wash solution. After a second wash the tube was spun again for a 
few seconds and traces of liquid from the bottom of the tube were carefully 
removed. The cosmid/Plasmid DNA was eluted from the glass milk by 
resuspending the pellet in 100 ýil sterile distilled water and incubating for 5 minute 
in 65*C water bath. After incubation the mixture was centrifuged for I minute at 
14,000 rpm (12,000g) to form a tight pellet of glass milk and a clear supernatant 
containing cosmid/plasmid DNA which was transferred to a new microcentrifuge 
tube. A second elution would probably yield an additional 10-20% 
cosmid/plasmid DNA. 
The concentration of DNA of each cosmid/plasmid DNA was estimated 
using a spectrophotometer at wave length 260 nm. 10 ýtl of purified DNA was 
diluted in 990 pl distilled water (1: 100 dilution fraction) and optical density (O. D) 
was measured at 260 nm. 
Because 1 O. D. at 260 unit corresponds to 50 [Lg of DNA per ml and the 
DNA was diluted by 100, the probe concentration was calculated using the 
fOllowing formula: Probe concentration = OD 260 X dilution factor X 50 = pg/ml. 
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2.4.3 Restriction enzvme to release probe insert 
To ensure that transformed bacterial cells contained the inserted DNA, 
enzymatic digestion of the purified DNA was carried out to release the inserted 
probes. 14 ýd of cosmid/plasmid DNA (7-10 gg) was digested in a 50 gl reaction 
volume using 4 ýtl of EcoRI (for MK5 and MK 29) or 5ýtl HincII (for SRY cosmid 
DNA), 5 ýfl of I OX enzyme buffer and 27pl ddH20. The mixture was incubated at 
37*C for 2 hours. The digest was loaded alongside I Kb ladder (Gibco BRL) on 
I% low melting agarose gel (Seakern agarose, Fmc bioproducts) in 1X TAE 
buffer and electrophoresed at 100 volts for 2-3 hours. The gel was visualised on a 
UV transillurninator (212nm) and 1.9 Kb or (0.9 Kb) bands were detected 
corresponding to the probe size of each MK5 and MK29 or SRY respectively. 
2.4.4 Probe labellin 
Probes are labelled with reporter molecules and fragmented into 200-500 
bp fragment, a size that maximises specific hybridisation and decreases 
fluorescence background. Typical reporter molecules include biotin, digoxigenin 
and dinitrophenyl (DNP), these reporter molecules are incorporated as labelled 
nucleotides using nick translation. 
In this study labelling of cosmid/plasmid probes was done by nick 
translation with biotin-1 1-dUTP (Sigma) and/or digoxgenin labelling I 1-dUTP 
(Sigma) according to the BRL Nick translation Kit protocol with some 
modification. 
(A) Biotin-labelling by nick translation: 
To I pg DNA, the following solutions were added sequentially in 1.5 ml 
microcentrifuge tube, 5 RI of solution A4,2.5 RI Biotin-I 1-dUTP, solution E up to 
45 gl and 5 ýtl of solution. The mixture was incubated for 90 minutes at 15"C. At 
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the end of labelling the reaction was stopped by adding 5 gl of solution D. The 
probe was then precipitated by adding 4.6 ýtl of 3M sodium acetate pH 5.2,1 gl 
of glycogen, 122 gl iced ethanol, mixed well by vortexing and then centrifuged at 
12,000 rpm for 30 minutes. The supernatant was removed and the pellet washed 
with 75% alcohol and then vacuum dried. The probe was dissolved in 10 111 TE 
buffer giving a concentration of 100 ng/41. The mixture was vortexed, briefly 
centrifuged and kept at room temperature for 2 hours with occasional mixing to 
ensure complete dissolving of the DNA. The probe was stored at -20"C until used. 
(B) Digoxiggenin-labelling by nick translation: 
The digoxgenin labelling of probes was performed using digoxigenin DNA 
labelling mixture and a nick translation Kit (Gibco BRQ. The labelling was 
carried out in the same way as biotin labelling except that to I ýIg DNA, 2 gl of 
digoxigenin-labelling dNTPs, solution E up to 45 pl and 5 PI of enzyme mixture 
(Solution C, Nick translation kit) were added. 
2.4.5 Slide preparation 
The quality of the slide is one of the most important factors affecting the 
degree of hybridisation. Metaphase chromosome spreads were prepared by 
dropping 3-4 drops of fixed cell suspension on to cleaned, wet slides and left to air 
dry. Slides were evaluated for quality by using phase contrast microscope. The 
slides were fixed for one hour in 3: 1 methanol: acetic acid fixative, allowed to air 
dry and then dehydrated through an ethanol series (50%, 70%, 90% 100%) 2 
minutes each. The slides were aged by overnight incubation at 42*C or at room 
temperature. Alternatively slides were pre-treated before hybridisation in 2X SSC 
pH 7.0 at 37C for 30 minutes. Treatment in 2XSSC artificially ages the 
chromosome, making them less sensitive to over denaturation. However the 
treatment was not necessary if the slides were more than 2 weeks old. Slides then 
dehydrated successively in 70%, 90%, 100% ethanol at room temperature for 2 
minutes each and allowed to dry. 
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2.4.6 Uni-colour flugrescence in-situ hybridisation 
To detect a single target on chromosome metaphases, uni-colour 
fluorescence in situ hybridisation was performed. Both biotin and digoxigenin 
labelled probes were applied in this project. The overall procedure of pre- 
hybridisation and hybridisation steps is similar for both biotin and digoxigenin 
labelled probes except for the detection step. The biotin-labelled probes were 
detected with either rhodamine or fluorescein conjugated avidin whereas the 
digoxigenin labelled probes were detected with monoclonal anti-digoxigenin 
labelled with fluorescein or with fluorescent con ugated anti-digoxigenin, i 
Z4.6.1 Probe mixture preparation andprobe denaturation 
In principle, suppression using competitive DNA (Blocking DNA) is 
required for single-copy clones in various vectors (e. g. plasmid, phages, cosmid), 
probes with interspersed repetitive (IRS) and unique sequences, and whole 
chromosome paint probes to suppress repetitive sequences in the probe and to 
prevent non specific hybridisation. For simultaneous hybridisation of two or more 
probes, 10 ýtg human Cot- I DNA or total human genome DNA should be added. 
Generally large probes with a large amount of repetitive sequence should 
be preannealed for a longer time. Moreover, repetitive, alpha-satellite and 
telemeric probes and most cDNA probes do not require suppression with Cot-I 
DNA because Cot-I DNA contains repetitive DNA sequences. 
In this study hybridisation mixtures were prepared with the proper 
concentration of labelled probes, the desired concentration of competitive DNA's 
and hybridisation buffer immediately before application to slides (Table 2.4). 
Generally, in experiments using a single cosmid/plasmid probe, 50-250 ng 
labelled DNA (0.5-2.5 ýil from 100 ng/pl stock) 10 pg sonicated human placental 
DNA (I pl from 10 mg/ml stock solution) and 0.8 pg sonicated salmon sperm 
DNA (0.8 pl from 10 mg/mI stock solution) were added to 8.9 pl hybridisation 
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buffer. In experiments using 3 cosmids together as with the DMD probes and 
fragile X probes, 100 ng of each labelled probe were used. 
All prepared probes were denatured at 7211C for 10 minutes to denature 
DNA. If the probes did not require suppression, the denatured probe(s) placed on 
ice. If suppression was required, the denatured probe(s) placed at 3711C and pre- 
annealed 60 minutes to several hours (Table 2.4 and 2.5). 
When co-hybridisation with X centromeric probe was performed I [d of 
DXZI (0.5 pg/ 50 ýtl) was denatured in 10 gl (I ng/gl) hybridisation buffer, cooled 
on ice and 0.5 ptl of it was combined with pre-annealed probes just before 
application to slides. 
When commercial probes XIST and KAL (Oncor) were used, the 
experiments were carried out according to the supplier's protocols. The probes 
were provided premixed with blocking DNA and suspended in Hybrisol VII (50% 
formamide 2x SSC). The probes were pre-warmed at 37*C for 5 minutes, gently 
vortexed and centrifuged 2-3 seconds to collect the contents in the bottom of the 
tube. Then 10 ýLl of probe solutions were applied to denatured slides. 
Microsatellite DXZ4 probe was prepared according to Oncor protocol as 
well. This probe was provided with hybrisol VI (65% formamide, 2X SSc). The 
probe was pre-warmed at 37"C for 5 minutes, vortexed and centnged for 2-3 
seconds. 31.5 ýtl of probe was placed in 0.5 ml microcentrifuge tube and 
denatured by heating in 70*C water bath for 5 minutes. The probe was then placed 
in 4"C ice bath until ready to hybridise. 
Total chromosome (Coatasome or Cambio paint) probes were also 
prepared according to Oncor or Cambio protocol. Specific paints were pre- 
warmed at 37T for 5 minutes, gently vortexed and centrifuged 2-3 seconds. 10 
pl of probe solution was placed in 0.5 ml microcentrifuge tube. This probe was 
provided with blocking DNA in hybrisol VII (50% formarnide, 2X SSQ. The 
probe was denatured by heating in 70*C water bath for 10 minutes and then 
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Z 4.6.2 Cellular DNA denaturation and probe hybridisation 
The target DNA was denatured by soaking slides containing metaphase 
chromosomes 2 minutes in 70"C denaturing solution (70% formamide/ 2X SSC) 
in a Coplin Jar in a 72T water bath. Slides were rinsed for 2 minutes in ice-Cold 
70% ethanol in coplin jar to stop denaturation. Then continued dehydration by 
incubating slides 2 minutes each in room temperature 80%, 90%, and 100% 
ethanol and allowed to air dry maximally up to 15 minutes. Then 10- 12 [d or 31.5 
gl of preannealed probe mix was added to slides and covered by 22 X 22 or 22 X 
So mm glass cover slip respectively, sealed with rubber cement and incubated 
overnight (16-20 hrs) in moist chamber at 37-42"C water bath (Table 2.4 and 2.5). 
Z4.6.3 Post hybridisation washes 
Prior to detection, post hybridisation washes were performed to remove 
non-specifically bound and weakly hybridised probes. During last 30 minutes of 
hybridisation, 50 MI of 50% formamide/2X SSC wash and 50 ml 2X SSC in 
coplin jars were warmed in 42"C water bath. The slides were removed from moist 
chamber, the rubber cement peeled off and the cover slips carefully removed. 
Slides were rinsed in 2X SSC at 42"C for 5 minutes. The slides then washed twice 
in 50% formamide/ 2X SSC and twice in 2x SSC at 42*C for 5 minutes followed 
by incubation in wash-A solution for 30 minutes at 371C. 
2.4.6.4 Amplification of hybridisation signals 
Signals of both biotin and digoxigenin-labelled probes were amplified after 
post hybridisation washes. 
Amplification of biotinviation sinals: 
Slides hybridised with biotinylated probes exposed to avidin were 
incubated with biotin-labelled antibody to avidin. Since every avidin molecule 
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contains four biotin-binding sites, biotin-labelled antibody to avidin can 
potentially bind the avidin molecule by a biotin-avidin interaction or an antibody 
interaction. A final amplification of fluorescence-conjugated avidin results in 
significant signal amplification. Detection of biotinylated signals was performed 
as follows: 100 ýd of 5 ýtg/ml FITC conjugated avidin (diluted in wash-A) or 100 
ýd of 5 ýtg/ml rhodamine-avidin (prepared in wash A solution) were applied to 
each slide, covered with parafilm, and incubated at 37C for 15-20 minutes. Slides 
were rinsed 3X5 minutes in wash-A at 42"C. Then 100 gl of 5 gg/ml biotinylated 
anti-avidin (diluted in wash A) was added to each slide, covered with parafilm, 
and incubated at room temperature. For FITC conjugated avidin detection system 
a final amplification was carried out by adding 100 gl of 5 ýLg/ml FITC conjugated 
avidin (diluted in wash A) and incubated for 15-20 minutes at room temperature. 
Finally, slides were rinsed 2X5 minutes at 42"C in wash-A and 2X5 minutes in 4 
X SSC, 0.5% Tween-20 at room temperature, dehydrated through an ethanol 
series 50%, 70%, 90%, 100% 2 minutes each and allowed to air dry. 
b) Amplification of signals from digoxigenin-labelled probes: 
Fluorescence signal for digoxgenin-labelled probes is achieved by 
sandwiching a non-fluorescent fragment of sheep anti-digoxigenin between the 
digoxigenin labelled probe and a fluorochrome-labelled anti-sheep IgG. Since 
more than one Fab fragment can attach to a single digoxigenin molecule and each 
of the Fab fragments is recognised by the fluorochrome-conjugated second anti- 
body, significant signal amplification occurs, The digoxigenin-labelled probes 
were detected as follows: 100 gl of 0.6 ýig/ml anti-digoxigenin fluorescin Fab 
fragment prepared in sheep (prepared in wash-A solution) was applied to the 
hybridised area, covered with parafilm and incubated at 37*C for 15-20 minutes. 
Slides were rinsed 3X5 minutes in 420C wash A and incubated with 100 ýtl of 
2.25 gg/ml fluorescent anti-sheep IgG for 15-20 minutes at room temperature. 
Slides were washed 2X5 minutes in 420C wash-A solution, 2X5 minutes in 4X 
SSC/ 0.5% Tween-20 at room temperature, dehydrated through an ethanol series 
50%, 70% 90% and 100% two minutes each and then air dried. 
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Z4.6.5 Chromosome counter staining 
Chromosomes were stained by adding 10- 12 41 of the appropriate counter 
stain. When probe was detected by FITC-avidin (green), chromosomes were 
counter stained using both DAPI and propidium iodide. I ýtl of DAPI (40 JIG/ML) 
and 2 ýtL of propidiurn iodine (20 gg/ml) were diluted in 97 gI of antifade 
mounting medium AF I (Citifluor Ltd), slides were covered with 22 mý coverslip 
and sealed with nail polish. Slides were stored in the dark at -2011C till scored. 
When rhodamine (red) was used, chromosomes were detected with counter 
stain containing only DAP 1.1 pl of DAPI (40 pg/ml) was diluted in 99 ýd of 
antifade solution. 
2.4.7 Multi-colour FISH 
A dual colour and a three colour combinatorial mixing FISH method was 
applied to metaphase chromosomes to detect simultaneously the probe sets 
specific for X chromosome or Y chromosome. A dual colour detection protocol 
can be used for two probes (one labelled with biotin and one with digoxigenin) but 
a third probe labelled with both can also be recognised. In dual colour the 
hybridisation mixture contained two specific probes of which one was labelled 
with biotin-11-dUTP and the other with digoxigenin-11-dUTP. When ratio- 
mixing FISH was applied a third probe was labelled with either biotin II -dUTP or 
digoxigenin II -dUTP and mixed in a 1: 1 combination (Table 2.6). 
2.4.8 Detection and counter stainina of multi-colour FISH 
The pre-hybridisation, hybridisation and post hybridisation washing steps 
for multi-colour FISH were performed as for uni-colour FISH except for detection 
step. In all multi-colour FISH studies the biotin-labelled probes were detected with 
avidin con ugated with rhodamine and the signals were amplified by using j 
biotinylated anti-avidin and adding a second layer of avidin conjugated with 
rhodamine. 
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Table 2.6: Hybridisation mixtures applied in the dual and in the combinatorial 1, ISH 
studies. 
lliotin probe Digoxigenin Il Iu ma n I lybridisation Pre- 
Probe placental Bu ffer annealing 
DNA Time 
DXZ I= I [LI DMI) = 3[tl* 1 pi 9 ý11 Ih 
DXZI=l PI FRAXA/E*= 3 1 pi 9 pi III 
ýtl 
KAL =10 pi DXZI =I pl 
DXZI =1 [d XIST =I 0 [tl 
DXZI =1 ýtl DXZ4 =31.5 p] 
PDP97 =I [LI DXZI I ýtl I Old 
DMD 3 ýtl* XIST 10 ýd 
KAL 10 ýd DXZ 31.5pt 
DMD =2.5 Iil FRAXA/E= I pi 8ýd 
2.5[il 
MK5 = 2.5 PI* PDP97 = 1ýtl 0.6 ýtl 9 ý11 
hocSRY = 2.5 1.0 IIDP97 =I [d 0.6 [d 9ýd 
MK29 = 2.5 W* PDP97 =I ýtl 0.6 ýd 9 [LI 
GMGY 10 -I ýtl III IY2.1 =I [tl - I O[LI 
hocSRY = 2.5 [tl* DXZI =I ýtl 0.6ýtl 9[d 
hocSRY = 2.5ptl MK5 2 [LI 0.6pl 9[d 
DXZI= I [d + DXZI =I ýtl 
KAL = 10 jd 
DXZI I pt DXZl =I pi 
XIST 10 pi 
DXZI I pl DXZI =I pl + 
DXZ4 = 31.5 pl 
DXZl I ItI + DXZl ýI [d 
DMD 3 [d FRAX =3 ýLl 
DXZI ýI pl + DXZI 1 [11 + 
KAI,:: 10 pi XIST 10 pi 
DXZI =I pi DXZI I ýtl 
DXZ4 31.5 W 
*The probe first pre-annealed to the competitor DNA and then the second probe was 
added to the mixture before application to the slide. 
Note: I lybridization temperature was at 390C to 420C for 16 hour, 
The digoxigenin-labelled probes were detected by FITC conjugated monoclonal 
anti mouse IgG. The detection method was as follows: 100 PLI of 5 gg/ml FITC 
conjugated avidin was applied to the hybridised area, covered with parafilm and 
incubated at 37"C for 15-20 minutes. Slides were rinsed 3X5 minutes in 42"C 
wash-A. 100 gl of mixture of 5 gg/ml of goat anti-avidin D and 5 ptg/ml of FITC 
conjugated monoclonal anti-digoxin prepared in mouse (diluted in wash-A) was 
added to the slide, covered with parafilm and incubated at room temperature for 
15-20 minutes. Slides were washed 2X5 minutes. in wash-A at 42"C and then 
incubated at room temperature for 15-20 minutes with 100 gl of a mixture of 
rhodamine avidin (5 ýtg/ml) and FITC conjugated anti-mouse IgG (5 Jig/ml 
prepared in wash-A solution). Slides were washed 2X5 minutes in 42T wash-A 
and 2X5 minutes. in 4X SSC/0.5% Tween-20 at room temperature, dehydrated 
through ethanol series 50%, 70%, 90% and 100% and air dried. Slides were 
counter stained and mounted in DAPI/antifade stain as previously mentioned. 
2.4.9 Visualisation 
All FISH studies were ex=ined and analysed using a fluorescence 
microscope with epi-illumination equipped with filter sets appropriate for the 
fluorochrome used (Zeiss Axioplan) (Table 2.7). A DAN filter set was used for 
chromosome identification and a triple-band-pass filter set was used for 
simultaneous viewing of multiple fluorochrome. The epifluorescence microscope 
also equipped with a Photometric charge coupled device (CCD) camera and 
computer software (SmartCapture; Digital Scientific). The images were captured 
and printed on sublimation printing paper (A4-SPW) using a Mitsubishi colour 
printer. 
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DAPI 345 425 1,2 Blue 
Propidium 520 610 9 Red 
iodide 
FITC 490 525 9,10 Green 
Rhodamine 540-560 580 15 Red 
2.5 Molecular Genetics stuft 
2.5.1 DNA extraction 
DNA was extracted from whole blood following the protocol described by 
Kunkel et al (1977). 5 -10 ml EDTA of blood were transferred to a falcon tube and 
lysis buffer (0.32 M sucrose, 10 rnM Tric-Cl pH 7.5,5 mM MgC12,1% Triton 
100) was added up to 50 ml. The samples were mixed and centrifuged in Beckman 
GS-6 centrifuge using GH-3.7 rotor (Beckman, California) at 2,500 rpm (1,430g) 
for 10 minutes at 40C. The supernatant discarded into a beaker containing 5% 
Chloros and the pellet resuspended in 3 ml nuclei mix (10 mM Tris, 0.4 M NaCl, 
2 mM EDTA, pH 8.2.200 ttl 10% SDS (Sodium Dodecyl Sulphate) and 100 ý11 of 
protenase K (10 mg/ml) were added. The mixture then vortexed thoroughly and 
incubated at 370C for 16 hr. I ml of 6M NaCl was added and the samples were 
shaken vigorously, and were centrifuged at 3,000 rpm (2,060g) for 15 minutes. 
The top layer was carefully transferred into a clean centrifuge tube and 800 ýtl 
phenol/chloroform added and mixed by inversion several times for I minute. The 
tube was then centrifuged at 2,500 rpm (1,430g) for 15 minutes. The supernatant 
was then transferred into a sterile tube and the DNA was precipitated by the 
addition of two volumes of 100% ethanol, The DNA was spooled out using a 
clean sealed Pasteur pipette, air dried and dissolved in 300-500 PI TE buffer (10 
mM Tris, I mM EDTA pH 7.5). The DNA was left to dissolve overnight at room 
temperature. The concentration of DNA was calculated by measuring the optical 
density at 260 nm and the DNA stored at 40C. 
ore. q 
1% agarose gel was prepared by dissolving 0.5 9 agarose powder (Seakem 
GTG, FMC Bioproduct) in 50 ml IX T13E buffer. The mixture was boiled, cooled 
down 551C, I ýd ethidium bromide was added (10 mg/pl) and then allowed to set, 
Samples were mixed with 1/5 volume of 6X TBE loading buffer (0,25% 
bromophenol blue, 0.25% xylene cyanol, 40% w/v sucrose in water) were loaded 
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and the gel electrophoresed in IX TBE buffer at 10-15 v/cm, until the 
bromophenol blue in the loading mixture migrated two thirds of the distance of 
the gel. The DNA was then visualised with a UV light (212 run) transilluminator 
and photographed. 
2.5.3 Oligonucleotide design and Ilreparation 
Oligonucleotides were designed to amplify DNA sequences from both 
YRRM (RBM-1) and SRY genes (Appendix I Tables 112 and 117). The computer 
program Oligo TM version 3.4 (Medprobe) was used for primer designing. Primers 
of 20 to 22 bases were designed to be, as much as possible, free of significant 
complementarity at their 3' termini, free of self-complernentarity and able to form 
a stable duplex (by calculating the free energy of duplex formation, AG) with the 
specific site only on the target DNA. The T. (melting temperature) difference 
between both primers and between the template and the less stable primer is kept 
to a minimum with avoidance of runs of C's or G's at the 3' ends of the primers. 
All primers, either published or newly designed (Appendix I) were 
synthesised in-house using an ABI 391-DNA synthesiser with " Trityl off' 
(Applied Biosystem). The end products existed as phosphate-protected, base 
protected phosphotriesters, therefore, complete deprotection. was required to 
produce active oligonucleotides. The extraction of the primers from the column 
was carried out as follows: 
The primers were cleaved and the cyanoethyl-protecting group (phosphate 
deprotection) was removed by treating the primers with fresh concentrated 
ammonium hydroxide for one hour. Base deprotection (ammoniolysis reaction and 
the removal of benzoyl and isobutyryol base protecting group) was followed by 
placing the vials contained the collected oligonucleotides in a 55"C water bath for 
5-18 hours. The ammonium hydroxide-oligonucleotide solution was cooled at 
room temperature for at least 30 minutes. Primers were then stored in ammonia 
eluant at -20"C till needed. Before using, purification of primers from ammonia 
was performed. Aliquots from the ammonia stock were left in opened tubes under 
the fume hood for 16-24 hours to ensure complete evaporation of the ammonia. 
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The concentration of the primers was estimated by measuring the O. D. using UV 
spectroscopy at 260 mn. Because 1 O. D. 260 of single-strand oligonucleotide 
represents approximately 33 microgram of DNA/ml therefore, primer 
concentrations were calculated as follows: Oligonucleotide concentration = OD 
260 X dilution factor X 33 = pLg/ml. The oligonucleotide solution was diluted to 5 
gM concentration and stored at -200C. 
2.5.4 Polvmerase chain reaction (PC 
Different sets of primers, both published and in house designed, were used 
for PCR to amplify exons and regions of interest from different genes (Androgen 
receptor (AR), SRY, and RMB-1] (Appendix I). All reactions were optimised 
individually. Each reaction was carried out in 50 gI final volume containing 250 
ng of genomic DNA as a template, 30 pmol of the relevant sense and antisense 
primer, 200 gM of each dNTPs, 5 gl of the 1 OX PCR buffer (100 mM Tris Hel pH 
8.3,500 mM KCI, 15 rnM MgC12,0.1% gelatine) and 2.5 units Taq polymerase. 
The reactions were mixed and then overlaid with mineral oil. The samples were 
subjected to 28 cycles of denaturation at 940C for I minute, annealing at the 
appropriate temperature for each segment for I minute and extension at 72 OC for 
I minute followed by a final extension step at 72 OC for 10 minutes. PCR products 
were checked by gel electrophoresis on I% agarose mini-gels with the product 
being compared against a 100 bp or I kb ladder (Gibco BRL). 
2.5.5 Multiplex PC 
Multiplex PCR screening methods were performed using 28 primer pairs 
(Appendix 1, Table 1-5) in five multiplex PCR experiments. These primer pairs 
were used to screen for the presence or absence of 28 Y-specific DNA sequences 
in Yq II in S6 infertile male patients. The screening method was applied according 
to Henegariu et al (1994) with some modifications. 
Primer start solutions for the multiplex PCR were optimised so that each 
primer concentration in each multiplex reaction was optimal for the amplification 
Of its corresponding genomic template (Table2.8). 
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Each multiplex PCR was performed in 25 gI PCR reaction, To each 
multiplex primer start solution, I SOng of genomic DNA, 200 gM dNTP mix, 5% 
DMSO (dimethyl sulfoxide), 2.5pd of 1OX PCR buffer, and 2.5 unit of DNA Taq 
polymerase, was added (Table 2.8). The complete PCR mix was overlaid with 
mineral oil and put directly in a thermocycler preheated to 940C. The templates 
were initially denatured at 940C for 5 minutes followed by 45 cycles at 940C for 
30 seconds (melting); 540C for 45 seconds (annealing) and 650C for 120 seconds 
(extension). A final extension at 650C for 5 minutes was performed. At the end of 
PCR amplification the tubes were stored at 40C or -200C till use. 
2.5.6 Gel analysis of multiplex PCR 
The PCR products were separated on 3% agrose gels (Seakern LE quality) 
by electrophoresis in I XTAE buffer at room temperature using a voltage gradient 
of 8 volt/cm. For increasing the sharpness of gel fragments Nuseive: Seakem (3: 1) 
gels in TBE buffer were used. SgI of 5X loading buffer (IS% Ficoll, 0.25% 
Xylene cyanol) was added to the PCR product and half of the PCR reaction mix 
was loaded on the gel and electrophoresed for 3 hours at 10 volts/cm then 
photographed. 
2.5.7 Southern blot analysis 
(A) Prohe preparation 
Digests were set up to release the probe inserts MK-5 and MK-29 from 
cosmid DNA in 50 ýd total volume reactions. 14 pl of cosmid DNA, obtained by 
the CIRCLE PREP kit, 2 jil (5 0 units) EcoRI restriction endonuclease, 10 gl I OX 
enzyme buffer and ddH20 up to 50 gl was incubated at 370C for 2 hours. The 
digest was electrophoresed alongside a IKb ladder (Gibco BRL) on 1% low 
melting agarose gel (Seakem agarose, FMC bioproducts) for 3-4 hours at 100 
volts. The gel was visualised on a UV transilluminator and the 1.9 kb insert band 
was cut by a sterile scalpel blade and placed in a pre-weighed 1.5 ml tube. The 
sample was weighed and 2 ml of sterile T. E. buffer was added for every gram of 
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sample. The insert was then boiled for 5 minutes and stored at -200C until used. 
(B) Southern blotting 
7 to 10 ýig of genomic DNA was digested using the appropriate restriction 
endonuclease in a total volume of 50 ýd containing IX appropriate enzyme buffer 
and 40 units of the specific enzyme. The digests were incubated in a water bath set 
at the recommended temperature for 16 hours. Digests were stored at -200C till 
used. 
The digested fragments were separated alongside aI kb ladder in 0.8% 
agarose gels prepared in IX TAE buffer and containing 0.5 pg/mI ethidiurn 
bromide. The gel was electrophoresed at 2 volts/cm for 16-20 hours. At the end of 
electrophoresis the gel was visualised and photographed alongside a ruler on a UV 
transilluminator. The gel was then transferred to a plastic box, rinsed several times 
in water, treated in a depurination solution (0.2M HCI) for 15-20 minutes then 
rinsed in water. The gel was then treated with the denaturation solution (O. SM 
NaOH, 1.5M Na Cl) for 30 minutes, rinsed in water and neutralised in two 
changes of neutralisation solution (3M NaCl, O. SM Tris pH 7.4) for 15 minutes 
each. 
The blotting apparatus was set up by placing a glass plate across a plastic 
box contained IOX SSC. The glass plate was covered by a double layer of 3MM 
Whatman paper with its ends dipped into the SSC. Any air bubbles between the 
paper and the platform was smoothed out. The treated gel was placed onto the 
wick making sure that there were no air bubbles between the gel and the 3MM 
paper. The gel was surrounded by a plastic wrap, to ensure that buffer would 
proceed only through the gel. A sheet of Hybond N membrane was cut to size, 
then layered over the gel avoiding air bubbles. Two layers of 3MM paper soaked 
in 2X SSC were then placed on to the membrane and air bubbles were removed. A 
stack of paper towels (- 10 cm high) was placed on top of the filter paper. A glass 
plate and a weight of - 500 g were laid on top of the absorbing paper stack. The 
blotting was carried out overnight. The next day the blot was dismantled and the 
filter was baked for 4 hours in an 800C oven to fix the DNA. 
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(C) Hybridisation of DNA blot 
Prehybridisation of filter 
The filter was placed, in the hybridisation bottle, with 10 ml of the 
prehybridisation solution (6X SSC, 0.5% SDS, 5X Denhardts) and 10 ýd boiled 
sonicated salmon sperm DNA (10 mg/ml) and incubated in an 650C hybridisation 
oven overnight. 
Probe labelling and filter hybridisation 
The probe was radioactively labelled using the random primed DNA 
labelling kit (Boehringer Mannheim) according to the supplier's protocol. 24 gI of 
the probe (in low melting agarose) were boiled for 10 minutes, then incubated at 
370C for one minute. The probe was then added to a mix of 2 jil each of dATP, 
dGTP and dTTP, 4 ýtl of the reaction mix, 1.5 gI of Klenow enzyme and 5 41 (50 
gCi) Of OC_32 P dCTP (Amersham). The tube was then incubated at 370C for 2.5 
hours. The labelled probe was then separated from the unincorporated CC- 32 P dCTP 
using G-50 sephadex NICKTm columns (Pharmacia Biotech. ). The column was 
washed with 3 ml IX SSC. The labelled probe (- 40 gl) was added to the top of 
the column and then 400 pl IX SSC was added and allowed to drip through. A 
ftuther 400 ýfl IX SSC was then added to the column and the drops were 
collected. 
The labelled probe was boiled for 4 minutes and added to the 
prehybridisation solution. The filter was left to hybridise overnight at 650C. 
After hybridisation, the hybridisation solution was discarded and the filter was 
washed in 2X SSC/0.1% SDS for 10 minutes at 650C. The filter was removed, 
monitored and placed in a plastic box with O. SX SSC/0.1% SDS and washed by 
shaking at 650C in a water bath for 5 to 10 minutes. If a signal greater than 10 
cpm (count per minute) was detected, the washing was continued with 
increasingly stringent solutions (650C, 0.25X SSC/0.10/0 SDS then O. IX 
SSC/0.1% SDS) until the filter had washed down to less than 5 cpm, 
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(D) A utoradlography 
The filter placed in an autoradiographic cassette with intensifying screens 
and exposed to Kodak Diagnostic AR Imaging film. The cassette was stored in a- 
400C freezer for at least one week. The autoradiograph was then developed and 
analysed. 
2.5.8 Single strand conformational polymori)hism (SSCP) analysis 
SSCP analysis was applied to screen for point mutations using MDETM 
gels (mutation detection enhancement), which significantly improve the resolution 
of DNA molecules with different conformations. 
Radiolabelled PCR amplifications of exons and regions of interest from 
different genes were performed. PCR amplifications were done using the standard 
PCR protocol. IS ýd PCR reaction mix was prepared to contain IX GeneAmp 
PCR buffer, 100 ýM of each dNTP, 1.5 pmol of each primer, 100 ng genomic 
DNA, 2 ýXi oc- 32 P dCTP and 2 units AmpliTaq polymerase. The reaction was 
overlaid with 25 ýfl mineral oil and was subjected to thermal cycling with the 
appropriate annealing temperature for each specific exon or segment (Appendix I). 
All segments of the SR Y gene, exons 2-7 of the AR gene and exons 1 -11 of the 
RBMI gene were screened by SSCP analysis. 
At the end of thermal cycling the amplified products were diluted 1: 9 in 
loading buffer (95% formamide, lOmM NaOH, 0.5% bromophenol blue and 0.5% 
xylene cyanol), heat denatured at 950C for 3 minutes then quenched on ice for at 
least 5 minutes before loading to SSCP gel. 3 pl of each sample was loaded on 
0.5X MDE non-denaturing gel containing 5% glycerol. The gel was 
electrophoresed in 0.6X TBE buffer at 5 watts for 16 hours at room temperature. 
After gel electrophoresis, the glass plates were separated gently and the gel 
was transferred to 3MM Whatman paper and covered with Saran wrap. The gel 
was dried under vacuum for 45 minutes at 80'C, with the Saran wrap upper most 
on a gel dryer (Biorad, Model 583). 
Autoradiography was carried out by placing the dried gel with the DNA 
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side facing the X-Ornat diagnostic AR film (Kodak) in an autoradiogrPhic cassette 
with intensifying screens. The gel was autoradiographed for 5 to 16 hours at - 
400C. 
2.5.9 Heteroduplex analysis 
This method was based on the protocol described by Keen et al (199 1) 
with some modifications. Non-radiolabelled PCR amplification was done using 
the standard protocol as previously mentioned. At the end of the PCR cycles the 
reaction was inactivated by adding EDTA to a final concentration of 5mM. PCR 
products of a test sample and a wild type control were mixed, heated to 95 OC for 
5 minutes and cooled slowly to room temperature over 20 to 30 minutes to form 
any heteroduplexes. Meanwhile, a 50 cm, I mm. thick, IX MDE gel was prepared 
in 1X TBE buffer and allowed to set for at least 1 hour. Samples were prepared by 
adding 10ýtl of 6X formamide loading buffer (95% deionized formamide, lOmM 
EDTA, 10 mg/ml bromophenol blue and 10 mg/ml xylene cyanol) for every 5 41 
PCR product. 5-10 41 of samples were loaded and electrophoresed in 0.6X TBE 
buffer alongside aI kb ladder and a positive control heteroduplex sample at a 
constant 800 volts for 20-24 hours. The gel was analysed by silver staining and 
photography. This technique was applied to exon 8 of the AR gene and exon 12 of 
the RBMI gene. 
2.5.10 Silver stainin 
The gel was first fixed in two changes of fixation solution (10% ethanol, 
0.5% acetic acid) each for 5 minutes with gentle shaking. Then, it was stained for 
15 minutes in freshly prepared 0.1 % silver nitrate, rinsed briefly with distilled 
water, incubated in developing solution (1 . 5% NaOH, 0.1 % formaldehyde mixed 
just before use) for 30 minutes, treated with 0.75% Na2C03 solution for 10 
minutes, sealed in a plastic bag and photographed. 
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2.5.11 Chemical cleavage of mismatches (CCM-) 
Chemical cleavage of mismatches analysis was applied as a part of the 
mutation detection strategy. The technique was performed according to Cotton et 
al (1989), with slight modifications. 
(A) Preparation of non-radiolabelled test DNA and radiolabelledprobe 
The open reading frame of the SRY gene was amplified by PCR using 
XEIO/XEII primers (Appendix 1-2) from four patients with sex reversal and 
gonadal dysgenesis following the standard protocol, in a total volume of 50 ýtl. A 
radiolabelled PCR product (probe) of the same segment from a normal control 
male DNA was also amplified by direct incorporation of 2ýtCi of a_32 PdCTP in 
the PCR reaction mix. 5 V1 of the PCR products were electrophoresed in a 1% 
agarose gel containing 0.5 Vg/ml ethidium bromide and visualised with a UV 
transilluminator to confirm the specificity of the PCR. The remaining 45 V1 PCR 
products were then cleaned using GenecleanTm purification kit (Bio 101 Inc. ) 
following the supplier protocol. 
( ""'Formation of heteroduplexes "V 
Hybridisation between probe and target DNA was set up in 10-20 fold 
molar excess of target DNA over the probe DNA. For each modification reaction 
approximately 5-10 ng, of probe DNA was hybridised with 100 ng test DNA in a 
mixture containing IX hybridisation buffer (0.3M NaCl; O. IM Tris-HCI, PH 8.0) 
in TO. IE buffer (lOmM Tris-110, PH 7.4; O. ImM EDTA). The reaction was 
layered with an equal volume of mineral oil in 0.5 ml Eppendorf tube, boiled for 5 
minutes and then incubated in a 650C water bath for 5-16 hours. The reaction 
mixture was then equally divided into two 1.5 ml siliconiscd Eppendorf tubes. 
750 pl of stop/precipitation mixture (63 mM Na acetate; 20 PM EDTA; 80% 
ethanol) and 3 [d of muscle glycogen (20mg/ml) were added to each tube, mixed 
well and kept on dry ice for 10 minutes. Tubes were then centrifuged in a 
microcentrifuge (Beckman, California) at 14,000 rpm (12,000g) for 10 minutes. 
The pellets were washed in 70% ethanol, air dried and resuspended in 7 ýtl To, IE 
109 
buffer. Tubes can be stored up to 24 hours at -200C before being used in the next 
step. 
(C) Chemical modification with osmium tetroxide and hydroxylamine 
A mixture of osmium tetroxide and pyridine was freshly made on ice by 
mixing 6.75 ýd pyridine with 1.5 ýd of 4% osmium tetroxide and 154 41 To, IE 
buffer. To each 7 41 hybrid mixture, 18 1A of osmium/pyridine mixture were 
added, mixed and the tubes incubated for 2 hours at 370C. Meanwhile, 1.39 grams 
of hydroxylamine was dissolved in 1.6 ml of water and the pH was adjusted to 6 
by adding approximately 1.5 ml of diethylamine. 20 pil of this solution was mixed 
with 7 ýA of the hybrid mixture and the reaction was then carried out at 370C for 
two hours. The modified reactions were stopped and precipitated by mixing 750 P11 
of stop/precipitation (63 mM Na acetate, 20 pM EDTA, 80% ethanol) solution 
with each reaction. Tubes were incubated on dry ice for 10 minutes and then 
centrifuged at 14,000 rpm (12,000g) for 10 minutes in microcentrifuge (Beckman, 
California). The pellets were washed in 70% ethanol and air dried. 
(D) Piperdine cleavage of the chemically modified mismatches 
50 jil of IM freshly prepared piperdine solution in water was added to each 
pellet, tubes were mixed by vortexing for 1 minute and incubated at 900C water 
bath for 30 minutes. At the end of incubation the reaction was precipitated as 
mentioned above. The pellets were dissolved in 10 ýd of formamide loading buffer 
(95% deionized formamide; I OmM EDTA; I Omg/ml each of bromophenol blue 
and xylene cyanol). 
(E) Polyactylamide gel electrophoresis 
Samples were denatured at 950C for 5 minutes, quenched on ice and then 
loaded alongside a radiolabelled I kb DNA ladder. The gel was 6% polyacrylamide 
containing 7M urea and prepared in IX TBE buffer. Electrophoresis was at a 
constant 2000 volts for approximately 3 hours then the gel was dried and 
autoradiographed for 16 hours at -400C. 
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2.5.12 Genomic Seauencina 
The amplified PCR DNA was directly sequenced using single stranded 
templates. Asymmetric PCR was performed according to a protocol developed by 
Mgone et al (1992) in which a PCR product was used as a template to generate 
single stranded DNA during the PCR reaction. DNA targets to be sequenced were 
prepared by the standard PCR technique. Amplified products were resolved by 
agarose gel electrophoresis and the desired bands were cut out, placed in 1.5 ml 
tubes with 50 ýd TE buffer and kept at -200C overnight. 5 gI aliquots were then 
used for asymmetric PCR amplification using the standard protocol of 40 cycles 
with the concentration of either the sense or antisense primers being in 50-1 OOX 
excess of the other primer. 5ptl of each reaction was checked by agarose gel 
electrophoresis for the production of single stranded DNA. Prior to sequencing, 
the asymmetric PCR products were cleaned to remove excess dNTPs, salt and 
primers. An equal volume of 4M ammonium acetate and two volumes of 
isopropanol were added to each reaction, mixed briefly and incubated at room 
temperature for 10 minutes then centrifuged in a microcentrifuge at -14000 rpm 
(12,000g) for 10 minutes. Pellets were washed in 70% ethanol, air dried and 
resuspended in 7 gI of ddH20 and used directly in the sequencing reaction. 
Sequencing protocol using USB sequenase version ZO sequencing kit 
Direct sequencing was carried out by the chain termination sequencing 
method (Sanger et al 1977) using the Sequenase version 2.0 sequencing kit (USB). 
25ýd of the T7 DNA polymerase was diluted with 25 pl inorganic 
pyrophosphatase and 150 pI of glycerol enzyme dilution buffer to obtain an 8 fold 
dilution of the enzyme to its working concentration of 1.6 units/gl. 
7 Al of the purified asymmetric PCR product were mixed with 2 gl 5X 
sequenase buffer to give a final concentration of 40 mM Tris-HCI pH 7.5,50 MM 
Na CI and 20 MM MgC12- I gl (I pmol) of the sequencing primer, either limiting 
or nested and complementary to the synthesised single strand was also added. The 
mixture was vortexed, briefly centrifuged and annealed by heating at 650C in a 
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PCR block for 2 minutes then slowly cooled to less than 350C over 15 to 30 
minutes and quenched on ice for few minutes. I gI of 0.1 M DTT, 2 gI of a 115 
dilution of labelling mix (1.5 gM of each dNTP except dATP), 0.5 gI of a- 
35SdATP (1000 Ci/mmol; lOgCi/gl) and 2 gI of a 1/8 dilution of T7 DNA 
polymerase were added, mixed well, briefly centrifuged and incubated at room 
temperature for 2-5 minutes. After the incubation, 3.5 gI of the mixturewas 
transferred to 2.5 gI of each termination mix at 420C incubated at420C for 5 
minutes. The termination mixes (4 mixes) contained 80 gM of each dNTP and 8 
gM of the appropriate dideoxyribonucleoside triphosphate (ddNTP). The reaction 
was then terminated by the addition of 4 gl formamide dye stop solution (95% 
fon-namide, 20 mM EDTA, 0.05% of each bromophenol blue and xylene cyanol). 
Tubes were then stored at -200C until further need. 
To read the sequencing close to the primer, I gl of Mn buffer (0.1 5M Na 
isocitrate, O. IM MnC12) was added to the labelling mix before adding the 
sequenase enzyme. Samples were denatured at 750C for 2 minutes and quenched 
on ice for 2 minutes. 2pl of each termination reaction was loaded onto a 
prewarmed (500C), 8% denaturing polyacrylamide gel containing 7M urea, 
prepared and run in IX TTE buffer (glycerol tolerant buffer). Electrophoresis was 
carried out at approximately 2500 volts at 500C for 2-4 hours depending on the 
area of interest. After electrophoresis the gel was dried in a vacuum gel dryer then 
exposed to Kodak X-Omat AR film using a cassette with intensifying screens for 





3.1 Cvto2enetic and molecular cvtoeenetic studies: 
3.1.1 Establishment of FISH technique and optimisation of probes: 
(1) Unicolour FISH usin, &, alpha satellite DNA probes 
To become familiar with the FISH technique, initial experiments were carried 
out with the highly repetitive sequence probes DXZI and PDP97 specific for the 
centromeric region of chromosomes X and Y respectively. These probes were used to 
optimise the uni-colour FISH. The DXZI probe was obtained commercially, pre- 
labelled with either biotin or digoxigenin. The probe PDP97 was available as glycerol 
stock in the department. This probe was grown, isolated and labelled with either 
biotin or digoxigenin using the standard nick translation method. The labelled probes 
(DXZ 1, PDP97) were then hybridised to metaphase spreads from peripheral blood 
samples. Imaging of FISH results was carried out using the CCD system and 
Smartcapture programme. The concentration required to produce intense and specific 
signals using each of the probes was optimised and found to be 0.5- 1 ng of DXZ 1 and 
5 0-100 ng of probe PDP79 per 2 cm2 hybridisation area (Figure 3.1). 
(A) Optimisation of X-chromosome specific probes 
A total of IS probes specific for chromosome X were used in this study 
(Figure 3.2). Nine were commercially available [XIST (Xql3.2), KAL (Xp22.3), 
DXZ4 (Xq24), whole X chromosome paint (WCPX), chromosome arm paint for the 
short and long arm of the X chromosome (CAP Xp/CAP Xq), telomeric sequences 
specific for the short and long arms of X chromosome, and DXZI (centromeric)] pre- 
labelled with either digoxigenin or biotin. The rest (6 probes) were available in the 
department as glycerol stocks. Three (cPTI, cPT4 cAL24) were specific for the DMD 
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locus at Xp2l. region of the X chromosome and three (VK21,14 1 R, G9L) were 
specific for the fragile X regions (FRAXA/E) at Xq27-28. The glycerol stocks of the 
probes were cultured, isolated from the host cell and the extracted DNA from each 
probe was individually labelled with biotin and/or digoxigenin. 
Initially the three DMD cosmids cPTI, cPT4, and cAL24 and the three 
FRAXA/E probes (VK21,14 1 R, G9L) were optimised individually. Different probe 
concentrations, competitor DNA concentrations, and hybridisation temperatures were 
tried and optimised to obtain clear and specific signals. The optimal final 
concentration of the DNA mixture (probe and competitor DNA) per 2 crný 
hybridisation area was found to be 200-300 ng of the probe and 20 ýig of the 
competitor DNA. The optimal hybridisation temperature was found to be 39-400C for 
14-16 hours incubation time (Figure 3.3). Using individual probes gave inconsistent 
results and occasionally weak signals. To improve the hybridisation efficiency and to 
obtain consistent signals, the three DMD probes were equally combined to produce a 
probe set (contig) at a final concentration of 200-250 ng/ 2 cm2 hybridisation area. 
Using this probe set, consistent and clear signal was obtained (Figure 3.4a). A probe 
set using the three FRAXA/E probes was then similarly prepared, assessed and also 
found to produce satisfactory results at concentration of 250-300 ng/ 2 crn2 
hybridisation area (Figure 3.4b). These studies revealed the suitability of the cosmid 
contigs for analysis of the DMD locus at Xp2l and of FRAXA/E loci at Xq27-28. 
The commercial probes used in this study (XIST, KAL, DXZ4, telomeric 
sequences, CAP and WCP of X chromosome) were applied following the supplier's 
protocols with minor modifications. Clear and strong signals were observed upon 
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(B) Optimisation of Y-chromosome specific probes 
Six different Y-specific probes (Figure 3.6) were optimised. The MK5 and 
MK29 cDNA probes (Ma et al, 1993) specific for azoospermia factor, and the 
hocSRY probe (Su and Lu 1991) specific for testicular determination factor (TDF) in 
male were supplied as cosmid DNA. These probes were individually transformed to 
an appropriate host cell for culture and preparation of glycerol stocks for further 
investigations. The amplified probe(s) were then isolated. Five ýtg of the extracted 
DNA was digested with the appropriate restriction enzyme and the presence of the 
insert was ascertained by agarose gel electrophoresis (Figure 3.7). One Pg of each 
extracted DNA probe was labelled with either digoxiginin or biotin. Uni-colour FISH 
analysis was optimised using different probe concentrations, competitor DNA 
concentrations, hybridisation temperature, and detection method. The optimal final 
concentration of the DNA mixture (probe and competitor DNA)/ 2 cm 2 hybridisation 
area was found to be 150-200 ng of the probe and 12 ýtg of the competitor DNA. The 
optimal hybridisation temperature was between 39-400C for 14-16 hours incubation 
time (Figure 3.8). The whole chromosome Y paint (WCPY: Cambio) produced 
complete coverage and clear signals on the Y chromosome (Figure 3.8). The two 
repetitive sequence probes GMGY 10 and PHY2.1 were treated exactly as the alpha 
satellite DNA probe without suppressionwith competitor DNA. The concentration of 
the probe(s) and the hybridisation temperature were assessed at 5-100 ng/ 2 crný 
hybridisation area and at 37-420C for 16 hours incubation time. For GMGY 10, the 
concentration required to produce intense and specific signals was found to be 10 ng/ 
2 cm2 hybridisation area at 39-42 OC. The PHY2.1 probe was found to give strong and 
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(2) Dual and multi colour FISH 
Following optimisation of uni-colour FISH, a dual FISH approach was 
employed to detect simultaneously two different probes hybridised to the same 
chromosome or to different chromosomes, in a single hybridisation experiment. A 
mixture of a biotin labelled probe and a digoxigenin-labelled probe was hybridised to 
metaphase spreads. Biotin-labelled probe was detected with rhodamine-avidin (red) 
and digoxigenin-labelled probe was detected with FITC (green). Each of the red and 
green signals was amplified using an extra layer of rhodamine-avidin and FITC. The 
chromosomes were counter-stained with DAPI, which allowed visualisation of both 
red and green signals on a blue background. The concentrations of probes used in dual 
FISH were guided by the optimal concentration, for each probe, used during the uni- 
colour FISH experiments and did not exceed a final concentration of 500 ng. Signals 
produced by each of the probes were strong, distinct and easily distinguished using 
this system. Figure (3.9a) shows a normal male metaphase spread simultaneously 
hybridised with digoxigenin labelled DXZ1 (green) and biotin labelled PDP97 (red) 
probes. 
Once the reliability of the probes had been established both singly and in pairs 
using various detection systems, a three colour combinatorial FISH approach was 
carried out to detect three probes simultaneously. In this technique, one probe was 
digoxigenin-labelled, a second biotin-labelled and a third consisting of a 1: 1 ratio of 
biotin and digoxigenin-labelled probe were combined in a hybridisation mixture of 
total volume 12-34 gl. Detection of the probes in three colour ratio mixing FISH was 
performed as in the dual FISH study. Biotin labelled probes were detected with 
rhodamine-avidin (red) and amplified once with biotin labelled anti-avidin and 
rhodamine-avidin. Digoxigenin labelled probes were detected with FITC labelled 
monoclonal anti-digoxigenin (green) and amplified by anti-mouse conjugated with 
FITC. A third colour (yellow) was produced by detection of the combinatorial- 
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labelled probe with both rhodamine and FITC. Figure (3.9b) shows a metaphase 
spread simultaneously hybridised to three different probes specific for chromosome X 
(XIST, KAL and DXZI). All probes used in this study were optimised to provide 
strong and well-defined signals on metaphase spreads. Although some slight 
background labelling can sometimes be observed, chromosome identification was 
always unambiguous. 
3.1.2 Applications of FISH technigue: 
(1) Patients 
FISH analysis was applied to two groups of patients. The first group of cases 
consisted mostly of Turner syndrome and its variants that had been shown 
cytogenetically to have a chromosome abnormality involving the sex chromosomes. 
The karyotypes of these patients are shown in table 3.1. The second group consisted 
of cases with disorders related to sex determination and sex differentiation associated 
with normal karyotype (Table 2.1). This group will be discussed later in the molecular 
part of the project. 
(2) FISH studies ofX and Y chromosomes aberrations 
FISH studies were applied to identify more precisely the chromosomal origin 
of the abnormal or marker chromosome using probes specific for the X and/or the Y 
chromosome. The karyotypes of the investigated cases were performed by the 
cytogenetics laboratory of Duncan Guthrie Institute (DGI) or by the Kuwait Medical 
Genetic Centre (KMGC), Kuwait. Between 20-50 metaphase spreads were analysed 
in each case (Table 3.1). Mosaicism was detected in 17/24 cases (70.8%) of which 
fifteen patients (62.5%) had a mosaic karyotype with 45, X cell line in addition to the 
cell line of interest. Two of these had an unidentified marker of potential Y origin 
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Structural abnormalities of X or Y were confirmed in 20/ 24 (83.3%) cases, including 
ring X, ring Y, i(Yq), isochromosome of the short arm and long arm of X 
chromosome, deletion of Xp, duplication of Xq, as well as X-autosome and X-Y 
translocations. Seventeen of the investigated cases had X chromosome abnormalities 
(70.8%%) and six had Y chromosome aberrations (25%). Table 3.1 summarises all 
the findings obtained by FISH studies. 
The objective in studying these cases was to obtain, if possible, additional 
information about the composition of the abnormal chromosome, to confirm the 
origin of the material present and to identify breakpoints more precisely. 
(A) FISH studies of cases with X chromosome abnormalities 
(1) FISH results from 9 Turner svndrome cases with riii'a chromosome 
The subjects of this study were females ascertained because of multiple 
congenital abnormalities or with features of Turner syndrome, with or without 
learning difficulties (cases 1-9). The clinical and cytogenetic findings of these patients 
are summarised in table 3.2. Routine cytogenetic analysis of 20 metaphases showed 
predominantly 45, X cell line and a second cell line containing a ring chromosome. 
Therefore a total of 100 cells were scored in all of the mosaic cases. In four of these 
cases the ring was small (smaller than chromosomes 21 and 22). Further identification 
was not possible by conventional cytogenetic techniques on any of these. Four cases 
contained a medium sized ring (size of chromosomes 16,17 and 18) and were thought 
to contain material from the X chromosome. 
In the remaining case (Table 3.2, L. D) the ring was large but contained only 
one centromere, and had been identified in the routine laboratory as containing both 
long and short arm regions of the X chromosome. However given the lack of banding 
in the ring chromosomes, content and breakpoints could not be unequivocally 
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identified and FISH studies were undertaken to identify the content of these ring 
chromosomes. 
(a) Detection of the origin of the ring chromosomes by FISH 
Initially slides from all nine cases were hybridised with whole chromosome 
libraries for the X and Y chromosomes and with centromeric probes DXZI (X) and 
PDP97 (Y). All the ring chromosomes showed complete coverage with the X 
chromosome library, and the X centromeric probe showed one signal in each ring 
(Figure 3.10). No signals were obtained in hybridisation experiments with the two Y 
probes, and it was concluded that each ring was derived from X chromosome 
material. FISH analysis using DXZI in 100 randomly selected metaphases confirmed 
the presence of the two cell lines (45, X/46, X, r(X) with the percentage shown in the 
inserted table. The rings varied in size from small to large ring X (Table 3.2). The 
frequency of the second cell line r(X) varied from 12% to 42%. 
Case)Vo Coorenelic results FISH results 
I 45, X[731/46, X, r(X) [271 45, Xf681/46, X, r(X) [321 
2 45, Xf721/46, X, r(X) r281 45, XF78j/46, X, r(X) [221 
3 45. Xf 80]/46, X, r(X) r2Ol 45, Xf85l/46, X, r(X) [ 51 
4 45, Xf5Ol/46. X, r(X) [501 45. xr581/46, X, r(X) f421 
5 45, Xf9Ol/46, X, r(X) flOl 45, Xf881/46. X, r(X) f 121 
6 45, Xf781/46, X, r(X) f221 45. Xf7ll/46, X, t(X) f 191 
7 45, Xf7ll/46, X, r(X) f291 45, Xf751/46, X, r(X) r251 
8 
- 
45, Xf671/46, Xr(M r331 45. xr691/46. X, r(X) f3 11 F9 7 
45, X[901/46, X, r(X) r 101 45. Xfg6l/46, X, t(X) rl4l 
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(b) Analysis of r (X) s breakpoints by FISH 
The ring chromosomes (cases 1-7) were hybridised to the panel of X 
chromosome probes and the results are shown in Table 3.3. As can be seen, it was 
possible to differentiate one of the medium sized rings which contained more long 
arm material [(case 7) (Figure 3.11)] from the other three which contained more short 
arm material [(cases 4,6 and 7) (Figure 3.12-14)], FISH analyses showed that the 
breakpoints could be distal to Xp2l and Xq24 in case 5 (C. B) and could be distal to 
Xp22 and Xq 13 in the other three cases with medium size ring X (cases 4,6 and 7). 
FISH study also showed that the cases with medium size ring (cases 3-7) also 
contained the locus for X-inactivation (XIST) (Table 3.3 and Figures 3.11-3.14). 
It was only possible to study three of the four small rings by FISH. All three were 
shown to contain XIST locus (Xql3) and the more distal probes for both the long and 
short arm showed no signal (Figure 3,15-17). Cases 8 and 9 could not be studied in 
detail due to lack of materials. Unfortunately, time did not permit the use of additional 
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(2) FISH analvsis of duplication 
Two cases with some Turner-like features (Cases 10 and 11) were referred for 
FISH investigation to identify and characterise their abnormal X chromosome. 
Routine cytogenetic analysis with G-banding in case 10 showed 46, X, dir dup(X) 
(qll. 2-). q22.3) karyotype, and case 11 had mos 45, X/46, X, dup(X)(q28-+q2l. l) 
karyotype suggesting an inverted duplication. 
Case 10: A female (D. O. B 2.7.82) referred to DGI with clinical features of febrile 
seizure, poor growth and deafness (right ear). She had short stature and some mild 
stigmata of TS. Routine cytogenetic analysis of G-banding confirmed, 46, X, dir 
dup(X)(ql 1.2-->q22.3) karyotype. 
Initially slides from this case were hybridised with whole chromosome library 
for the X chromosome in order to determine if the extra material of the abnormal X 
was derived from X chromosome or another chromosome. FISH study using whole 
chromosome library for X chromosome on metaphase spreads showed a complete 
coverage of the normal and abnormal X chromosomes and revealed the extra 
chromosomal region to be either duplication of Xq or other X chromosome material 
(Figure 3.18a). Slides were then hybridised to a panel of X chromosome specific 
probes, DXZI (centromere), DMD (Xp2l), XIST (Xql3) and DXZ4 (Xq24). FISH 
study of this case showed that the patient had two copies of XIST locus (Xql3) and 
one copy of DXZ4 (Xq24) on the long arm of the abnormal X chromosome and one 
copy of the DMD locus on the short arm of both X chromosomes (Figure 3.18b). 
These results indicated an interstitial duplication of Xq region confinning and 
refining the cytogenetic interpretation with the final karyotype being 46, X, dir 
dup(X)(q I 1.2->q22.3). 












A 16 years old female was referred due to clinical features of Turner 
syndrome. Routine cytogenetic analysis using G-banding showed mosaicism for X 
chromosome. Four out of 25 cells showed 45, X karyotype and the remaining showed 
a count of 46, with one normal X chromosome and one X chromosome Mth 
additional material on the distal long arm at Xq28 with banding pattern suggesting an 
inverted duplication of the region (X)q28-*22.1. Her karyotype was interpreted as 
mos 45, X/46, X, dup(X)(q28 ->q21.1). 
Slides from this case were hybridised with whole chromosome library for the 
X chromosome and showed a complete coverage of the normal and abnormal X 
chromosomes (Figure 3.19b). Slides were then hybridised to a panel of X 
chromosome specific probes, DXZI (centromere), DMD (Xp2l), XIST (Xql3) and 
DXZ4 (Xq24). FISH analysis of case II revealed two copies of the DXZ4 and one 
copy of XIST loci on the long arm of the abnormal X chromosome and one copy of 
DMD locus on the short arm (Figure 3.19c and d). These results confirmed 
duplication of Xq22. I ->Xq28. 
Unfortunately, due to lack of material and probes it was not possible to 
confinn precisely the type or the nature of duplication (either direct or inverted 
duplication of Xq). This could have been confirmed by using probes in the region 
Xq25-28 or telorneric. The FISH analysis findings of case II are surnmarised in the 
inserted tabIe. 
Case# 11 WCpX -DXZI DMD XIST -DXZ4 
X-paint X-cent Xp2l Xql3 Xq24 




f3) FISH studv of 46, X,? i(Xp) 
Two -cases with Turner phenotype and with cytogenetic findings of 
46, X,? i(Xp) and 46, =46, X,? i(Xp) were investigated by the FISH technique to 
identify the status of the presurned isochromosome. 
Case 12 
This female was referred with Turner phenotype. Routine cytogenetic analysis 
using G-banding showed 46, X, i(Xp) karyotype. 
FISH analysis of 100 metaphase spreads using X-centromeric (DXZI) and 
whole X chromosome paint on old slides (- 4 months old) revealed no mosaicism in 
this patient. FISH analysis using probes specific for the short and the long anns of the 
X chromosome were applied. As can be seen from Figure 3.20, this case was shown 
to contain one copy of the DMD locus (Xp2l. 2) on each arm of the abnormal X 
chromosome and no signal for the FRAXA/E probe was detected. The XIST probe 
was also applied and clear signals were observed on the long arm of the normal 
chromosome, however, the XIST signal could not be delineated precisely on the 
abnormal X in the 15 cells analysed due to overlapping or superimposing of DXZI 
probe (Figure 3.20d). The superimposing of DXZI over the XIST signal could be due 
to the condensed chromosome seen in these slides. However, this observation was not 
detected in any studied cases by the XIST probes. Therefore, the interpretation of 
i(Xp) may be incorrect in this instance. The possibility of Xp; Xp translocation has 
been raised. This case has been recently reinvestigated by another PhD student in the 
department DOI (Glasgow), and it has been proven that this case is not an i(Xp) (Dr. 
Boyd personal communication, 1999). 








Normal X + + + + 
AbnormalX ++ ?* not clear 
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This 8 year old female was referred with Turner phenotype. Routine 
cytogenetic study using G-banding confirmed the presence of two cell lines. The first 
cell line showed an apparently normal 46, XX karyotype. The second cell line showed 
one normal X chromosome and one structurally abnormal X chromosome. Her 
karyotype was interpreted as mos 46, XX/46, X,? i(Xp) in the ratio of 52% and 48% 
respectively. 
FISH analysis was carried out to delineate the structural rearrangement of the 
derivative X chromosome [der(X)l using probes DXZI, DMD, KAL, XIST, and 
DXZ4. FISH results in this mosaic case revealed one copy of both DMD and XIST 
probes on the normal X and the abnormal X chromosomes. Hybridisation with KAL 
(Xp22) probe demonstrated two copies of KAL signals one on each arm of abnormal 
X and one copy of KAL on the short arm of the normal X chromosome. In addition, 
hybridisation with DXZ4 probe (Xq24) to the same case showed clear signals on the 
long arm of the normal X chromosome, while no signals could be detected on the 
abnormal X chromosome (Figure 3.21). The in situ hybridisation studies 
demonstrated this abnormal X chromosome to be a derivative chromosome arising 
from a translocation between two X chromosomes with the breakpoints at p22.1 and 
q22, resulting in monosomy for the region (X) q22-+Xq ter and trisomy for the region 
(X) p22-+Xp ter in this cell line. These studies thus reinterpreted the karyotype to 













46, XX[581/46, derX, t(X, -X)1421 -- Normal X + + + + + 
Abnormal X1 ++ 
---. 
+- +-A + 
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(4) FISM result of i(Xq) 
Case 14 
Fixed material from phytohaemaglutinin (PHA) stimulated blood culture was 
obtained from a Turner syndrome patient. Chromosome analysis by G banding 
showed the presence of 3 cell lines. The first had 45, X karyotype in 3 out 30 cells 
examined, while the second had a 46 count with one normal X chromosome and one 
isochromosome for the long arm of the X in 25 out of 30 cells examined. The third 
cell line has a count of 47 with one normal X chromosome and two copies of the 
isochromosome for the long arm of the X in 2 out of 30 cells examined. A molecular 
study of her DNA by Dr. Chu showed the presence of Y chromosome (Yq) sequences. 
For that reason, this case was forwarded for FISH study to determine whether low 
grade mosaicism. of Y chromosome was present. 
The status of the abnormal X chromosome and the percentage of mosaicism 
was confirmed by FISH experiments with X-centromere and X-paint probes. The 
whole X-paint showed a complete coverage of the normal X chromosome as well as 
the abnormal X (iXq). No translocation was detected on any other chromosome. X- 
centromere probe DXZ1 revealed the presence of two copies of signals on the 
abnormal chromosome (dicentric) and one copy of DXZ1 on the normal X 
chromosome (Figure 3.22). Moreover, X chromosome paint for the long arm (CAP) 
revealed complete coverage of both arms of the abnormal X chromosome confirming 
the cytogenetic diagnosis of i(Xq) of the abnormal chromosome. FISH analysis using 
Y specific probes (PDP97, PHY2.1, Y-paint) on metaphase spreads of this patient 
showed no signals with any of the panel of Y chromosome specific probes. The 
molecular cytogenetic (FISH) results failed to detect the presence of Y material in this 
patient and confirmed the cytogenetic finding of the patient with a karyotype of 45, X 




(5) FISH results from Turner svndrome with Xp deletion 
Case 15 
This female was referred with clinical features of Turner syndrome. The 
cytogenetic studies using Giemsa banding technique of this Turner patient revealed 
that she had a karyotype, of 46, XXp- (pter-ýp 11). FISH analysis using DXZ I probe on 
metaphase spreads of her peripheral blood lymphocytes showed hybridisation signals 
at the centromeric region of the normal chromosome and on a large acrocentric like 
chromosome. Application of the X-paint demonstrated a complete coverage of the X- 
paint over the normal X and the acrocentric like chromosome (Figure 3.23). FISH 
study using KAL probe specific for the short arm of X chromosome on metaphase 
spread from patient's blood samples demonstrated the presence of the KAL probe 
only on the short arm of the normal X. Moreover, X chromosome Paint for the long 
arm (CAP) revealed complete coverage of the paint over the abnormal X indicating 
that the abnormal chromosome contained only Xq material. Hybridisation analysis 
studies thus demonstrated that the short arm of the abnormal X chromosome was 
entirely deleted confirming the karyotype to be 46, XXp-. Summary of FISH analysis 
is shown in the table below. 





Normal X + + _ + + 
Xp- + +-I + 
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(6) FISH investization of a short stature Female 
Case 16 
A 16 years old female who presented at 9 years of age with short statue, 
solitary right kidney, clitoral hypertrophy, urogenital sinus with bladder diverticulum 
and enuresis. She was later found to have an absent left ovary also. Chromosomal 
analysis of 20 metaphases showed an apparently nonnal 46, XX karyotype. This case 
was referred for FISH investigation to exclude the possibility of 46, = 46, XY or 
45, X/46, XX mosaicism. FISH studies on 100 metaphase cells and 100 interphase 
nuclei of the patient with Y chromosome specific probes, PHY2.1, PDP97, and 
WCPY (Y-paint) revealed that the patient was negative for all three tested probes. 
FISH study using DXZ I and WCPX (X-paint) probes specific for chromosome X on 
100 mitoses demonstrated two cytologicaHy normal X chromosomes. These findings 
indicated that the patient has a 46, XX karyotype with no detectable aneuploidy either 
for X or Y chromosomes. 
Case 16 WCPX DXZ1 WCPY PDP97 PHY2.1 
_(X-paint) 
(X-cen) (Y-paint) 
_(Ygl2) 46, XX ++ ++ 
short stature 
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(7) FISH analvsis of 45, X146, XY Turner smdrome 
Cases 17 and 18 
Both female cases presented at a few months of age with failure to thrive and 
went on to have short stature. Both had gonadectomy at 6 years and 2 years of age 
resPectively. Routine cytogenetic analysis of 50 G-banded metaphases confirmed 
mosaicism 45, X/46, XY in both cases in the ratio of 40%, 60% in case 17 and 52%, 
48% in case 18. 
Fluorescence in situ hybridisation was performed on those two cases using 
centromeric probes and whole chromosome paints of chromosomes X and Y. The 
percentage of mosaicism using interphase nuclei and metaphase FISH study revealed 
48% of the 45, X cell line in one case and 42% in the other case. No structural 
aberrations of chromosomes X or Y were detected. Thus the status of the cytogenetic 
finding is confirmed by FISH. 
Case No Karyotype DXZI WCPX WCPY PDP97 
17 45, X [421 + + 
46, XY [581 + + 
18 45, X [481 + +I . " 
46, XY f521 - .I + + 
156 
(8) A case with marker chromosome 
Case 19 
A female aged 21 years old presented with Tumer phenotype. Chromosomal 
analysis by G-banding revealed the presence of two cell lines. One cell line showed a 
45, X karyotype and the second showed a 46, X, +a small marker chromosome of 
unknown origin in 6% of her cells. DNA analysis by PCR had been carried out and 
confinned the presence of Y-specific sequences. Dual FISH study using DXZ1 and 
PDP97 centromeric, X and Y probes respectively on metaphase chromosomes 
revealed two copies of PDP97 hybridisation signals on the mark-er chromosome 
(dicentric, Figure 3.24). Dual FISH using biotin labelled WCPY and digoxigenin 
labelled WCPX paints detected the presence of both X and Y sequences on the 
marker chromosome. The Y sequence was sandwiched between X material suggesting 
X-Y translocations leading to isoclicentric t(X; Y) (Figure 3.24). These signals are 
most likely to be real hybridisation and not due to cross hybridisation. as they could 
not be detected in normal male control. Therefore, the karyotype of this case can be 
interpreted as 45, X/46, X, i dic t(X; Y) in the ratio of 96% and 4% respectively. 
Unfortunately, due to small amount of sample, fariher investigation-using panels of 
both X and Y specific probes could not be carried out to delineate the rearrangement 
more precisely. 
Case 19 WCPX DXZ1 WCPY PDP97 
(X-cen) (DYZ3) 
-45, 
X [961 + + - 
. -46, 
X, + mar [41 ++ + ++ ++ 
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(9) FISH studv of a case with 46AXP 
Case 20 
A female presenting with dysmorphic features, developmental delay, epilepsy 
and anal abnormalities was referred to the cytogenetic laboratory to investigate her 
chromosomal constitution. G-banding technique revealed an abnormal female 
karyotype 46, XXp+. This case was then investigated by FISH technique bearing in 
mind that the extra material could be from chromosome 22 based on some of her 
clinical features such as heart defect, anal abnormalities, mental retardation and 
dysmorphic features. 
FISH analysis using whole chromosome libraries for X and 22 chromosome 
(Cambio) showed a normal hybridisation pattern of both probes (Figure 3.25a and b). 
No translocation or deletion could be detected using these two probes. This result 
implied that the extra material could originate from an X chromosome. 
The slides were then hybridised to a panel of X-specific probes. Two different 
probes specific for the short arm of the X chromosome were used (KAL and Xp- 
telomere) and one signal for each probe was observed on the short arms of both 
normal and abnormal X chromosomes (Figure 3.25c and d). However, it was noticed 
that the Xp-telomeric probe on the abnormal X chromosome consistently showed 
reduced signal intensity in comparison to normal X chromosome. Also there is 
material distal to it. 
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Three specific probes for the long arm of the X chromosome were also applied 
(FRAXA/E, DXZ4 and Xq-telomere). Normal hybridisation signals were detected on 
the normal and abnormal chromosomes (Figure 3.25e-g). 
Recently, chromosome arm DNA painting (CAP) probes specific for the X 
chromosome were obtained and applied to metaphase spreads from this patient. 
Application of Xp CAP showed complete coverage of the paint on the short arm of 
the normal X chromosome and a partial coverage on the short arm of the abnormal X 
chromosome. FISH study using Xq CAP revealed complete coverage on the long 
arms of both normal and abnormal X and no signal was observed on the short arm of 
the X chromosomes (Figure 3.25h-i). These results indicated that the extra material 
could be of autosornal or Y chromosomal origin and that there was a misleading result 
obtained upon using the whole X chromosome library (Figure 3.25a). 
The fixed materials were then hybridised to individual chromosome library 
probes for all autosomes and sex chromosomes using the Cytocell Multiprobe Kit 
(Cytocell), and the extra material on the short arm of the abnormal X chromosome 
was shown to have originated from chromosome 16 (Figure 3.26). This result was 
reconfirmed upon the application of Cambio whole chromosome 16 library. FISH 
study using chromosome arm paint (CAP) specific for the short arm and long arm of 
chromosome 16 was applied and revealed that the extra material on the X 
chromosome originated from the long arm of chromosome 16 (16q) (Figure 3.26b). 
Therefore comprehensive FISH analysis confirmed X: 16 translocation in this patient, 
leading to trisomy 16q with final karyotype of (46, X, -X, + t(X; l6)(p22.3; q24]. 
Detailed FISH analysis is summarised in the table below. 
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Case 20: 46, YXp' [t(X; 16)] 
Observation 
Probes 
Normal X Abnormal X IderMl 
WCPX (CAMBIO) + + 
WCP22 (CAMBIO) + + 
DXZI (X-cen) + + 
KAL (Xp22) + + 
Xp tel + +/- (reduced intensity) 
DXZ4 (Xq22) + + 
FRAXA/E (Xq27-28) + + 
Xq tel + + 
CAP Xp + +/- (incomplete coverage) 
CAP Xq + + 
Cytocell MTK(1-22, XY) There were 3 signals for 16, one on the 
abnormal X chromosome 
WCP16 (CAMBIO) Confirmed 3 copies of chromosome l6q, one 
on the abnormal X chromosome 
CAP 16p 
CAP 16q There were 3 signals for l6q, 
one on the short arm of the 





I dim (K) 16 
(C) ((1) 
Figure 3.26: Application of the Cytocell Multi probe revealed a complete 
coverage of the Xpaint over the normal and a partial coverage over the abnormal 
X chromosome (a). Whole 16 library showed a complete coverage of the paint 
over both chromosome 16 and extra hybridisation signal was detected oil the 
abnormal X chromosome (b). FISH study of 16q-CAP showed complete 
coverage of the q arm of chromosome 16 and the p arm of the abnormal X 
chromosome (c). Partial G-banded karyotype showing the derivative X 
I t(X, 16) 1, non-nal chromosomes X and 16 (d). 
Ab = abnormal. 
(B) FISH studies of cases with Y chromosome abnormalities 
Case 21 
A phenotypically normal female with primary amenorrhea was cytogentically 
investigated and showed a 46, X, t(Xp; Yq) karyotype. 
FISH analysis using Y-paint probe to metaphase spreads of this case showed 
the presence of hybridisation of Y sequences on the abnormal X chromosome (Figure 
3.27a). FISH analysis using DXZ1 and PDP97 probes to metaphase spreads showed 
that the abnonnal X was positive for the X-centromeric probe (DXZI) and was 
negative for PDP97 probe (Figurc3.27b). Hybridisation study using GMGYIO and 
SRY probes (both hybridise to the TDF region) revealed no signals of these probes in 
either metaphase or interphase nuclei. Y-chromosome long arm-specific probes (MK5 
and PHY2.1) hybridisation studies showed clear and strong signals of these probes on 
the short arm of the abnormal chromosome X (Figure 3.27b, c, d). Dual FISH analysis 
using XIST (Xql3) and PHY2.1 (Yqh) showed clear signals of both probes on the 
abnormal X chromosome and revealed that the abnormal X chromosome carries the Y 
material on the short arm (Figure 3.27d). These findings of FISH analyses 
reconfirmed the cytogenetic finding of translocation of Yq to the short arm of the X 
chromosome and showed the absence of the TDF region in the abnormal X. 
WCP-Y DXZI PDP97 MKS PHY2.1 XIST GMGYIO SRY 
Case 21 Y-paint (X-cen) (Y-cen) (Yqll) (Yql2) (Xql3) (Ypll) (Ypll) 
















A female referred with history of primary amenorrhea was investigated. 
Cytogenetic analysis using G-banding technique confirmed her karyotype as mos 
45, X/46, X, iY(q) in the ratio of 74% and 26% respectively. 
FISH study to metaphase spreads using PDP97 probe showed 70% of the 
examined cells to be negative for this probe confiming the presence of 45, X cell line, 
while 30% of the cells showed hybridisation signal of the Y chromosome (Figure 
3.28a). Dual FISH study using both X and Y chromosome paint (WCP X and Y) 
probes and unicolour FISH study using Y chromosome long arm-specific probe 
(PHY2.1) revealed X-paint coverage over the normal X chromosome and Y paint on 
the abnormal Y chromosome (Figure 3.28b) and two copies of the PHY2.1 signals at 
both arms of the abnormal Y (Figure 3.28c). Moreover, hybridisation with Y- 
chromosome short arm-specific probes (GMGYIO, SRY) showed no signals on the 
abnormal Y indicating absence of Yp material in the abnormal Y chromosome. These 
results confirmed the cytogenetic interpretation of the karyotype, as 45, X/46, X, i(Yq). 
Karyotype PDP97 
Y-cent 
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A male patient with ambiguous genitalia with the karyotype mos 
46, XY/46, X, +mar (? derY) was reassessed to delineate the status of the abnormal Y 
chromosome material. FISH analysis using centromeric probe (PDP97) revealed that 
the abnormal Y chromosome was positive for Y centromere. However dual colour 
FISH using biotin labelled WCPY paint and digoxigenin. labelled WCPX paint 
revealed a complete Y-paint coverage over the normal and abnormal Y chromosome 
(Figure 3.29). Dual colour FISH analysis using GMGY1O (Ypl 1) and PHY2.1 (Yq12) 
probes revealed one copy of each probe adjacent to each other on the abnormal Y 
chromosome (Figure 3.29) suggesting the possibility of a ring Y chromosome [r(Y)] . 
Dual colour FISH analysis using PDP97 and MKS (Yql 1) probes showed one copy of 
apparently large Y centromeric probe (PDP97) sandwiched between two copies of the 
MKS probe (Figure 3.29) suggesting the possibility of dicentric Yq or isodicentric 
Yq. Therefore, FISH analysis confirmed the karyotype of the patient contain multiple 
cell lines mosaicism involving structural abnormalities of the Y chromosome. 
Cytogenetic reassessment of the case using G, C, and Q banding reconfinned the 
FISH results. The revised karyotype was interpreted as mos 46, XY[91]/46, X, i(Yq)[6] 
/46, X, r(Y)[3] (Figure 3.30). 






46, X, i(Yq)r6l - + Not done Not done ++ + 







Figure 3.30: C-banded partial inetaphase spreads of' 
cytogenelically reinvestigated case # 23 showing Y chromosome 
abnorinalities. (A) Normal Y chrornosorne. Two partial metaphase 
spreads with ring Y (B) and with I(Yq) (C). 
3.1.2 X-inactivation study 
In addition to the FISH studies, replication status of the ring chromosomes in 
7 patients (cases 1-7) out of the previously described 9 cases and in one case with 
46, XXp+ were attempted using a terminal pulse of BrdU (B-pulse) and Giernsa 
staining (RBG) according to Latt et al (1977) with some modifications. Replication 
studies were performed by introducing BrdU (39lig/ml) to lymphocyte culture 7 hours 
prior to harvest (case 24). This technique results in a modified R-banding pattern with 
lightly stained late replicating regions (Figure 3.3 1). One hundred cells containing 
rings were analysed in each case. 
(I) X-inactivation study of r(X) [Cases 1-71 
Variation in the presentation of the rings was noticed during analysis of the 
stage in which the DNA in the ring chromosome was replicating. Details of this study 
are as follows: 
(1) W. L1. 
This case has a Turner phenotype with normal mentality. The cytogenetic 
study of her peripheral blood showed 45, X/46, X, r(X) in the ratio of 73: 27%. The r(X) 
was found to be small. The activation status of the X chromosomes was investigated 
and one hundred rings were examined. The normal X chromosome was always active, 
and the ring X was found to be active (early-replicating) in 50% of cells where it was 























(2&3) D. C. and J. H. 
Two patients with Turner phenotype who needed an extra help in school were 
found to have 45, X/46, X, r(X) karyotype with 28 and 20% respectively, of their cells 
showing small ring X chromosome on routine cytogenetic analysis. X-inactivation 
study of 100 r(X) showed that 50 and 46% of their rings, respectively, were active 
whereas their normal X chromosome was active (early-replicating) in all cell lines 
(Figure 3.33). 
(4) F. R. 
Cytogenctic analysis of this patient with Turner phenotype showed a 
45, X/46, X, r(X) with 50% of medium sized ring. The X inactivation study of 100 
rings revealed 14% of the rings were in the early-replicating stage (active). The 
normal X chromosome was always active in all cells irrespective of the state of the 
ring X. Two percent of her rings were dicentric and always inactive (late-replicating) 
(Figure 3.34).. 
(5) C. B. 
A 45, X/46, X, r(X) patient with Turner phenotype showed 10% of her cell lines 
carrying medium sized ring X chromosome. X-inactivation study of 100 rings showed 
88% of the rings were late-replicating (inactive). One large ring X chromosome was 
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Figure 3.34: BrdU labelled replication study in a Turner Patient (F. R. ) carrying a 
medium size ring X chromosome. (a) 14% of r(X) were observed in the early 
state of replication (active). (b, c) show late replicating r(X) (inactive). 2% of rings 
were dicentric and were inactive (c). E. R = early replication; L. R = late - 
replication; Arrow = r(X). 
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(6) C. F. 
This case had a Turner phenotype and needed an extra help in schooling. 
Cytogenetic analysis of mitosis cells showed a 45, X/46, X, r(X) karyotype with 20% of 
her cells carried medium sized r(X). The replication pattern of the X chromosomes 
was carried out. Critical analysis of 100 rings (X) showed three different types of 
rings (Table below). The majority of the rings were of medium size (87%) while 8% 
were small and 5% were of large size. 3 1% of the rings were active, of these 20% 
were medium, 7% were small and 4% were large sized rings (Figure 3.36). 
Active r(X) Inactive r(X) Total r(X) 
Small Medium Large 
7 20 4 
Small Medium Large 
1 67 1 100 
(7) K. R. 
Cytogenetic study of the peripheral blood of this case showed 45, X/46, X, r(X) 
[71: 29) karyotype with 29% of metaphase spreads carried a medium sized r(X). The 
replication patterns of the normal and r(X) was done and 100 cells with 46, Xr(X) 
were analysed. The normal X chromosome was always active. 20% of the rings were 
early-replicating (active) and 80% of the rings were late replicating (inactive). 2% of 
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(2)X-inactivation study of a case with 46, XXp+ 
Case 20 
In this case FISH investigation revealed an X/autosome [t(X; 16)] 
translocation. The short arm of the abnormal X chromosome contained materials from 
chromosome 16 as previously mentioned (Figure 3.25 and 3.26). This case was also 
studied for the replication pattern of the abnormal and normal X chromosomes. Fifty 
cells were examined and all showed the abnormal X chromosome was late-replicating 
(inactive). The translocated segment 16q-qter on the short arm of the abnormal X 






Figure 3.38: (a) The X-mactivation study ol'a case with 46. X, t(X: 16) showing 
the abnormal X chroniodoine late replicating wrrow). (b) Sl loWing dl 111CI-entlal 
replication ofthe 16q on the short arni ofabnormal X chromosome (arro%ýs). 
(c) Partial metaphase ol'G-banded chromosome showing the abnornial X 
chromosome (arrow) and two nornial chromosome 16 X and 16. 
3.2 Molecular studies: 
3.2.1 Androgen Receptor gene (AR) 
The subjects evaluated in this study were five unrelated individuals with 
androgen insensitivity syndrome (AIS). All subjects had normal 46, XY karyotype. 
Three of the subjects were referred as the complete form (CAIS), previously known as 
testicular ferninisation syndrome. Two of patients were presented at birth with genital 
ambiguity and diagnosed as the partial form of AIS (PAIS). 
3. ZI. I PCR amplificatioll ofthe AR gene exonsfrom genonlic DNA 
Fourteen pairs of oligonucleotide primers were used in amplification of the 
eight exons of the coding region of the AR gene (2800 bp coding sequences). Exons 
2-8 were amplified from gcnomic DNA using flanking intronic primer sets. Exon 1 
(1615 bp) was amplified using four overlapping primer sets (Figure 3.39). PCR 
reactions were optimised using the published conditions as starting points. 
3. ZI. 2 Mutation detection strategy 
After PCR amplification of all the . 4R exons from 5 AIS patients, PCR 
products were analysed on ethidium, bromide-stained 1% agarose gels to detect major 
sequence alterations. If no alteration was detected, PCR products were screened by 
the means of SSCP and heteroduplex analyses to detect point mutations and minor 
sequence alterations. Since nearly all reported mutations in the AR gene were detected 
in exons 2-8, direct sequencing of these exons were performed from all AIS patients 
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PCR amplification of all the AR exons from the screened patients revealed proper 
product sizes indicating the absence of major sequence alterations (Figure 3.40). 
SSCP analysis was optimised and performed according to Orita et al (1989). 
Since SSCP is more sensitive when smaller PCR fragments were used, PCR products 
from exons 3,5,6 and 8 (171 to 347 bp) were used in this analysis. Denatured 
radiolabelled PCR products were analysed on 0.5% MDE gels with or without 5% 
glycerol ran at room temperature and at 40C. A mobility shift was detected in PCR 
products of exon 8 from one CAIS patient when compared to other patients and a 
normal control (Figure 3.41). 
Heteroduplex analysis was known to be simple to perform with a mutation 
detection rate comparable to that obtained upon the SSCP analysis. The MDE gel 
matrix significantly improved resolution of conformationally different, heteroduplex 
DNA molecules and was used by many researchers to detect single base substitutions, 
deletions and insertions in variety of diseases (Keen et al, 199 1; Perry et al, 1992; 
White et al, 1992). The effective range for comparison of DNA containing single base 
pair mismatches is approximately 200-600 bp. Heteroduplex analysis of PCR 
products of the AR gene exons 1,2,4 and 7 (from 415-605 bp) from all patients was 
performed on 50 cm IX MDE gels. No abnormal migration was detected in any of 
them. In all experiments a positive heteroduplex control sample were included (Figure 
3,42). 
To confirm the nature of the mobility shift detected upon SSCP analysis of the 
CAIS patient direct sequencing of the asymmetric PCR products from AR gene exon 8 
185 
from this patient was performed. A point mutation, 4109 G->T that causes a missense 
Val 889 Leu change was detected (Figure 3.43). The 4109 G-*T change created an 
extra AM enzyme restriction site which upon digestion of exon 8 PCR products (347 
bp) revealed four bands of 127,109,64 and 47 bp respectively. Digestion of exon 8 
PCR products from normal controls revealed only 3 bands of 174,109 and 64 bp 
respectively (Figure 3.44). A hundred normal controls were screened using AM 
restriction analysis of their AR gene exon 8 PCR products and none were found to 
have this mutation. 
To detect any possible mutations in the AR gene, direct sequencing of the 
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Figure 3.40: Ethidiurn bromide stained I ý,, o agarose gels. electrophoresed at 100 volts 
for 45 minutes and photographed under UV light. (a) PCR prodUCtS from exons 2 to 8 
of the 4R gene. (b) PCR products from the four segments spanning exon one ofthe., IR 
gene. Normal sized products were obtained from all screened patients indicating tile 
absence of deletions. insertions or structural rearrangements. LI= 100 bp DNA ladder, 
L2 =I kb DNA ladder. 
L2 11 L2 III 
(a) 
(h) 
Figure 3.41: (a) Examples of radiolabelled SSCP screening of 
exons 3,5 and 6 of the AR gene. NO abnormal band shift was 
detected in any of the screened patients. (b) SSCP analysis ofthe 
AR gene exon 8. A mobility shift (lane 4) is seen in one of the 
screened patients. The PCR prodticts were clectrophoresed in 
0.5X MDE gel containing 5% glycerol at 5 watts for 16 hours at 
room temperatUre. 
Exon 3 Exon 5 Exon 6 
1 
Exon I Exon 2 Exon 7 
Figure 3.42: Examples of heteroduplex analysis of exons 1,2 and 7 of 
tile 4R gene. No heteroduplex band were detected in any screened 
patients. Arrows indicate the 394 bp heterodUplex band in the positive 
control (C). The PCR products were electrophoresed in IX MDE gel at 
800 volts for 20 hours. The gels were stained with silver nitrate. 
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Figure 3.43: Direct sequencing of the asymmetric PCR product from exon 
8 of the AR gene revealed 4109 G --b. T Mutation in the patient (P) 
compared to the normal control (N). The PCR products were resolved in 
80/ýo denaturing polyacrylarnide gel containing 7M urea. Electrophoresis 







Figure 3.44: Alul restriction enzyme digestion of PCR 
products from exon 8 of the AR gene. Lanes I to 4 show 
normal digestion products of 174,109 and 64 bp. Lane 5 
shows the digestion products from the patient who carries 
the 4109 G ý--) T mutation. The normal 174 bp product was 
digested into two products of 127 and 47 bp (arrow heads) 
due to this mutation. The PCR digests were run on 1% 
agarose gel at 100 volts for 2 hours, stained with ethidiUM 
bromide and v1suallsed under the UV light. 
L= 100 bp DNA ladder. 
3.2.2 SRY-Rene 
Patients: 
Subjects included in this part had abnormal sexual differentiation. Two cases 
presented as 46, XY females with primary amenorrhea and were diagnosed as pure 
gonadal dysgenesis syndrome. The ultrasound scan showed no ovaries and 
laparotomy study revealed streak ovaries. Two cases with ambiguous external 
genitalia and dysgenetic gonads were referred as 46, XY partial gonadal dysgenesis 
and were also investigated. Four cases with 46, XX sex reversal were studied. One 
was referred because of ambiguous external genitalia (undescendent testicles). Three 
were identified at the infertility clinic. 
3.2.2.1 46,, YY Females 
The SRY gene (sex-determining region Y gene) was proposed as a candidate 
for the testis determining factor (TDF) (Sinclair et al., 1990) and it has been reported 
that approximately 10% of 46, XY females with gonadal dysgenesis show point 
mutations or deletions of the HMG (high mobility group) box-like motif of the gene 
(Jager et al., 1992). In this study, four 46, XY females with gonadal dysgenesis were 
analysed for the presence of major deletions, point mutations or minor sequence 
alterations in the SR Y gene. 
In order to detect major deletions in the TDF region, fluorescence in situ 
hybridisation (FISH) analysis using hocSRY (SRY-cDNA specific and hybridises at 
Yp11.2) and GMGY1O (hybridises to the TDF region at Ypll. l) probes was 
performed. Hybridisation study on metaphase spreads from all patients revealed 
positive signals of both probes at Yp II region of the Y chromosome indicating the 
absence of major deletion of the SRY gene in the studied patients (Figure 3.45). Two 
cases [46, X, t(X, Y) and 46, X, i(Yq)] with cytogenetically determined deletions of the 
192 
Yp region were used as negative controls and showed no hybridisation of hocSRY or 
GMGY 10 probes on the abnormal Y chromosomes or on any other chromosomes. 
Since the SRY gene is a single intronless gene, that encodes 223 amino acids, 
its open reading frame (ORF) was PCR amplified using flanking oligonucleotide 
primers XES I ONES 11 from the four studied patients. PCR products of expected size 
were obtained from all patients excluding deletions, insertions or other major 
sequence alterations. Moreover, PCR amplification from the two negative controls 
(Yp deleted patients) revealed no products from the SRY region (Figure 3.46). 
With one exception (Tajima et al., 1994), all known SRY mutations cluster in 
the HMG box of the gene. Two PCR primer sets were used to amplify the whole 
HMG (conserved) domain in two overlapping segments (217 & 246 bp) from the four 
studied patients. PCR products from these segments were used in the SSCP analysis 
study as a first attempt to detect point mutations or minor sequence alterations. 
MDIP gels, with and without 5-10% glycerol, running at room temperature were 
used in this study. No abnon-nal mobility shift was detected in any of the studied 
patients (Figure 3.47). 
As no abnormalities were detected upon the SSCP analysis, the whole open 
reading frame (ORF) of the SRY gene was PCR-amplified from all patients and 
screened by chemical cleavage of mismatch (CCM) analysis, yet no cleavage products 
were obtained from any of the screened patients (Figure 3.48). 
As a last attempt to screen for mutations in the SRY gene of these patients, 
direct sequencing of the asymmetric PCR products from the whole ORF, part of the 
promoter sequences and part of the 3' untranslated end of the gene were performed 
using 6 overlapping primer pairs (Figure 3.49). No sequence abnormalities could be 
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Figure 3.46: PCR aniplification products (7 10 bp) froill (lie open reading fraille 
of the SR)'gene. (a) No major sequence alterations could be detected ill aliv of 
the screened patients. (b) Lanes 2 and 4 show no amplification from patients 
vvith Yp deletions (negative control). Lane I (normal male control) and lanes 3. 
5 and 6 (three 46AY female patients) sho\, \- the 710 bp PCR products. The IICR 
prodUCtS were rUn oil 1%, agarose gel at 100 volls for in hour. stained with 
ethidaini bromide, visualised and photographed under UV light. C= control. P 
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Figure 3.47: Radiolabelled SSCP analysis of tile two segments that 
coverthe HMG domain oftheSRYgene usIngO. 5X M[)El\lgel with 5"o 
glycerol. No mobility shift could be detected in any of the studied 
patients (P). Tile PCR products were rLin at 5 watts for 16 hours at room 
temperature. C= control. 
W i. 
Figure 3.48: An example of'chemical c1ca\agc ofmismatch ()NIIIIIIIII 
tetroxide (OT) and hydroxylarninc (HA) are the chemicals Used to 1110(lity either 
T or C mismatches respectively. The CCM of the whole open reading Frame of 
the SR Y gene from four fernale patients ( 1-4) with 46AY gonadal dysgenesis 
and nomial male controls (5-7). No cleavage prodUCtS were detected Upon their 
HA or OT modification. C= positive control. L=I kb DNA ladder. 
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3. ZZ2 Study of the. XX males 
46, XX male syndrome are one of the rarest sex chromosomal disorders in 
humans. In most cases the cause is due to unequal interchange between Xp and Yp 
termini during paternal meiosis as was proposed by Ferguson-Smith (1966). The 
pattern of Y-sequences present in XX males shows considerable variations. In most of 
the reported patients the Y segment includes almost 75% of Yp (Affara et al 1986). 
However, in very few cases, the translocated segment is very small (3540 kb), but 
since it includes TDF, sex reversal occurs (Lopez et al 1995). By contrast, most 
46, XX males with abnormal genitalia lack sequences for SRY in genomic DNA 
(Ferguson-Smith et al 1990). 
Patients: 
Four phenotypically male individuals confirmed to have 46, XX karyotype 
were referred for molecular investigation to exclude sex chromosome mosaicism or 
structural abnormalities of the X and Y chromosomes. Three out of four cases (aged 
between 35-48 years old) had a history of primary infertility. One 5 year old male was 
referred with bilateral undescendent testes (cryptorchidism). 
FISH study of 46, XX males 
In the present study, a 46, XX karyotype was found in the four patients vvith sex 
reversal. FISH study on metaphase spreads from all patients were carried out with 
PDP97 (Y-centromeric) and PHY2.1 (Yqh) probes, which detect highly repetitive Y- 
specific DNA sequences to exclude the possibility of =Y or XX/XXY mosiacism 
or other structural rearrangement. All patients were negative for both probes. 
200 
To detect the presence of a translocation of chromosomal material encoding TDF 
from the Y to X chromosome or autosomes, FISH analysis using hocSRY and 
GMGYlO probes which both hybridise to the Ypl 1-12 region of the Y chromosome 
were done. Hybridisation analysis on metaphase spreads revealed 3 cases of 46, XX 
males with clear signals of the hocSRY and/or GMGYlO probes on the short arm of 
one X chromosome. The fourth case showed no signals with either probe 
(Figure 3.51, Table 3.4). 
PCR study 
To examine the extent of transfer of Y-specific sequences in the four 46, XX 
males, four different Y-specific PCR primers were used. Y1/Y2 (DYZ3) primer set 
was used to amplify Y-centromeric sequences. No such sequences were detected by 
PCR in any of the 46, XX male patients compared to normal male controls confirming 
the FISH analysis results. PCR analysis using SRY, ZFY (zinc finger Y protein) 
(Ypl 1.2) and PAR (pseudo-autosomal region) primers that =plify DNA sequences 
from Yp12 region of Y-chromosome, showed amplifications of the corresponding 
regions in three cases of XX males. The fourth case, which showed negative FISH 
analysis for SRY probes, showed no PCR amplification products using the 
aforementioned PCR primer sets. The results are summarised in Table 3.4 
and Figure 3.52. 
201 
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Figure 3.52: PCR amplitication of DNA t'I'OlII thC StUdiCd 4(), XX 11411es LI1, IIIg I'k)Lll' 
different Y-specific primers. Primer YI/Y2 (170 bp) showed no ampl It icat loll In aII 
four patients (bands in P I. P2. P4 & C2 are non specitic). SRY (710 bp). ZFY (735 bl)) 
and PAR ( 1.1 kb) primers showed arriplification in three patients (P2.113 and P4). No 
products were obtained from any Y-specific sequences Upon PCR amplification From 
PI DNA. The PCR products were run in 1% agarose gel at 100 volts for an hour, 
stained with ethidiurn bromide. visualised and photographed under UV light. P 
patient, Cl= normal niale controls: C2= normal fernale control; 1.1 100 bp DN A 
ladder. L2= I kb DNA ladder. 
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3.2.3 Mutation analysis of the azoospermia factor (AZF) region 
Cytogenetic analysis of anomalies in YqI 1 of the human Y chromosome in 
sterile males with azoospermia or a severe oligozoospermia suggests the location of 
azoospermia factor (AZF) controlling spermatogenesis in distal YqI I (Tiepolo and 
Zuffardi, 1976; Vogt et al, 1992a). The existence of genes associated with 
spermatogenesis on the human Y chromosome was provided by the detection of 
interstitial, usually submicroscopic Yq deletions in azoospermic men (Chandley ct a], 
1989). Ma et al. (1993) identified two closely related genes, BMI and RDM2 whose 
absence, they proposed might be the cause of azoospermia. Recently, Reijo et al 
(1995) identified a novel gene, called DAZ (deleted in azoospermia), that was deleted 
in a proportion of idiopathic azoospermic men and they claimed it to be the AZF 
candidate gene. 
3. Z3.1 Patient selection 
56 infertile men aged from 22-53 years old were enrolled in this study. The 
clinical screening of sterile patients was started by filling in a questionnaire during 
clinical examination of each patient in one of the two infertility clinics from Kuwait 
participated in this study. Each patient was asked and examined for potential gonadal 
abnormalities, testis volume, varicoceles, prostatic abnormalities, chronic illnesses, 
previous genital injury, infection or orchitis, toxic environmental exposure or 
urological surgical procedures. Twelve patients had undergone testicular biopsy. 
Details of their spermatogenetic activity and histopathological findings were known. 
Urological. investigations did not reveal any kind of physical obstruction 
except in one case, which was then excluded from the study. One case with varicoccle 
was also excluded from the study. Quantitative analysis of the follick-stimulating 
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hormone (FSH), luetinizing hormone (LH) and testosterone were done in all cases. 
Patients' hormone levels of testosterone were within the normal range (5.2-22.9 
nmol/L). The level of the follicle stimulating (normal ranges 1.7-11 IUAL) and 
leutinizing (normal ranges 0.5-5 IU/L) hormones were normal or increased. Sperm 
analysis of all patients showed either azoospermia or severe oligozoospermia (sperm 
count <2x 106 / MI). 
All patients were then asked for analysis of their chromosomes in order to 
exclude the cytogenetically detectable chromosome abnormalities known to be 
associated with infertility. Chromosomal study using G, Q and C-banding techniques 
were performed for all the 56 patients. Q and C-banding techniques showed intact Y. 
heterochromatic region in all patients. Four patients with small testis, showed 
47, XXY karyotype (Klinfelter's syndrome). As this karyotype is known to be 
associated with sterility these patients were excluded from the molecular analysis. 
One case showed 47, XYY karyotype. Although this karyotype was not known to be 
associated with male infertility, yet this case was excluded because of varicocele as 
previously mentioned. The remaining 50 cases showed normal 46, XY male 
karyotype. Table 3.5 summarises the clinical and cytogenetic examination of sterile 
men. 
3. Z3.2 Screeningfor deletion in the Yq11 region 
PCR screening: About 10% of idiopathic sterile males were found to have 
microdeletion in the interval six of the Yq1 I (Ma et al 1993). In the present study, 50 
idiopathic sterile males with 46, XY karyotype were screened. A rapid molecular 
screening technique was applied and optimised using both multiplex and single PCR 
techniques in order to detect small interstitial deletions in Yqll. Thirty pairs of 
primers covering this interval were used in either single or multiplex PCR reaction. 
Twenty-eight Y-specific STS (sequence-tagged sites) PCR primer pairs were 
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optimised and used in five multiplex PCR reactions (Figure 3.53). Each multiplex 
experiment was repeated three times in order to evaluate the sensitivity and 
reproducibility of any deletion in the multiplex reactions. In case of detected deletion 
by multiplex-PCR analysis, experiments were repeated by single PCR reaction with 
primer pair(s) of the deleted STS loci. Two primers specific for the RBAf genes were 
also optimised and used in single PCR reactions. The multiplex PCR study detected 
microdeletions in only one case (case 20) out of 50 patients. Six PCR primer products 
were deleted in four (out of five) multiplex reactions (Figure 3.54). The deletions 
detected in the multiplex PCR study were ftirther confirmed using the specific primer 
sets in single PCR reactions. Screening of fifty normal fertile males, using the five 
multiplex PCR reactions, were performed and revealed no deletion with any primer 
pair. False deletions upon multiplex PCR analysis were detected. PCR amplification 
using the specific primer set in a single reaction revealed normal amplification from 
that segment (Figure 3.55). 
In order to find if any of the 28 STS primers used in the multiplex reaction 
was located in the coding sequence of the RBMgene(s), Southern transfer of the five 
multiplex PCR reactions products was performed and the membranes were then 
probed using both MKS and MK29 cDNA probes. No hybridisation signals were 
detected in any of the filters indicating that none of them is Part of the RBAf gene 
coding sequences, Because of this RBM-specific primers were used to screen all 
patients' DNA for deletions. Normal PCR amplifications from the RBAf genes were 
obtained from all studied cases including the case (case 20) which showed deletions 
upon the multiplex PCR screening (Figure 3.56). 
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Figure 3.53: Pattern of multiplex PCR analyses of 28 loci. I lic 
making up each mixture are ordered according to decreasing length of their 
amplification products as indicated in the table. The PCR products were resolved oil 
ail ethidium bromide stained 31/, o agarose gel (3 parts NUSCive :I part Seakem). 
clectrophoresed at 10 volts/cm for 3 hours and v1sualised under UV light. 
I- - 100 bp DNA ladder. Arrm% s indicate the 300 bp DNA band. 
MIX I mix 11 x III ML MLX IV mix v 
I sY84 I sY 143 1 sY86 I sY 14 1 pY6Bati34pr 
(326bp) (311 bp) (320bp) (472bp) (9 1 Obp) 
2= sY134 2 sY157 2 sY105 2- sY9 2- Fr-Ilpr 
(301 bp) (285bp) (301 bp) (303 bp) (313 bp) 
3= sYl 17 3 sYSI 3 sY82 3= sY127 3= Y6HP52pr 
(262 bp) (209 bp) (264 bp) (274 bp) (258 bp) 
4ý sY102 4 sY182 4= Y6HP35pr 4= sY109 4= Y6HP35pr 
(218 bp) (125 bp) (226 bp) (233 bp) (226bp) 
5= SY151 %N 147 
5= Y6PHc54pr 5= sY149 5- Y6Dl4pr 
(183 bp) (100 bp) 
(166bp) (132 bp) (134 bp) 
6= sY94 6= sYI53 
(150 bp) (139 bp) 
7= sY88 7- sY97 





. 0--- sV 14 (472 bp) 
600 I)p---oo- 
N'l 4 (4 72 1) p) ---o- 
(c) 
(b) 
Mix V Single PCR Reaction 
C P2 L P2 
600 bp (d) 
0 
Figure 3.55: Examples of false deletion upon the multiplex IICR screening of 
46AY intcrtile maics. (a) and (c) sho", the apparently deleted bands ill two 
different patients. Single PCR reactiOll LlSlllg the deleted primer(s) showed 
amplification of the specific segment from the falsely deleted bands ill these two 
patients (b and d). The PCR products were resolved ill all ethidium bromide 
stained Yo agarose gel (3 parts NLISCIVC :I part Seakem). elect rophoresed at 10 
volts/cm for 3 hours and photographed Under UV light. 1,100 bp DNA ladder, C 
= control. Pý patient. 
Pi 















Figure 3.56: PCR analysis of patient's DNA using RB. M and RBM2 gene-specific 
primers. Patient (Px) who showed ni I crodelet ions In tile 111LIltiplex PCR (Figure 3.54) 
showed no deletion with these primers. The PCR products were clectrophoresed on 
an ethidium bromide stained I O, o agarose gel at 10 volt, cm for 45 mintiles. 








Figure 3.56: PCR analysis of patient's DNA using RBAII and RBA12 gene-specific 
primers. Patient (Px) who showed rn icrodelet ions in the multiplex PCR (Figure 3.54) 
showed no deletion with these primers. The PCR products were electrophoresed oil 
an ethidiurn bromide stained Po agarose gel at 10 volt/cm for 45 minutes. 
L= 100 bp DNA ladder; C= control 
b) FISH study: - FISH study using probe PHY2.1 of the DYZ2 locus showed normal 
hybridisation pattern (Figure 3.57) from all screened patients indicating the presence 
of the Yq12 (interval 7) and confirming the previous cytogenetic findings obtained by 
Q and C-banding techniques. To detect the presence of deletions in the RBM1 and 
RBM2 genes cDNA probes MK5 and MK29 were used. No such deletion were 
detected in the studied patients including the patient who showed microdeletion in the 
Yq1 1 region by PCR study (Figure 3.57). 
3. Z3.3 Mutation analysis of the RBMI gene 
Since the RBM genes are a multicopy gene family, Southern blotting analysis 
was applied to detect gene-copy deletions in all studied 50 idiopathic sterile males. 
Southern blotting analysis using MK5 probe and two different restriction enzymes 
(EcoRI, Taq]) revealed multiple RBM1 hybridisation fragments from patients' DNA. 
No abnormal pattern was detected in any DNA sample compared to normal male 
controls (Figure 3.58). Southern analysis of DNA from the patient who showed 
microdeletion by PCR could not be performed due to DNA degradation. 
To characterise the molecular pathology of the RBMI gene in idiopathic sterile 
males, DNA samples from all studied patients were further investigated for the 
presence of point mutations in this gene. Exon-intron boundary sequences of the 
RBMI gene A type were kindly provided by Dr. H. J. Cooke, Medical Research 
Council, Human Genetics unit, Western General Hospital, Edinburgh. He also, 
generously provided the exon/intron boundaries of exon 2, which is proposed to have 
an RNA binding motif, in B, C and D copies of the gene. PCR primers to amplify all 
these exons were designed using the Oligý program and PCR reactions were 
optimised to get single specific amplification product from each of them (Figure 
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3-59a and b). Screening for point mutation in the RBM-I gene A type exons 2-11 and 
in exon 2 of B, C and D gene copies was performed by means of the SSCP analysis. 
Radiolabelled PCR amplifications of the specific exons were analysed by non- 
denaturing 0.5X MDE gel electrophoresis with and without 5% glycerol at room 
temperature. Few false positive results were detected which disappeared upon second 
gel electrophoresis of the same samples (Figure 3.60). No other positive SSCP results 
were obtained. 
For exon 12 (43 7 bp) of the RBM gene heteroduplex analysis using IX MDE 
gel was performed to screen for point mutation in that exon from all screened 
patients. No abnormal band pattern was detected in comparison to normal control 
(Figure 3.61). 
3. Z3.4 Microdeletion screening of the DAZ (Deleted in Azoospermia) gene in 
idiopathic sterile males 
Recently, Reijo et al (1995) reported anew gene called DAZ that was deleted 
in some azoospermic idiopathic sterile males. They also, refined the physical map of 
the AZF region deleted in the azoospermic men. Using this information, theSO 
azoospermic and severe oligozoospermic infertile men included in this study were 
further screened for microdeletion in YqlI using 19 single STS PCR primer sets, 
included two sets (sY254, sY255) within the DAZ gene and one DAZ gene-specific 
PCR primer set. No further patients with deletions were, detected in the screened 
cohort. The patient who showed microdeletion upon multiplex PCR analysis showed 
deletion of the DAZ gene-specific PCR primer set and of 16 STS PCR primer sets 
including the two sets within the DAZ gene (Figure 3.63). The deletions in this patient 
were found to span the area between DYS232 and DYS239 which is localised to 
intervals 6C and 6F on the distal part of YqI I (Figure 3.64). 
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Figure 3.58: Examples of Southern blot analysis using Mk5 cDNA and two 
different restriction enzymes (1-. *(-oRl and Kull). Male genomic DNA hybridised 
with the RBMI (Mk5) sequence dernonstrated IIILlltlple locations of tile RB, %I 
gene. No deletion(s) was detected in any screened patient. The digested 
fragments were separated in 0.8% agarose gel containing 0.5 pg/nIl etlildmill 
bronlide and electrophoresed at 2 volts/cm for 16-20 hOUrs. 
P= patient, C= control. 
. 44- 
Exon 4 1, Exon 5 Exon 7 
Figure 3.59a: PCR products from exon 2 of the RBM gene family (A. B&C- 113 
bp, D- 100 bp) and from the RBM / gene exons 3 (128 bp), 4( 190 bp). 5( 179 bp) 
and 7( 125 bp). The PCR products were run in an ethidium bromide stained I"o 
agarose gel and clectrophoresed at 10 volts/cm for 45 minutes. Arrows indicate 100 
bp band. L= 100 bp DNA ladder. 
Expn 2 
DcB Exon 3 
Exon 6 Exon 8 Exon 9 
1 
411M 411M 
1, Exon 10 
Figure 3.59b: PCR products from the RBAf I gene exons 6 (119 bp), 8( 136 bp), 9 
( 150 bp). 10 (127 bp). 11 (105 bp) and 12 (437 bp). The PCR products were run ,I all 
ethidiUrn bromide stained I% agarose gels at 100 volts for 45 Minutes. v1suallsed and 
photographed under UV light. Arrows indicate 600 bp band. L -- 100 bp DNA ladder. 













Figure 3.60: (a) Examples of radiolabelled SSCP analysis of the 
RBAII gene exon 2 (A. B, C and D) copies. (b) False positive 
(arrows) results of SSCP analysis of exon 3 obtained in two 
different patients. The PCR products were run in 0.5X MDF. gel 
containing 50o glycerol and clectrophoresed in OM TBE buffer at 5 
Watts for 16 hours at roorn temperature. 
AB 
PPCP 
Figure 3.61: Example of the heteroduplex analysis of tile RBAf / 
gene exon 12 on aIX MDE gel (run at a constant 800 volts for 18 
hours) detected by silver staining. Arrow indicates tile 
heteroduplex band of a positive control sample. 
P- patient, C= positive control. 
(a) 




'4- sN'2154 (350hp) 




. *- 800hp 
Figure 3.62: (a) Multiplex PCR analysis of DNA from intlertile men using two 
primer sets within the D. 4Z gene (sY254 and sY255). (a) only tile previous 
patient (Px. Figure 3.54) showed deletion of both primer sets. (b) PCR 
analysis of the patient (Px) showing deletion of tile whole 1)-4Z gene but no 
deletion of the RBM I gene. The PCR products were rcsolVCd Oil all ethidIL1111 
bronlide stained 11o agarose minigel for 45 minutes at 10 voltcm. Px patient 
with microdeletion, P= patient, Ll= 100 bp DNA ladder. L2= I Kb DNA 
ladder. 
RBMI DAZ 
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SY86 syl 51 SY97 syl 05 SY1 17 SY1 34 
syl 53 





6A 6B 6c 6D 6E 6F 7 1 
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Normal sY232 sY147 sY242 SM2 SY249 
SY254(DAZ) SY24a sY267 
Deleted ................................................................... 
Figure 3.63: Deletion map of the AZF region on human Y-chromosome. 
(a) Diagram of the human Y chromosome. (b) Low resolution analysis of Y 
chromosome of one case of azoospermia with microdeletion. Along top border are 
listed deletion intervals 1-7 and, immediately below, 22 STS and YRRM loci. 
Shown below are results of tested fertile and infertile men for the presence (solid 
black line or absence (minus sign) of each STS. (c) Higher resolution map of AZF 
region. Along top border are listed the STS intervals used in this study. Below are 





Detection of mutations is one of the most important areas of molecular 
biology and it plays an important role in the diagnosis of human inherited diseases 
(Cotton P, 1993; Grompe M, 1993). The present study focused on application of 
different screening strategies that could detect large or minor sequence alterations 
in patients with sex chromosomes aberrations, sex determination (e. g. in the SRY 
gene), sex differentiation (e. g. AR gene) and in male patients with non obstructive 
infertility (RBMI gene). These strategies involved the application of cytogenetic, 
molecular cytogenetic (FISH) and molecular investigations. The spectrum of the 
investigated mutations ranged from cytogenetically visible chromosome 
abnormalities to microdeletion and finally to single base alteration (Table 4.1). 
4.1 Cytogenetic and molecular cytogenetic studies 
In this study the 24 cases included had different clinical manifestations 
and chromosomal abnormalities identified by standard cytogenetic techniques 
(Giemsa banding, G-banding, late replication of X). Two thirds of these patients 
(16/24) were ascertained because they had phenotypes suggestive of Turner 
syndrome or its variants. Reassessment of the chromosomal constitution of these 
patients using fluorescent in situ hybridization technique was carried out to 
delineate and characterize the chromosomal abnormalities more precisely. 
In only 4/24 (16.7%) cases were the cytogenetic findings fully consistent 
with the FISH results (one case of 46, XX, one with 48, XXXX, and two cases with 
45, X/46, XY karyotype). In the remaining 20 cases (83.3%) application of FISH 
yielded additional information not available by the standard cytogenetic method. 
Mosaicism of X and Y chromosomes and structural rearrangements of the 
sex chromosomes are two of the major causes for gonadal dysfunction, infertility 
or abnormal sexual development in both males and females (Therman and 
Susman, 1990; Hsu L, 1994; Ogata and Matsuo, 1995). 
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Since the first cytogenetic report of 45, X karyotype in females with Turner 
syndrome (TS) by Ford et al (1959), a variety of numerical and structural 
abnormalities of X and Y chromosomes have been reported. Recent studies have 
confirmed that the majority of cases with 45, X demonstratqs mosaicism as 
confirmed by applying molecular techniques. These individuals present with 
varying degrees of clinical and pathological manifestations (Therman et al, 1990; 
Ogata and Matsuo, 1995). At conception, loss of an X chromosome resulting 
from mciotic nondisjunction is lethal. Almost all females with 45, X, karyotype 
have gonadal dysgenesis, with few exceptional cases, in whom the possibility of 
mosaicism (45, X/46, XX) cannot be absolutely excluded (Zinn et al, 1993; Jacobs 
et al, 1997). Since the development of banding techniques there is a consensus 
that a minimum of 20 cells or even more should be scored to exclude low grade 
mosaicism. Recently, application of FISH (X specific probes) has confirmed that 
-99% of the Turner syndrome cases are mosaic and the pure 45, X cell line is very 
rare (Fernandez et al, 1996; Jacobs et al, 1997). The high percentage of fetal and 
embryonic miscarriage with 45, X karyotype points to the necessity of mosaicism 
for survival (Hook and Warburton, 1983). Routine analysis of 20-30 metaphases 
has limited the ability to exclude low grade mosaicism. The rate of detection of 
mosaicism is affected by many factors; (a) tissue types and number of tissues 
analysed, number of cells analysed, (b) sensitivity of the techniques applied, (c) 
cell selection, leading to disappearance of cell lines (Fernandez et at, 1996). The 
most frequently observed mosaicism is 45, X/46, XX, occurring in about 30-35% 
of the cases (Fernandez et al, 1996). Mosaicism, for structural abnormality of one 
of the X chromosomes (isochromosome for Xq or Xp ) has been reported to occur 
in 20-25% of cases and an unidentified 'marker' chromosome or fragment (der X 
or Y) has been observed in 12-15% of the cases (Fernandez et al, 1996). 
Application of molecular techniques such as FISH and PCR substantially 
improves the rate of detection of low frequency cell lines and possible structural 
rearrangements. 
The first advantage of application of FISH technique is to confirm the 
cytogenetic finding especially in an unusual situation. For instance, the female in 
case # 16 with short stature and solitary right kidney was thought to have a 46, XX 
karyotype by routine cytogenetics. Application of FISH using whole X and Y 
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chromosomes paint and centromeric probes for X and Y chromosomes did not 
show any mosaicism or structural rearrangement of the X. FISH study excluded 
the presence of Y material in this case. Thus, application of FISH technique has 
been useful in excluding low grade mosaicism in this patient who presented with 
short stature and some stigmata of Turner phenotype. 
A young female (case # 24) with minor dysmorphic features and multiple 
congenital anomalies was confirmed to have 48, XXXX karyotype. Whole 
chromosome painting of X and centromeric probe for X analysis in this patient 
confirmed 4 copies of the X chromosome. No mosaicism was detected. Late 
replication studies using BrdU technique showed 3 inactive X chromosomes. 
This case was investigated as a positive control for X inactivation analysis as well 
as to ascertain the specificity of the X chromosome specific probes. Females 
with tetra X resulting from post zygotic nondisjunction have been reported with 
clinical features of microcephaly and dysmorphic features (Nielsen et al, 1977; 
Therman and Susman, 1993). 
Marker or ring X{r(X)) chromosomes of varying size have been 
reported in 5% of Turner syndrome patients (Jacobs et al, 1997). The phenotypic 
effects of the r(X) chromosomes are variable. Some had typical Turner syndrome 
phenotype, while others had a more severe phenotype including mental 
retardation, and other abnormalities (Cole et al, 1994). The more severe 
phenotype was usually associated with very small r(X) chromosomes which did 
not include the X-inactivation (XIST) locus (Migeon et al, 1993; Janie et al, 
1995). Presumably, the abnormal phenotype was due to functional disomy for the 
duplicated X chromosome regions (Callen et al 1995; Turner et al, 1998). 
However, not all the findings were in favor of this suggestion. Severe phenotypes 
were also observed in patients with late replicating markers (Dennis et al 1993). 
Regardless of the inclusion of XIST locus on the mar (X), clinical findings of the 
45, X/46, X, +mar(X) karyotype differ from those found in the present study 
(Tumer et al, 1998). 
The second advantage of FISH application is to identify the nature of the 
marker or unknown chromosome. This goal was achieved in the first nine cases 
(cases #1-9) included in the present study. In all these cases the nature of the ring 
chromosome was identified and proved to be X chromosome derived with no Y 
material. In addition, application of the FISH technique demonstrated the presence 
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of the XIST locus in the 7 patients tested (cases # 1-7) with ring X chromosome. 
In Turner patients with small ring X (cases # 1-3) in the present study, DXZ1 
(centromeric) and XIST (Xql3) were present while DMD (Xp2l) and KAL 
(Xp22) were absent, suggesting the breakpoints in these 3 patients to be proximal 
to Xp2l. and distal to Xql3. Due to lack of other pericentromeric probes suitable 
for FISH analysis, finer assessment of the breakpoints were not possible, Turner et 
al, (1998) by applying FISH have reported two patients with small ring (Xs) with 
breakpoints Xpll. 23-Xqll. 2 and XpII. 23-XqII. I. In the same respect, Callen et 
al, (1995) reported two patients with small ring (Xs) with the breakpoints of 
Xpll. 21-Xql2 and Xpll. 21-Xql3. Recently, a breakage hot spot in a 3Mb 
region of Xpl 1.21 has been suggested (Wolff et al, 1994). Based on the presence 
of this hot spot at Xpl 1.21 and on the comparison of the ring size in the present 
cases and of those reported ones, the short arm breakpoint of these 3 cases with 
small rings is most likely to be at Xp 11.2 1. However, further studies defining the 
Xp breakpoints of these 3 cases are needed. 
Four cases of the present study had medium size ring (Xs). Three of them 
(cases # 4,6 and 7) showed the presence of KAL (Xp22) and XIST (Xq 13) loci 
and absence of DXZ4 (Xq24) so demonstrating the breakpoints to be distal to 
Xp22 and proximal to Xq24. The last case (# 5) gave positive signals with DXZI, 
XIST and DXZ4 and negative signals with the short arm probes (DMD and KAL) 
suggesting the site of the breakpoints to be proximal to Xp2l. and disW to Xq24. 
The XIST gene is a candidate for a gene which determines X inactivation 
since it is only expressed from the inactive X, and maps to the region known to 
contain the X inactivation region (Brown et al, 1992). Ring chromosomes 
containing XIST are likely to contribute to the patient's phenotype. When XIST is 
absent, the euchromatin of the marker will be active resulting in a disomic 
expression of normal genes. The subsequent over expression and interactions of 
these genes is the genetic basis for the abnormal phenotype. 
It is now established that patients with a small ring marker derived from 
the X chromosome in association with a 45, X karyotype show the typical Turner 
phenotype if the X inactivation centre is present (Callen et al, 1995). In the 
present work late replication studies of 7 cases with r(X) (cases # 1-7) showed 
that some of the r(X) were early replicating, in the range of 12%-54%, while 
others were late replicating ranged from 46%-88%. In all seven cases the normal 
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X in the cell line containing the r(X) was always active. However, no 
phenotype/genotype correlation could be made for those cases with r (X) and the 
size of the ring or the replication pattern. This is due to the presence of the 45, X 
cell line, which invalidates the attempts of genotype-phenotype correlation (Ogata 
and Tsutomu, 1995). On the other hand the lack of additional phenotypic 
abnormalities might be attributed to inactivation of the ring (X) (Callen et al, 
1995). Although an association of ring (X) with mental retardation has been 
previously reported in Turner syndrome (Cole et al, 1994), the nine cases with 
ring (X) in the present study were associated with a typical Turners phenotype 
with normal mentality. 
The third advantage gained from FISH application is the precise 
identification of the breakpoint of chromosomal rearrangement. This was obvious 
in the cases #10 and #11 where the duplicated region has been verified precisely. 
These two cases represent a very rare cytogenetic finding with 46, X, dir dup(X) 
(ql 1.2-ýq22.3) and mos 45, X/46, inv dup(X) (q28->q22.2) respectively. 
Reassessment of their karyotype by applying FISH technique using whole 
chromosome paint (WCPX) and X-specific probes, XIST (Xql3), DXZI 
(centromere), DMD (Xp2l) and DXZ4 (Xq24) has precisely verified the 
duplicated region in each case. In case #10 two copies of XIST and one copy of 
DXZ4 loci on the long arm of the abnormal X chromosome were observed 
indicating duplication of the segment ql 1.2-*q22.3. In case 411 FISH analysis 
confirmed the presence of 45, X cell line and duplication of the segment 
Xq22.1 ->q28. However, a more precise assignment of break points could have 
been possible by using single copy probes for the segment Xq25-Xq28 or 
telomeric specific probes. Direct or inverted duplication of the long arm of the X 
chromosome is very uncommon and has been reported in only 25 cases (Garcia- 
Heras et al, 1997; Zhang et al, 1997). In the majority of cases the rearrangement is 
maternally inherited (Zhang et al, 1997). In only two cases was mosaicism 
reported, suggesting a post-zygotic error in the carrier mother. Alternatively an 
inverted duplication may have resulted from an unequal interchange (crossing- 
over) between homologous chromosomes (Zhang et al, 1997). Dup(X) in males 
have been often associated with severe growth and mental retardation, hypoplastic 
genitalia (undescended testes) and hypotonia (Yokoyama et al, 1992). In females, 
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dup(Xq) is associated with gonadal dysgenesis, short stature, minor anomalies and 
developmental delay. These phenotypic features are probably due to expression of 
genes on the active X chromosome, imprinting effect and/or gene dosage effect 
(Aughton et al, 1993; Zhang et al 1997). In the majority of non mosaic cases with 
dup(Xq), a pre-zygotic origin is suggested by the absence of a normal cell line. 
Aughton et al (1993) have suggested that the clinical effects of dup Xq reflect the 
extent of duplication and the break points. Larger Xq duplications have been 
exclusively reported in females (Zhang et al, 1997). Females with dup(X) may 
present with apparently normal phenotype and or minor anomalies/delayed mental 
development (Ogata and Matsuo, 1995). The pathogenesis could be attributed to 
the replication pattern in the different tissues and/or mosaicism. De novo 
inversion duplications are an extremely rare occurrence. Sporadic cases with dup 
Xql3.1 -+Xq2l. 2 seem to have no effect on the fertility in females (Garcia et al, 
1997; Zhang et al, 1997). Parental origin of the der(X) could also contribute the 
phenotype in de novo duplications of Xq. 
Application of FISH in case # 15, presenting with the stigmata of Turner 
syndrome and 46, XXp-(pter-p 11) karyotype, identified the nature of the 
derivative chromosome, excluded the presence of mosaicism and detected the 
breakpoints. FISH study has shown that this patient has deletion of the whole 
short arm of the X chromosome. Patients with terminal Xp deletions have short 
stature and may have some somatic traits of Turner syndrome while gonadal 
function is generally preserved (James et al, 1998). Short stature has recently been 
shown to be a result of the deletion of a homebox gene SHOX, which escapes X- 
inactivation and is located in the pseudoautosomal region Xp (Rao et al, 1997). 
Regions of both Xp and Xq are thought to carry genes involved in normal ovarian 
function. Recently it has been proposed that the gene DFFRX located at Xpl 1.4 
may play such a role (James et al, 1998). The genes responsible for the other 
somatic features of the Turner phenotype have not been identified. Studies of 
patients with deletions of Xp have led to the suggestions that a gene (s) 
responsible for the stigmata of Turner syndrome may lie proximal to Xpl 1.2 or 
along the length of Xp and in Xq2l -q26 (Ferguson-Smith, 199 1; Rao et al, 1997). 
Isochromosome of the short arm of the X chromosome [i(Xp)] does not 
seem to be viable (Dalton et al, 1998). Indeed monocentric constitutional i(Xp)s 
with no long arm material appear not to exist, presumably because of the lack of 
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the XIST locus and their consequent failure to inactivate (Dalton et al, 1998). 
Therefore, two cases with suspected i(Xp) (cases 412 and 413) in the present 
study were investigated by FISH technique in order to identify the status of the 
presumed isochromosome. Case # 12 was diagnosed by conventional cytogenetics 
as 46, X, i(Xp). Reassessment of this case by FISH analysis using FRAXA/E 
(Xq27-28), DXZl (centromeric), XIST (Xql3) and DMD (Xp2l) probes 
confirmed the presence of a monocentric chromosome containing two short arms 
(one copy of DMD locus was pre§enton each arm of the abnormal X). The long 
arm material (Xq27-28) was absent. Unfortunately, the XIST probe gave an 
inconclusive result. DXZ1 and XIST probes application showed a big fused signal 
on the abnormal X chromosome, which has not been seen in any other cases of the 
present study. The old condensed chromosomes of this case might be the cause of 
the fusion of the signals of the DXZ1 and XIST probes in such case. Therefore, 
the diagnosis t(Xp; Xp) has been raised. Late replication. study could not be 
performed due to the lack of blood sample and the application of other probes 
specific for Xp and Xq was also not possible. 
On the other hand, case # 13 was identified by G-banding as 
46, XX/46, X? i(Xp). FISH study using different X-specific probes demonstrated 
the abnormal chromosome to be a derivative X in the form of (X; X) translocation. 
Hence, FISH has provided the final diagnosis and identified the breakpoints as 
t(Xp22; Xq22). 
In the mean time G-banding for case # 14 showed i(Xq)s (defined as 
monocentric). It is difficult to distinguish between mono- and dicentric 
isochromosomes by GTG-banding due to the fact that one centromere in a 
dicentric is often inactivated which means that its site is not marked by a 
constriction (Fernandez et al, 1996). This limitation has been overcome by the use 
of the DXZI X-specific centromere probe in FISH technique, which gave two 
copies of the DXZI in the i(Xq) cell lines. This isodicentric chromosome is shown 
to have two copies of the q arm and two centromeres located very close to each 
other. The idic(Xq) generated complex mosaics of three cell lines. 
Isochromosomes for the long arm of the X chromosome are the most common 
structural abnormalities of the X being found in 15% of Turner syndrome patients 
(Hook and Warburton, 1983; Fernandez et al, 1996; Fernandez and Pasaro, 1998). 
Isochromosomes, can originate either in meiosis or in mitosis. Wolff et al (1996) 
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suggested that the majority of i(Xq)s arise not by centromere misdivision but via 
breakage and reunion of susceptible regions of the short arm. The resulting i(Xq)s 
would be dicentric, leaving unstable acentric Xp fragments to disperse. The 
absence of a detectable 46, XX cell line indicates the meiotic origin of these 
chromosomes. Dicentric X chromosome of different derivatives were reported 
using FISH by Fernandez and Pasaro (1998). De La Chapelle and Stenstrand 
(1974) first suggested that some isochromosomes might be mitotically unstable 
and therefore give rise to a 45, X cell line. The degree of instability would depend 
on the amount of material between centromeres, so that a stable i(Xq) would be 
possible only when the centromeres are very close and acting in coordination or 
when, if relatively distant, one is rendered effectively inactive. Wolff et al (1996) 
observed in i(Xq) a direct correlation between the distance between centromeres 
and the presence of 45, X cell line, suggesting that a structurally dicentric i(X) 
might originally include two ftinctionally active centromeres. These can form an 
anaphase bridge causing the isochromosome to break during early division of the 
zygote, thus giving rise to a 45, X cell line. The remaining cells, which still contain 
the isochromosome, would survive only if one of the centromeres become 
inactive, thus conferring stability (James et al, 1997; Dalton et al, 1998). 
Moreover, application of Y centromeric and PHY2.1 (Yql2) probes failed to 
detect any Y sequences in this patient although PCR analysis of her genomic 
DNA revealed the presence of Yq sequences (DYZ1 and DYZ2). Although FISH 
technique can detect low grade mosaicism, this requires scoring large numbers of 
cells. In such situation PCR analysis is widely used for detection of cryptic 
mosaicism of Y material (Chu et al, 1995, Osipava et al, 1998). It has been 
reported that 4%-30% of Turner patients are positive for Y material, Thus it is 
highly recommended to screen Turner patients by FISH as well as by PCR in 
order to detect hidden Y chromosome mosaicism (Chu et al, 1995; Lopez et al, 
1998; Patsalis et al, 1998; Robinson et al, 1999). 
The patient # 20 presented with multiple congenital anomalies and proved 
to have 46, XXp+ karyotype by G-banding technique. Detailed FISH analyses 
using a panel of X-specific probes and whole chromosome libraries of all 
chromosomes revealed that the extra material on the abnormal Xp was derived 
from chromosome 16. This finding was reconfirmed by using chromosome 16 
arm paints (CAP 16p and l6q) which revealed that the Xp+ segment is of 16q 
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origin. Therefore, the comprehensive FISH analysis has detected the cryptic 
unbalanced translocation X: 16 in this patient, leading to trisorny 16q and Xp 
monosomy. FISH analysis enabled the precise delineation of the karyotype in this 
case, which was not diagnosed by routine cytogenetic methods and the final 
karyotype was interpreted as 46, X, -X, +t(X: l6)(p22.3; q24). 
The abnormal phenotype in this patient could be due to partial trisomy 
16q(q24-*qter) or monosomy for Xp22. Late replication analysis confirmed that 
the der(X) was inactive in all the 50 cells scored. In females with balanced 
X/autosome translocation a preferential inactivation of the normal X in all the 
cells is exclusive. In case# 20, the der(X) due to t(X; 16)(p22; q24) was confirmed 
to be inactive. However, the translocated segment 16q24-*qter showed 
differential replication pattern. Thus the minor anomalies in the index case could 
be attributed to partial trisomy 16q as a result of unbalanced translocation. 
Parental karyotypes were normal. 
The occurrence of balanced/unbalanced structural rearrangements 
involving an X chromosome and an autosome is very rare. They are associated 
with normal to severe pathogenesis, depending on the chromosomes involved and 
the extent of monosomy/trisomy of the segments involved. Inactivation and 
spreading effect may also contribute to the severity of the phenotype and 
pathogenesis. In human X/autosome translocations have been reported for all 
autosomes (1 -22), The most frequently involved autosomes are 15,21 and 22 
(Schmidt and DuSart 1992; Borgaonkar 1997). The clinical significance of 
inactivation pattern in X/autosome translocations has been extensively reviewed 
by Schmidt and DuSart (1992). Unbalanced t(X; 16) has not been reported 
previously. Davies et al (1976) have reported a case of familial balanced 
t(X; 16)(pll; q24) in two normal female sibs inherited from the mother. The der X 
was confirmed to be late replicating in 100% of the cells. Partial trisomies 16q 
have been reported in many cases compatible with survival up to a year (Savary et 
al 1991). Most of the cases reported are de novo mutations, except for the case 
reported by Hirai et al (1981), resulting from unbalanced segregation of a parental 
translocation. Savary et al (199 1) reported a case of trisomy 16q23-*qter resulting 
from maternal balanced t(13; 16)(pl2; q23). However the trisomyl6q phenotype 
has not been delineated as a clinical entity due to concomitant occurrence of 
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partial monosomy/trisomy of different autosome involved. The smallest segment 
of 16q trisomy reported by Savary et al (1991) presented with low birth weight, 
hypotonia, failure to thrive, and abnormal shape of the skull and high prominent 
forehead. 
Normal male development depends on the presence of Y chromosome in 
human and other mammalian species. This chromosome is involved in numerous 
structural abnormalities (Hsu, 1994), and the phenotype of individuals with Y 
chromosome abnormalities depends on the deleted genes. 
One of the important aspects of application of FISH in screening patients 
with Turner syndrome mosaics is to look carefully for the presence of a 46, XY or 
46, X, +mar (? Y) cell line as these females have an increased risk (10%-20%)for 
the development of gonadoblastoma (Page D, 1987). The possibility of XY or 
marker chromosome (? der Y) should be suspected if the phenotype presents with 
ambiguous genitalia and mild stigmata of Turner syndrome. Here, two cases 
(cases # 17 and 18) presented with failure to thrive and developmental delay, and 
their karyotype was interpreted as mos 45, X/46, XY in the ratio 48: 52 and 42: 58 
respectively. Application of FISH using X and Y specific probes confirmed the 
mosaicism in both cases. In one study, either an entire Y chromosome or a portion 
of it (e. g., marker derived from aY chromosome) was present in 90% of 
individuals with dysgenetic gonads who develop germ cell tumors (Toeche and 
Hernandez, 1986). Other recent studies have implied that genes within the 
pericentromeric region of the Y chromosome are important in the causation of 
gonadoblastorna. Tsuchiya et at (1995) implicated a 4Mb region proximal to the 
centromere, while Salo et at (1995) implicated a 1-2 Mb region just distal to the 
centromere. These studies suggest that any female with aY chromosome (or 
partial Y) containing these regions would be at an increased risk for the 
development of a gonadoblastoma (Schwartz et at 1997). 
In the present study two cases (# 19 and # 23) interpreted by conventional 
cytogenetics using G-banding as having 45, X/46, X, +mar and 46, XY/46, X, +mar 
(? Y) karyotypes respectively were investigated. Reassessment of the karyotypes 
by applying FISH has delineated the marker chromosome in case 19 as iso die 
t(X; Y). The detection of Y material in this patient has an important implication for 
increased risk of gonadoblastoma development. In the second case (# 23), FISH 
identified the 46, XY cell line in 42 cells examined (84%), 5 cells (10%) were 
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demonstrated by using different Y-specific probes to be i(Yq) while r(Y) was 
detected in 3 cells (6%). Application of FISH technique had delineated the 
presence of a third cell line. Thus these findings demonstrate successfully the 
value and necessity of FISH utilizing DNA probes in the identification of sex 
chromosome markers. 
Two females with primary amenorrhea have been ascertained by FISH 
analysis to have structural Y chromosome abnormalities with absence of the SRY 
sequences. Application of FISH using a panel of X and Y specific probes in case # 
21 who presented with the karyotype of 46, X, t(Xp: Yq) by GTG-banding had 
precisely delineated the breakpoints in this case. Her final karyotype was 
interpreted as 46, X, der(X)t(X; Y)(Xqter-->Xp22:: Yqll-+Yqter). This is the most 
common type of X/Y translocation. Twenty-five of such cases have been reported 
and reviewed by Hsu (1994). In this type of translocation there is a normal X 
chromosome and the second X chromosome is a derivative X with a portion of Y 
(Yql I to Yq12) translocated onto the distal short arm (Xp22). All the cases 
reported were females. Because of the deletion of the distal short arm of the X 
including the telomere (monosomy for Xp22.3), many of these patients were short 
with short limbs. Most patients were either proven to be fertile or said to have 
normal ovaries. Some had mental retardation (Hsu, 1994). Application of FISH 
analysis on the second case #22 confirmed her karyotype as 45, X/46, Xi(Yq). The 
i(Yq) was found to be monocentric. Fisher et al (1990) proposed that the haplo- 
insufficiency of a gene (ribosomal protein gene, RPS41) mapped on Yp 
contributes to the Turner phenotype and concluded that one or more Turner genes 
are probably located in the interval IAL The almost exclusively monocentric Yq 
isochromosomes may arise because inactivation of one of the centromeres renders 
stability to the chromosomes and prevents their loss at anaphase. 
The basic sex determining factor responsible for switching on male 
development is known as the SRY gene, located at Yp 11.2 (Sinclair et al, 1990) 
Cases # 19 and #21 in the present study were females. No SR Y gene was found in 
those two cases and thus their female phenotype might be attributed to the 
absence of a regulatory SRY gene product. Individuals with no Yp and therefore 
lacking SRY are all phenotypic females with sexual infantilism and streak gonads 
(Hsu, 1994). 
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Several previous studies have used PCR and PCR-Southem blot analysis 
to detect the presence of SRY and/or other Y specific loci in Turner syndrome 
patients after conventional cytogenetic technique failed to identify aY 
chromosome cell line in their karyotype (Binder et al, 1995; Henegariu et al, 
1998; Lopez et al 1998). Recently Kocova et al (1993) and Chu et al (1995) have 
shown that when Y-specific PCR is combined with Southern blotting, 4%-30% of 
45, X patients are positive for some part of the Y chromosome. Medelj et al (1992) 
detected SRY gene in 1 (2.5%) of 40 patients using PCR amplification. This low 
prevalence identified in a low level of Y mosaicism was confirmed by Binder et al 
(1995) and Patsalis et al (1998). 
4.2 Molecular studies 
4.2.1 Mutational analysis of the AR gene 
Androgen insensitivity syndromes (AIS) are the clinical manifestations of 
end-organ resistance to androgen actions. In this inborn error of sexual 
differentiation, the most common cause of end-organ resistance is altered 
androgen receptor (AR) function. It is an X-linked disorder in 46, XY subjects in 
whom normal male sexual differentiation in utero is altered and subsequent 
neonatal and pubertal virilization is absent or impaired (Brown 1995; Quigley et 
al 1995). The mechanism of action of the androgen receptor involves binding of 
the ligand, which promotes conformational. changes to overcome the inhibition to 
dimerization. The receptor is translocated to the nucleus then it binds to a specific 
region of DNA, the hormone response element, eliciting its actions within the 
target cells (Siegel SF, 1995). 
Many qualitative and quantitative AR abnormalities, causing a broad range 
of AIS phenotypes, have been described (Gottlieb et al 1996). The spectrum of 
phenotypes ranges from individuals with completely female external genitalia and 
absence of Mullerian and Wollfian duct derivatives (complete AIS) to patients 
with ambiguous genitalia or with mild hypospadias (partial AIS) (De Bellis et al 
1994; Quigley et al 1995). Infertility in phenotypically normal men has also been 
reported as a manifestation of androgen insensitivity (Wang et al 1998). 
Quantitative and qualitative alterations in androgen receptor binding activity can 
usually be demonstrated in cultured genital skin fibroblasts from affected subjects. 
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More recently, the molecular lesions responsible from AIS have been identified as 
a variety of mutations in the AR gene (Batch et at 1992; McPhaul et at 1993). The 
greatest numbers of different mutations so far identified are located within exons 
encoding the steroid-binding domain properties (Brown et at 1994; Murono et at 
1995). 
The androgen receptor is encoded by a single gene containing eight exons 
located on the Xqll-12 (Lubahn et at 1989). Like the other steroid hormone 
receptors, the AR consists of distinct functional domains. The N-terminal part is 
involved in transcription activation and is encoded by exon I (Faber et at 1991). 
Two highly conserved DNA-binding zinc clusters recognizes specific 
consequences, whereas the C-terminal zinc cluster is involved in dimerization 
(Jenster et at 199 1; Luisi et at 199 1). Parts of exon 3 and 4 encode the hinge 
region, which contains a nuclear import, and exons; 4-8 encode the ligand-binding 
domain (McPhaul et at 1993). 
The patients investigated in the present study constituted a heterogeneous 
group according to their clinical phenotype. Two individuals presented with 
classical features of testicular feminisation (complete AIS: CAIS), while three 
patients had a predominantly male phenotype and clinical findings consisted of 
hypospadias and/or micropenis (partial AIS: PAIS). The coding regions of the 
gene were amplified by the polymerase chain reaction and screened for mutations 
by means of SSCP and HA. Then was followed by DNA sequencing of putative 
mutant segments. 
Initially, cytogenetic and molecular studies showed no deletion in the Y 
chromosome or in the coding region of the AR gene in all investigated patients. 
Around 5-10% of the AR gene mutations causing AIS are due to deletions. 
Complete AR gene deletion in two families and partial deletions involving 
multiple exons (4-8,3-8, and 6-7) and single exons (2,3, or 5) have been reported 
for families with complete AIS (Brown TR, 1995). 
PCR-SSCP analysis in the present study revealed an abnormal migration 
in a 347 base pair fragment amplifying exon 8 of the AR gene in one patient (Fig 
3.40). This substitution resulted from point mutation at nucleotide 4109 G -+T 
transversion causes Val 889 Leu. Screening 100 chromosomes from unrelated 
individuals revealed absence of this base pair substitution indicating that it was 
not a polymorphism. This and other studies (Batch et al 1993; De Bellis et al 
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1994; Quigley et al 1995; Gottlieb et al 1996; Bruggenwirth et al 1997) indicate 
that complete as well as partial AIS could arise from altered function of the DNA 
and steroid-binding domains of the AR. The possibility of associated mutations in 
noncoding regions of the AR gene has not been excluded completely. 
In the present study conversion of valine to leucine at amino acid 889 
resulted from a single base mutation in exon 8 was associated with complete AIS. 
Previous studies of alternative amino acid substitutions at the sarne given codon 
Val 889 in the AR gene were also reported in CAIS subjects (Pinsky et al 1992; 
De Bellis et al 1994). Valine at codon 889 was replaced by methionine in two 
unrelated subjects with complete AIS. Conversion of valine to leucine was 
reported in exon 7 of the AR gene four times in AIS patients (Gottlieb et al, 199 ' 
6). 
Both valine and leucine are non-polar amino acids. However, there are known 
examples of conservative missense mutations that can results in a disease 
phenotype if they occupy sites in the protein that are key determinants of stability 
or function (Pinskey at al, 1992; De Bellis et al, 1994; Gottlieb et al, 1996). 
The valine 889 by leucine substitution, which lies in the ligand-binding 
domain of the receptor within the conserved region, postulated to function as a 
dirnerizaton domain (Fawell et al 1990). This is a relatively conservative amino 
acid change and even though the mutation was not detected in any of the other 4 
patients or 100 normal males screened, it could not formally discount the 
possibility that it is a polymorphism, with no effect on receptor function. 
Functional studies of an androgen receptor containing this mutation will provide 
an unequivocal resolution of this uncertainty. However, this effectofVal889 
replacement by Leu alone could be sufficient to cause the complete lack of 
masculinization during fetal development. The mutation also created a restriction 
site for Alul, which could allow the carrier status of female(s) to be determined, 
and a prenatal diagnosis to be performed. This mutation in the steroid-binding 
domain provided more insight into the mechanisms of receptor function and could 
attribute also to the growing database of the structure function map of the AR 
gene. 
Great numbers of different mutations so far identified are located within 
exons encoding the steroid-binding domain properties (Murono et al 1995; 
Gottlieb et al 1996). Relatively few mutations occur within the most C-terminal 
region of the steroid-binding domain encoded by exon 8. However, the occurrence 
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of AIS related to these mutations demonstrates the critical nature of this region for 
maintenance of steroid binding and transcriptional activity of . 4R (Brown TR, 
1995). 
Mutations at several different sites in exons 2-8 encoding the DNA and 
androgen-binding domains with a relatively high number of mutations in two 
clusters in exons 5 and 7 have been recently been identified in AR gene in subjects 
with both complete and partial androgen insensitivity (Evans et al 1996). The 
number of mutations in exon one are extremely low (Batch et al 1993; Brown TR, 
1995; Gottlieb et al 1996; 1997). CAIS is most often attributed to point mutations 
in the AR gene causing amino acid substitutions, aberrant splicing, or premature 
termination (Shkolny et al 1995; Bruggenwirth et al 1997). The evidence to date 
indicates that a mutation of the AR gene is responsible for most if not all cases of 
CAIS (70%) (Emery and Muller 1992). In contrast, many patients with PAIS 
demonstrate no defect in the androgen binding and no AR gene mutation could be 
identified in them (Batch et al 1992; McPhaul et al 1993). In such cases, it must 
be assumed that partial androgen insensitivity is the result of defects in other 
genes, whose expression is controlled by the androgen receptor gene during 
genital development (Batch et al 1992; Viner et all 996). 
Recently, a database of the AR gene mutation has been established and 
described by Gottlieb et al 1996. It shows the androgen-binding phenotype of the 
mutant AR, the clinical phenotype of the affected persons, the family history and 
whether the pathogenicity of a mutation has been proven. The database has 
allowed substantiating and amplifying the observation of mutational hot spots 
within exon encoding the AR binding (exon 4-8). 
Molecular genetic analysis for diagnostic purposes employing SSCP has 
proven to be a very use1l approach to a variety of diseases (Orita et al 1989). It 
has been used with success by several groups for characterization of point 
mutations in the AR gene (Hiort et al 1994; Bruggenwirth et al 1997; Wang et al 
1998). SSCP has the advantage that laborious sequencing reaction can be limited 
to the very few samples that have shown a different migration pattern on the gel 
electrophoresis. Using PCR-SSCP analysis, three cases with PAIS and one case 
with CAIS in the present study were found to have no mutation in the coding 
region of the . 4R gene. The present study and other reported ones showed that in 
242 
some individuals, clinically diagnosed as having AIS, no mutation was found in 
the coding region and exon-flanking intronic sequences of the AR gene 
(Bruggenwirth et al 1996; Weidemann et al 1996) and DNA sequencing (Morel et 
al 1994), in spite of clear phenotypic, endocrinological, and biochemical evidence 
for AIS. Mutations might be missed because PCR-SSCP is not 100% sensitive. 
Often, only the exonic sequences and their flanking intronic regions are screened, 
leaving mutations in important intronic and promoter regions undetected. 
Recently, Bruggenwirth et al (1997) reported intronic mutation in a family with 
PAIS. By sequencing part of intron 2, a T->A mutation was found 11 bp from 
exon 3. Furthermore, mRNA analysis of the same family, revealed that splicing 
involved a cryptic splice site, located 71nObp upstream of exon 3, resulting in 
generating mRNA with an insert of 69 nucleotide. For the AR gene, if cells from 
patients are available, RT-PCR studies and western immunoblotting can be very 
informative, in particular when mutations are present in intronic regions (Ris- 
Stalpers et al 1990; 1994). Expression of a number of genes involved in male sex 
differentiation and development is regulated by the androgen receptor (AR). 
There are other explanations for the apparent absence of AR mutations in 
several AIS cases. Neutral mutations for example have to be interpreted with 
caution. Ritchard and Beckmann (1995) have found a 'neutral' point mutation in 
the cDNA of the calpain (CANP3) gene, which turned out to be pathogenic, 
because a splice donor site was created. Kallio et al (1996) suggested that, in 
46, XY subjects without a mutation on the AR gene and with a typical AIS 
phenotype, post receptor defects might be the cause of the disease. This may 
involve receptor-specific cofactors or corepressors. Recently, a family with 
dominant inheritance of thyroid-hormone resistance was reported, which could 
not be linked to defects in the thyroid hormone-receptor alpha or beta gene (Weiss 
et al 1996). It was postulated that an abnormal cofactor, playing a role in 
regulation of thyroid-hormone action, might be involved. Most cofactors reported 
to date are not AR specific, so mutations in these factors will probably be lethal or 
give rise to a complex phenotype. Yeh and Chang (1996) have reported one 
coactivator, ARA70, which binds specifically to the ligand-bound AR. It is not 
known whether mutations in the gene encoding ARA70 correlate with certain 
forms of AIS (Bruggenwirth et al 1997). 
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Although CAIS, is not life threatening, affected individuals are infertile 
and require counseling, gonadectomy, hormone therapy, and sometimes 
vaginoplasty (Davies et al 1995). Many families therefore request genetic 
counseling. On the other hand, PAIS is a much more variable condition, which 
present with an intersex phenotype at birth. Therefore, management of PAIS 
requires a decision regarding sex rearing based on the genital phenotype, genital 
reconstruction surgery and hormone therapy. 
Once a mutation is found, it may be used to provide infon-nation for 
genetic counseling of other family members. Alternatively, the intragenic 
trinucleotide repeats in the N-terminal region of the receptor may be used as 
polymorphisms to follow the affected X chromosome through the family (Davies 
et al 1995). 
4.2.2 Mutational analysis of SRY gene in sex reversed patients 
Sex differentiation is a complex physiologic process that most likely 
involves the products of many genes, not only on the Y chromosome, but also 
several that are X-linked and autosomal. For an infant to develop as 
phenotypically complete male or female a cascade of complex molecular and 
morphologic events must occur at the appropriate time and in the correct 
sequence during ontogeny. Normal human sex differentiation consists of three 
basic steps (Jost A, 1972). Each of these steps involves a number of complex, 
sequential processes, The first step is the establishment of genetic sex, which is 
determined at fertilization. In the second step an indifferent gonad differentiates 
into a testis in the XY male or an ovary in the XX female. In the absence of they 
chromosome, a tests-determining pathway fails to be initiated or is blocked, and 
development of the fetal gonads follows an inherent ovarian pathway. Testis 
development from the embryonic bipotential gonad depends on the inheritance of 
aY chromosome-encoded gene, which was previously referred to as the testis 
determining factor (TDF) and subsequently identified as the SRY (sex- 
determining region Y) gene (Sinclair et al, 1990). SRY most likely activates a 
succession of other genes which switch the inherently female pattern of 
development to that of the male, beginning with testis formation. The final step in 
the pathway of normal sexual differentiation, the translation of gonadal sex into 
phenotypic sex, depends on the type of gonad formed. Indifferent internal and 
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external genitalia precursors are converted to male or female structure, depending 
on whether or not a testis develops (with notable exceptions exemplified by the 
testicular feminization syndrome). Hormones produced by the fetal testis are 
responsible for the induction of masculinizatoin of the external genitalia and 
development of the structures of the male reproductive tract, as well as prevention 
of the development of the uterus and fallopian tubes (Angle et al, 1997). 
The investigation of subjects with sex reversal has been a central strategy 
in the study of mechanisms responsible for normal gonadal and genital 
differentiation. Information from the study of 2 types of sex reversal was used to 
map the locus of the testis-determining factor (TDF) gene to the distal short arm 
of the Y chromosome (Vergnaud et al, 1986). One type included the so-called 
46, XY females. The other included subjects with 46, XX sex reversal (Turner et al, 
1995). 
4.2.2.1 XY females 
Studies in the past few years have clearly established the SRY gene (sex 
determining region, Y) to be the primary testis-determining gene in humans 
(Sinclair et al, 1990; Koopman et al, 1990). The SRY gene is located on the short 
arm of the Y chromosome and consists of a single exon. Analysis of the SRY open 
reading frame (ORF) has identified a domain termed the HMG box, which is 
conserved with regard to a number of proteins associated with DNA, including the 
high mobility group (HMG) nuclear proteins (Gubby et al, 1990; Sincalir et al, 
1990) and various transcriptional factors, such as T cell factor I and lymphoid 
enhancer factor I (Ferrari et al, 1992). Mutations in the SRY gene can cause a 
failure of testicular development that may result in complete or partial male to 
female sex reversal. In some cases, these mutations have been demonstrated to 
alter the DNA-binding and/or bending properties of the SRY protein (Pontiggia et 
al, 1994; Veitia et al, 1997). 
The term 46, XY gonadal dysgenesis has been used to describe various 
conditions of abnormal gonadal differentiation. The 46, XY complete gonadal 
dysgenesis is characterized by absence of testes, affected subjects presenting with 
female genitalia, normal Mullerian structures and streak gonads like those of 
Ulrich-Turner syndrome. This condition is also called 46, XY pure gonadal 
dysgenesis (Sohval AR, 1965). In some individuals, there is partial testis 
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determination and affected subjects present ambiguous genitalia of a mixed 
Mullerian and Wolffian structures and dysgenetic gonads. These cases are 
referred as 46, XY partial or incomplete gonadal dysgenesis (Berkovitz et al, 
1992), although terms such as 46, XY dysgenetic male pseudohermophroditism 
(Federman DD, 1967) have also been applied (Marcantonio et al, 1994). 
Swyer (1955) was the first author to document cases of XY gonadal 
dysgenesis, and this condition was initially referred to as Swyer syndrome. Over 
120 cases of gonadal dysgenesis have been reported (Bercu. and Schulman1980). 
Sporadic cases occur, but many have been familial, compatible with autosomal 
recessive inheritance limited to karyotypic males or X-linked recessive 
inheritance (Hersh et al, 1980; Phansey et al, 1980). 
In the present study cytogenetic, molecular cytogenetic (FISH) and 
molecular studies of 4 subjects with 46, XY sex reversal were carried out to 
delineate their molecular pathology. Two cases presented as pure gonadal 
dysgenesis (complete gonadal dysgenesis and the other two presented with 
ambiguous genitalia and dysgenetic gonads (partial gonadal dysgenesis). 
Cytogenetics and molecular cytogenetics (FISH) using X and Y centromeric 
probes analyses performed on blood failed to detect 45, X and/or 46, XX cell lines 
in all investigated cases. In some patients, intersex abnormality is associated with 
sex chromosomal mosaicism, particular 45, X (Wolman et al, 1985; Liou et al, 
1997). Thus, it is very unlikely that the abnormal sexual development in all 
patients is related to the presence of Y chromosome mosaicism. Yet, cytogenetic 
analysis of cells from both gonads was not studied and it needs to be investigated 
in all patients in order to exclude gonadal mosaicism. Moreover, in situ 
hybridisation to the XY female's chromosome using hocSRY/GMGYIO probes 
specific for SRY region (Figure 3.45) showed that the SRY gene was located on 
the short arm of their Y chromosomes. Therefore, the possibility of presence of 
microdeleltion or Y chromosome rearrangement was also excluded in all 4 
investigated patients. The pathogenesis of the XY gonadal dysgenesis phenotype 
appears to be heterogeneous, resulting from a variety of defects in the testis- 
dctermining/differentiation pathway. Some XY females with gonadal dysgenesis 
have lost the sex-determining region of the Y chromosome by terminal exchange 
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between of the sex chromosomes (Vergnaud et al 1986) or by other deletions 
(Davis RM, 198 1; Page et al 1990). 
A 790 bp PCR product of SRY open reading frame (ORF) encompassing 
the HMG-box was amplified from genomic DNA from 4 unrelated XY sex 
reversal subjects. The radiolablied PCR products were analysed for mutations by 
CCM assays revealed none of the PCR products from the SRY open reading frame 
region showed aberrant CCM pattern. As confirmed in this study, the majority of 
XY females with gonadal dysgenesis show no evidence for alteration in the DNA- 
binding domain of the SRY In some cases, sex reversal could result from 
mutations in regulatory regions of the SRY gene, which manifest itself 
immediately because of the hemizygous state of the Y chromosome (McElearvey 
et al, 1992b). In this study a 422 bp segment of the SRY promoter region was 
included in the SSCP analysis. Two overlapping PCR fragments, together 
spanning position -444 to -22 of the SRY promoter region (Behlke et al, 1993) and 
at position 429-650 of poly A tail, were amplified for DNA of the same patients 
also revealed that these two regions have no aberrant SSCP pattern in all 
investigated patients, Sequencing of the SRY ORF, promoter and poly A tail 
regions further, indicated all 4 patients harbor normal sequences. The absence of 
mutations in the SRY promoter region is consistent with a recent study that 
described a single strand confonnation polymorphism screening of 360 bp 
including the minimal promoter, in a group of 45 patients in whom no sequence 
variants were detected (Schmitt-Ney et al, 1995). An independent analysis of 2 kb 
DNA immediately 5' to the SRY ORF of 49, XY females and XY intersex subjects 
detected two base changes; one was the common polymorphism and the other was 
unique but familial (Kwok et al, 1996). This suggests that mutations in the 
promoter regions essential for gene expression, although documented in a few 
cases, are rare events when compared with the frequency of mutation in coding 
regions (Koivisto et al, 1994). These results suggest that there may be other 
sequences crucial for the regulation of the SRY gene lying outside the regions 
studied or other sex reversing gene(s) able to produce indistinguishable 
phenotype. 
To date, 24 mutations have been described in the coding region of the SRY 
gene, most of them being located in the HMG box. However, these mutations 
have been identified in only about 10-15% of XY females without aY 
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chromosome deletion have mutation in the SRY gene (Berta et al, 1990; Hawkins 
et al, 1992; Schmitt-Ney et al, 1995; Kwok et al 1996; Veitia et al, 1997). The 
majority of mutations that have been tested are de novo and are not share by the 
fathers of these XY daughters (McElreavey et al, 1996; McElrearvy and Fellous, 
1997; Brown et al, 1998), yet familial type of SRY mutations have been reported 
(Zeng et al, 1993; McElreavey et al, 1996). In other cases male to female sex 
reversal in the presence of a wild-type SRY ORF, the phenotype may result due to 
mutations in the regulatory region of the SRY gene (Schmitt-Ney et al, 1995), or 
because of mutations in other sex-determining genes may be located on the X 
chromosome or autosomes (Eicher and Washburn, 1986; Bennett et al, 1993; 
Foster et al, 1994). 
To date, genetic approaches in sex reversed patients have identified 
several genes and regions involved in sex determination. An autosomal sex 
reversal locus, SRAI, has been identified in XY females with campomelic 
syndrome (Tommerup et al, 1993). Mutation in the Wilms tumor (IFTI) 
suppressor gene in XY individuals reported to show abnormal development 
(Pelletier et al, 1991). Another autosomal sex reversing genes are located on distal 
9p and distal 10q (Bennett et al, 1993; McElreavey and Fellous, 1997). A gene 
which regulates SR Y has not yet been discovered. Regulation of SRY may involve 
the autosomal or X-linked genes describes, or an unknown locus. Thus, XY 
gonadal dysgenesis is heterogeneous phenotype (Angle et al, 1997). 
X-linked genes have been implicated in several familial cases of XY 
gonadal dysgenesis. Recently, a locus termed DSS (dosage sensitive sex reversal) 
has been defined, which consists of 160 Kb located at Xp2l, 3. Male to female sex 
reversal has been observed in individuals to be associated with duplications of this 
regions in individuals with 46, XY karyotype (Am et al, 1994; Bardoni et al, 
1994). The severity of the abnormalities appears to depend upon the extent of the 
duplication. The DSS region at Xp2l. 3 was not screened for duplication in this 
study. Therefore it could not exclude the existence of a small duplication of this 
region. These results are in agreement with the previously reported studies 
(McElreavey and Fellous, 1997; Veitia et al, 1997). These cases may be candidate 
for harboring mutations at autosomal loci or X-linked. These results indicate that 
mutations involving the SRY gene on the Y chromosome are an infrequent cause 
of 46, XY gonadal dysgenesis. 
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4.2.2.2 XX males 
The 46, XX male syndrome represents the most common condition in 
which the testes develop in the absence of a cytogenetically detectable Y 
chromosome. Most cases are sporadic. The incidence is estimated at about I in 
20,000 newborn male infants (de la Chapelle A, 1981). As early as 1966, 
Ferguson-Smith suggested that the male phenotype in XX males arise as a result 
of unequal X-Y interchange during paternal meiosis. 
During normal meiosis in male, crossover occurs between the tip of the 
short arm of the Y chromosome and the tip of the short arm of the X chromosome. 
These regions of the X and Y chromosomes contain highly similar DNA 
sequences. Because this crossover resembles the behavior of autosomes during 
meiosis, the distal portion of the short arm of the Y chromosome is known as the 
pseudoautosomal region. It spans approximately 2.5 Mb. Just centromeric to the 
pseudoautosomal region lies a gene known as sex determining region on the Y 
(SRI). This gene, which is expressed in embryonic development, encodes a 
product that interacts with other genes to initiate the development of the 
undifferentiated embryo into a male (e. g., Sertoli cell differentiation, secretion of 
mullerian inhibiting substance (Koopman et al, 199 1). The SR Y gene was mapped 
to a 35-kb segment on the distal region of Yp (Palmer et al, 1989; Sinclair et al, 
1990). 
The identification of SR Y gene as the gene for TDF (Koopman ct al, 199 1) 
made it possible to confirm Ferguson-Smith's (1966) hypothesis by demonstrating 
that genomic DNA from most normal appearing subjects with 46, XX maleness 
contained sequences for SRY. By contrast, most 46, XX males with abnormal 
genitalia lack sequences for SRY. Similarly, almost all subjects with 46, XX true 
hermaphroditism lack sequences for SRY in genomic DNA (Ferguson-Smith ct al, 
1990; McElreavey et al 1993a; Turner et al, 1995). 
In the present study cytogenetic analysis, fluorescent in situ hybridisation 
(FISH) and molecular amplification have been used to detect the presence or 
absence of Y sequences and to characterise the transfer of Yp fragments to 
Xp22.3 in 4 XX males. PCR amplification of the SRY gene, ZFY, PAR and 
Yl/Y2 sequences along the Y chromosome were applied to characterise the Y 
chromosome sequences present in 4 XX males, In three cases, PAIZ, SRY, and 
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ZFY sequences were amplified, while YI/Y2 (centromeric sequences) failed to 
amplify (negative). Some authors have reported that the Y sequences present in 
the XX males extend from distal Yp to Y centromere, showing a variation in the 
size of the fragment exchanged from less that 40 kb (Sinclair et al, 1990) to more 
than II Mb (Affara et al, 1986; Ferguson-Smith et al 1990). The similarity of the 
clinical features in all cases reported in the literature confirms that SRY gene is 
responsible for testicular determination, and that other genes on the Y 
chromosome are not so important in defining the phenotype. XX males wich are 
SRY positive are the most frequent type of XX males reported (Affara et al, 1986; 
Page et al, 1987). This confirms the relative frequency of an Xp/Yp interchange 
originating through unequal crossing over between homologous pseudoautosomal 
regions in the paternal meiosis extending the exchange to sex specific sequences 
(Ferguson-Smith 1966; Weil et al, 1994). Some cases of Y; autosome translocation 
have been described in 45, X subjects with sex reversal (Munke et al, 1988). 
However, only one subject of 46, XX male with a Y; autosome translocation has 
been reported by Ester et al (1998). 
In this study all patients had the Y chromosome DNA transferred to 
Xp22.3 as found in all other reported cases (Van der Auwera et al, 1992; 
Anderson et al, 1986; Magenis et al, 1987). The phenotype described in these 
cases is that of males with sterility owing to the absence of germinal cells and 
hypogonadism. without sexual ambiguities, consistent with the clinical data 
detected in patients investigated in this study. The clinical features were very 
similar in those 3 cases, showing a male phenotype with small testes, testicular 
atrophy, and azoospermia. These patients had normal intelligence and a stature 
within normal male range. 
Only one subject presented in this study had 46, XX sex reversal and 
absence of SRY. This was demonstrated by failure to detect SRY sequences in 
genomic DNA by PCR amplification and FISH analysis, In addition, all 4 subjects 
lacked sequences for Y centromere, Hidden mosaicism with a Y-bearing cell line 
was ruled out due to the absence of Y centromeric sequences by FISH analysis 
(Figure3,51) using PDPY97 probe and by PCR using YI/Y2 primer sets. 
Therefore, FISH analysis and PCR test confirmed this finding. 
Direct detection of Y sequences in XX males has been previously shown 
to be possible by isotopic in situ hybridisation (Anderson et at, 1986; Magenis et 
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al, 1987; Schempp et al, 1989). However, the procedure and the interpretation of 
the results is facilitated in FISH (Fan et al, 1990). The first report in which 
translocation of an SRY-bearing fragment to an X chromosome in XX males 
could be directly demonstrated using FISH (Van der Auwera et al, 1992). Ester et 
al (1998) have used cytogenetic, FISH and PCR amplification to characterise the 
transfer of Yp fragments to Xp22.3 in six XX males and they have prenatally 
diagnosed XX male in the fetus with male genitalia detected by ultrasound and a 
46, XX karyotype in aniniocytes and fetal blood. Molecular analysis of fetal DNA 
showed the presence of the SRY gene. FISH techniques also showed Y 
chromosomal DNA on Xp22.3 in metaphase cells of a fetus. This is the second 
molecular prenatal diagnosis reported of an XX male but, the first one to be of aY 
positive XX male, as the only other prenatal case reported was XX male fetus 
lacking any Y sequences (Vilain et al, 1994). The case of a prenatally diagnosed 
XX male is especially interesting as an example of the problems that may arise in 
a laboratory when the sex of a fetus is different from that expected based on 
prenatal cytogenetic analysis. FISH and molecular studies allowed the 
confirmation of the XX male diagnosis in the fetus. Other cases were detected 
only after the birth of a male following cytogenetic prenatal diagnosis of 46, XX 
(Sachs et al, 1992), and where postnatal allowed the possibility of a sample error 
or maternal cell contamination to be ruled out (Ester et al, 1998). 
46, XX males can be classified as Y positive or Y negative, depending on 
the presence or absence of Y-sPecific sequences (Ferguson-Smith et at, 1990). In 
Y negative cases, autosomal or X-linked mutations may be responsible for 
testicular determination in the absence of SRY (de la Chapelle, 1987; Ferguson- 
Smith et al, 1990). Most 46, XX male patients with normal genitalia are SRY 
positive. In contrast, the majority of the XX males with genital ambiguity are 
SRY negative (Ferguson-Smith et al, 1990; McElreavey et al, 1993b). 
Nevertheless, exceptions do occur and Y negative XX males may exhibit 
complete masculinization (McElreavey et al, 1993b; Ramos et al, 1996; Zenteno 
et al, 1997) while genital ambiguity can be observed in Y-positive XX males 
(McElreavey et al, 1992a; McElreavey et al, 1993a; Lopez et al 1995). 
The present study also confirmed the existence of one SRY negative XX 
male. This SRY negative XX male was also negative for all other Y sequences 
tested by FISH or PCR test. Other analysis using DNA amplification also revealed 
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some XX males who were Y-negative for several Y sequences, including ZFY 
(Oster and Clayton, 1989) or SRY (Ferguson-Smith et al, 1990) and excluding 
XX/XY or XX/der (Y) mosaics with an unprecedented sensitivity. The male 
phenotype in such cases might be explained by mutation (s) in one or more 
gene(s) downstream from SR Yin the sex-determining pathway. The elucidation of 
the different steps and genes involved in the mechanism of testis developments 
may allow testing of this hypothesis. With respect to the phenotype, some authors 
have described abnormalities in the external genitalia (hypospadias, 
cryptochidism) and a more prominent gynecomastia in Y negative XXmales 
(Abbas et al, 1990; Ferguson-Smith et al, 1990). 
XX-individuals lacking SRY who exhibit masculinization (complete or 
partial) are proposed to be defective in other genes and are able to express male 
sex determination in the absence of the master gene (SRI) of a regulatory cascade. 
On the contrary, XY sex reversal with an intact SRY gene can carry a mutation 
that renders another gene of the cascade insensitive to SRY action (McElreavey at 
al, 1993a). Many familial cases have been negative for Y chromosome-specific 
probes (Abbas et al 1990; McElreavey et al, 1993b). Pedigree analysis lead to the 
hypothesis that they carry recessive mutations (McElreavey at al 1993a). 
Three clinical categories of sex-reversed 46, XX individuals have been 
identified: phenotypic males, male with ambiguity, and true hermaphrodites (de la 
Chapelle A, 1987). All patients are shorter than normal XY males, which is 
probably due to the absence of Yq-specific growth gene(s) (Ogata and Matsuo, 
1992) and to the lack of an appropriate testosterone-dependent pubertal growth 
spurt (Boucekkine et al, 1994). Although all XX males have similar genotypes, 
different phenotypes have been described, suggesting that in the same cases SR Y 
alone is adequate for complete male sexual differentiation while in others it is not 
sufficient for normal virilisation. In contrast, SRYnegative males have ambiguous 
genitalia and bilateral testes or ovotestes, i. e.; they are true hermaphrodites (Lopez 
et al, 1995). 
The availability of specific DNA probes for different regions of the Y 
chromosome demonstrated that approximately 80- 90% of XX males carry Y 
sequences due to an illegitimate X/Y interchange during paternal meiosis (Abbas 
et al, 1990; Ferguson-Smith et al, 1990; Weil et al, 1994). The rest who lack Y 
material their maleness is probably due to mutations in autosomal genes as in 
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campornelic dysplasia (1 7q) and WAGR syndrome (I I p) and in 9p-, or in X- 
linked testis determining genes as in DSS gene (McElvery et al, 1993a, b; Wolf U, 
1995; Ramos et al, 1996). Molecular studies in this study confirmed the absence 
of Y-derived material (PAR, SRY, ZFY, and Yl/Y2 centromeric) in one patient 
with ambiguous genitalia, as all the specific sequences analysed did not amplify, 
while they were present in male controls. 
To explain the occurrence of Y-negative XX males, McElreavy et al 
(1993a) proposed that the SRY gene act by inhibiting a regulatory autosomal 
recessive gene, termed Z, whose product is a negative regulator of male sex 
deten, nination. According to this model, XX individuals lacking SR Y who exhibit 
a complete male phenotype would be homozygous for aZ null mutation. In 
contrast, XX males with genital ambiguity and XX true hermaphrodites may carry 
leaky Z mutations that conserve some residual activity, thus explaining the 
phenotypic variability. An alternative model suggested by Jimenez et al (1996) 
who proposed that X-linked locus, DSS located in Xp2l and subject to X 
inactivation, may act as a repressor of the male pathway. This implies that a single 
active copy of this gene can repress the male pathway in XX females, while in XY 
males it is inactivated by SRY, equating DSS to the hypothetical Z gene. 
According to this model, SRY-negative XX males with normal genitalia are 
homozygous for deletions or loss-of-function mutations in DSS, while SRY- 
negative XX males with genital ambiguities could be heterozygous for a DSS 
allele, such that the proportion of cells of the indifferent gonad in which the DSS 
+ is inactivated would determine the degree of residual maleness. A gene isolated 
from the Xp2l region DAM, has been proposed to be identical to DSS (Bardoni 
et al, 1994; Zenteno et al, 1997). 
In summary, PCR amplification of SRY, PAR, ZFY, and DXZ3 (YI/Y2 
centromeric) sequences could be effectively used in cases where cytogenetic 
analysis fails to detect the Y chromosome. PCR is more effective, and can provide 
detection of Y chromosome material in as few as I of 1,000 cells (Osipova et al, 
1998). Further, it is more specific, and can be used for the precise detection of 
sequences responsible for the development of testicular tissue (SRY), or for 
regions implicated in the development of gonadoblastorna development (e. g., 
AMGLY). In this cohort, this approach considerably improved the diagnosis 
compared to classical cytogenetic analysis in 3 of 4 cases, and may be 
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recommended as an important tool in cases of cytogenetically undetectable 
markers or virilization of unknown origin. 
In conclusion, the present study has shown that FISH is a valuable 
technique for the rapid detection of Y sequences in XX males. This technique 
provides direct evidence for the presence of Y sequences, including SRY, on the 
Xpter in XX males, and allows the detection of Y material with Yp-specific 
probes hocSRY and GMGYlO in metaphase and interphase nuclei of all Y 
positive males. Furthermore, PCR amplification using markers along the Y 
chromosome has allowed the Y sequences present in each patient to be defined 
and correlation with the phenotype to be established. Subsequently, the location of 
Y fragments has been further determined by in situ hybridisation on metaphase 
chromosomes. 
Molecular and FISH techniques are very useful for detecting and locating 
Y sequences in cytogenetically XX males, allowing an accurate diagnosis and 
correct management of the patient. Testing new Y chromosome markers in XX 
males will make it possible to narrow the breakpoints fixther in each case and to 
establish correlation with the clinical features, identifying the Y region implicated 
in the definition of the phenotype (Ester et al, 1998). 
4.2.3 Mutational analysis of male infertility 
Between 2% and 12% of couples world wide are infertile, with the man 
responsible in approximately half of the cases (Cooke et al, 1998). Large 
proportions of these men are infertile either because of insufficient sperm 
(oligoospermia) or lack of sperm (azoospermia). Proposed causes of infertility in 
men include varicocele, obstruction of the spermatic ducts, agglutination of 
sperm, high semen viscosity, necrospermia, low volume of ejaculate, ejaculatory 
dysfunction, and high sperm density. When no cause is known, the man is 
described as having idiopathic infertility (Proyor et al, 1997). The cause of these 
defects in sperm production is unclear, but recent work points to both potential 
environmental and genetic causes. 
In this study, 56 patients with either azoospermia or oligoospermia, were 
screened for the presence of mutation in the AZF region using 5-step strategies. 
To screen for large deletion and/or other structural rearrangements, all patients 
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included in this study were examined by (1) routine cytogenetic study, (2) 
multiplex PCR analysis, (3) Southern blot hybridisation and (4) FISH analysis 
with RBM cDNA probes, Lastly, to screen for point mutation and/or minor 
sequence alterations in the RBM1 gene family, all patients were screened by 
SSCP, HA analyses and by DNA sequencing. 
Cytogenelic study 
Chromosome banding allows an analysis of the entire karyotype at one 
time, and is the preferred technique for routine diagnosis; therefore all patients 
were first analysed for chromosomal study in order to exclude the cytogenetically 
detectable chromosome abnormalities. Among the 56 men with infertility, the 
most common assigned diagnosis were idiopathic infertility with normal male 
karyotype (50 men or 89.2 %) (Table 3.5). Abnon-nal karyotype were found in 5 
(8.9%) of the 56 subj ects studied. Of these 5 subj ects, 4 (7,1 %) exhibited 47, XXY 
(80%) karyotype, the remained 1 (1.8%) had 47, XYY karyotype. Thirty-two of 
the men with infertility (57.1 %) had azoospermia, four had 47, XXY karyotype 
and one had evidence of spermatic duct obstruction. As 47, XXY karyotype is 
known to be associated with sterility, these patients were excluded from the 
molecular analysis. One azoospermic subject with 46, XY karyotype was also 
excluded from molecular study because of obstructive azoospermia. Twenty-four 
(42.9 %) had severe oligoospermia, one of them had 47, XYY and varicocele. This 
case was also excluded from the molecular study because of the presence of 
varicocele. Thus, only 50 idiopathic infertile men with normal 46, XY karyotypes 
were further investigated by different molecular strategies in order to establish 
their pathogenesis. 
Association between human male infertility and chromosomal anomalies 
has been known for a long time (Chandley A, 1979; Faed et al, 1979). The 
incidence of karyotype abnormalities among infertile men has been reported to 
range between 2.2 and 19.6% (Pandiyan et al, 1996; Gunduz et al, 1998; Mclaren 
A, 1998). Thus, it would not be unusual to find chromosomal abnormalities in 
men attending infertility clinics. Therefore, karyotyping every male attending the 
infertility clinic would be necessary to identify or exclude those with genetic 
defects. 
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The exact mechanism by which chromosomal anomalies induce infertility 
is not clear. It is likely that the presence of abnormally distributed chromatin may 
interfere with meiotic division, therefore, reduces sperm production. Spermatozoa 
bearing abnormal chromosomes may cause abnormal embryonic development that 
can in turn cause early pregnancy loss (Evans et al, 1978). In the presence of the 
47, XXY abnormality in Klinefelter syndrome, severe spermatogenesis failure 
causing a marked reduction in testicular size and azoosperrnia is the rule. Thus the 
reason for the patient's infertility is clear. In the 47, XYY abnormalities, however, 
testicular histology may be either normal or abnormal. Testicular size may be 
normal with only minor changes in the seminal profile (Pandiyan et al, 1996). 
Multiplex and single PCR screening 
Clinical experience indicates that large deletions of the Y chromosome, 
which can be seen under the microscope in late prophase and are detectable on 
routine karyotype, are uncommon in infertile men. However, submicroscopic 
deletions of the long arm of the Y chromosome, not detectable on karyotype and 
therefore called microdeletions, are present in 10-15% of azoospermic men (Vogt 
et al, 1993; Nagafuchi et al, 1993; Henegariu et al, 1994; Najmabadi et al, 1996). 
These microdeletions can be detected by polymerase chain reaction (PCR)-based 
sequence tagged sites (STS) mapping or by Southern hybridisation or by FISH 
analysis (Ma et al, 1992; Henegariu et al, 1994). 
In the present study, molecular analysis of sequence tagged sites (STS) in 
azoospermic and oligoospermic males was done. The screen was focused to 
Yql 1; the region of genetic Y factors controlling spermatogenesis defined as AZF 
(i. e. azoospermia factor: Tieplo and Zuffardi, 1976). A rough molecular 
estimation of the length of the DNA region in YqI 1, where AZF should be 
localised, indicates a minimum extension of 3-5MB (Vogt et al, 1993). 
Consequently, Y DNA probes used to screen for deletions of AZF gene sequences 
have to be spread along this Y region. However, a focus of the screening 
programme can be proximal and distal to Yql 1, since microdeletions in this 
region have already been diagnosed in some azoospermic males (Vogt et al, 
1992a; Nagafuchi et al, 1993; Henegariu, et al, 1994; Kaboyashi et al, 1994). In a 
series of PCR experiments it can be shown that polymorphic amplification 
products are not visible and deletion breakpoints can be mapped reliably using the 
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maps of Ma et al (1992). Since Us PCR Y analysis is possible without 
sophisticated blotting techniques and radio-labelled DNA probes, it became 
feasible to screen the Y chromosome of idiopathic sterile males ininfertility 
clinics. 
A total of 49 Y-specific STSs sets of primers covering Yq region were 
used in this study. 28 pair sets were used in 5 multiplex PCR reactions and the rest 
(21 pairs of primers) were used in single PCR reactions. Two pairs were RBM 
specific and two were within DAZ gene and one pair was DAZ gene specific. Most 
of STSs are located within YqI I region. 
Of the 50 men with idiopathic infertility only one azoospermic male (2%) 
was found to have aY chromosome microdeletion. This approach showed, in one 
patient (case 25 in table 3.6), no amplification of six pairs PCR primers detected 
in 4 out 5 multiplex reactions. These deletions involved sY153 (subinterval Q, 
sY147 and Y6HP52pr (subinterval D), sY 157 and sY 149 (subinterval E), and 
Fr15-1 lpr (not determined). No amplification failure was observed in 50 normal 
male controls including the father of the patient with microdeletions. The absence 
of an STS amplification product indicates the presence of a microdeletion in 
interval 6. Therefore, by molecular deletion analysis using multiplex PCR, the 
breakpoints in Yq II was estimated to be in subinterval MX-MXII of the Ma map 
(Ma et al, 1992) between interval 6C and 6F according to Vollrath deletion map 
(1992). 
Detailed deletion analysis using 21 STS primers within intervals 5 and 6 of 
Yq1 I region showed that this patient had deletions in 16 more STSs. These 
refined physical map results confirmed the deletion between DYS232 and 
DYS239 which is localised to interval 6C and 6F on the distal part of Yq1 I 
according to Vollrath et al (1992) deletion map. 
Nearly all DNA loci listed in appendix Il are single copy loci, which mean 
that their location in Yq1 I is unique. It has been shown that lower repetitive DNA 
sequences are spread in Yql I (Vogt et al, 1992b; Ma et al, 1992; Vollrath ct al, 
1992). A deletion of an Y-specific repetitive DNA locus can be detected by PCR 
analysis only if all sequence copies of this DNA locus are deleted. However, a 
critical analysis of PCR experiments should stress not only its higher sensitivity 
but also its sensibility for experimental artifact. It is highly recommended that the 
reproducibility of any deletion in the multiplex PCR experiment to be tested as 
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well in single PCR experiment using the corresponding primer since false deletion 
events are possible (Henegariu et al, 1994). This was the case when a few false 
deletions were detected by multiplex PCR, but the corresponding primer(s) was 
extended during a single PCR experiment. 
Great interest has been devoted in the last several years to the 
identification of the gene(s) within the Y chromosome which are involved in the 
etiology of idiopathic male infertility (Vogt et al, 1992b; Nagafuchi et al, 1993). 
Two Y-specific candidate gene families have been cloned by deletion mapping of 
infertile men with Yq1 1.23 (interval 6) deletions and proposed as candidates for 
the putative AZF locus, the RNA-binding motif (RBM)-containing gene family 
(Ma et al, 1993; Naimabadi et al, 1996), and the deleted-in-azoospermia (DAZ) 
gene family (ReiJo et al, 1995). Both are multiple-copy gene families. The RBM 
gene family has more than 30 copies spread through the Y chromosome 
(Meschede and Horst, 1997). Most of the copies are located in deletion interval 
6A and 6B (Bhasin et al, 1997). The DAZ gene family has 6-10 copies (Cooke ct 
al, 1998) located in interval 6D and 6E. At least two members of the RBM gene 
f=ily, RBM-1 and RBM-2 are expressed in the testis (NaJmabadi et al, 1996). 
The presence of RBM in the predicted protein sequence suggests that these genes 
play a role in RNA processing. However, the precise role of the RBM protein(s) 
in germ cell development remains unclear. On the other hand, DAZ has a testis- 
specific pattern of expression and encodes RNA-binding protein of yet 
undetermined function (ReiJo et al, 1995). In the present study, using RBMI and 
RBM2 specific primer pairs revealed that all patients included the patient with 
Yql I microdeletions have retained RBM gene family. This could mean that 
RBM I is not the only gene involved in the failure of spermatogenesis. In addition, 
because of the multigenic and dispersed nature of R13M sequence, only very large 
deletions would be expected to remove the entire possible PCR target. 
Using DAZ specific primer pairs revealed that all patients and controls 
retained the DAZ gene, yet it was deleted in the patient with microdeletion. The 
father of the patient retained DAZ gene. Therefore, the patient in this study 
retained the RBMI and RBM2 genes but has a deletion of the DAZ gene. The role 
of the RBM genes in male infertility has been challenged by the observations that 
many infertile men with Y deletions have had RBM sequence present. In fact, 
deletions of interval 6 have been detected in infertile subjects retaining RBM 
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(Kaboyashi et al, 1994; Reijo et al, 1995; Stuppia et al, 1996b). Moreover, 
deletions of DAZ have been identified inpatients with different spermatogenic 
disorders (Reijo et al, 1995; Vogt et al, 1995). Although deletions involving the 
DAZ gene(s) appear to be the most frequent, several groups have described Y 
deletions that are outside the DAZ regions (Vogt et al, 1996; Pryor et al, 1997), 
which suggests that AZF could be owing to more genes (Reijo et al, 1995; 1996). 
Furthermore, only 10-15% of infertile men have Y deletions. These data suggest 
that additional Y-specific and/or autosomal genes may be involved in the 
infertility phenotype. Some observations suggest that RBM and DAZ are not the 
only genes responsible for idiopathic infertility (Meschede and Horst, 1997). 
Microdeletions in Yq 11 were reported in up to 10% of idiopathic sterile 
males (Ma et al, 1992; Vogt et al, 1993) while in the present study only 2% of 
idiopathic sterile men showed microdeletion. When the PCR experiment fails to 
detect a deletion event in the Y chromosome of sterile males, different 
explanations are possible. First, the Y chromosome of the patient is normal with 
no deletion of AZF gene sequences in Yq1 1. Second, mutation in the gene 
structure of AZF can not be detected because they are either point mutations or 
very small deletions not hit by current set of screening probes. Clearly, analysis of 
deletions in Yql 1 generally gives only an indication of the deletion of the AZF 
gene sequences as long as the gene structure of AZF is not known at the 
molecular level. Therefore, the PCR-Y-screening programs can hint at the 
deletion of AZF gene sequences but can not yet prove that this occurs. It is 
essential to prove that'the extension of any DNA deletion detected on the Y 
chromosome by multiplex PCR analysis is restricted to the patient's Y 
chromosome and is not present as a rare polymorphic event in the male of the 
patient's family (Henegariu et al, 1994). Interestingly, the microdeletion detected 
in one patient was not detected in the rest of patients' investigated and male 
controls including the father of the patient with microdeletion. Therefore, this 
deletion probably includes at least part of the AZF gene structure. Moreover, 
clinical diagnostic tools for selecting patients with a potential disruption of AZF 
gene sequences out of the large idiopathic patient group are still very crude (Vogt 
et A 1992a; 1992b). Microdeletions in Yql I have been found in azoospennic as 
well as in severe oligozoospermic males (sperm count between 1.5 X 106 per ml). 
The patient's hormone level of LH and testosterone is usually normal. The level 
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of FSH is normal or increased within a broad range (Vogt et al, 1992a; Henegariu 
et al, 1994). 
Recently, the rate of reported microdeletion ranges from 3-18% (Vogt et 
al, 1996; Meschede and Horst, 1997). The variability is most likely explained by 
different selection criteria for the study subjects. Most, but not all, Yq 
microdeletions described so far includes the DAZ gene cluster (Qureshi et al, 
1996; Vogt et al, 1996). This has led Vogt et al (1996) to postulate the existence 
of three non-overlapping regions containing different azoospermia factors, termed 
AZFa, AZFb and AZFc. On the basis of the testicular histology in these men, the 
deletion of AZFa was associated with the presence of only Sertoli cells. The 
deletion of AZFb was associated with the developmental arrest of germ cells at 
the pachytene stage, and the deletion of AZFc with the developmental arrest of 
germ cells at the spermatid cells (Vogt et al, 1995). The AZFc coincides with the 
DAZ locus, but no candidate genes for AZFa and AZFb have been designated yet. 
Vogt (1996) also postulated that the different categories of Yq microdeletions 
might be specifically associated with particular types of testicular histopathology. 
However, studies by other groups have not confirmed this claim (ReiJo et al, 
1995; Qureshi et al, 1996; Meschede and Horst, 1997). 
In this study the ultrasound examination in the patient with the 
microdeletion of interval 6 displayed normal testes without any appearance of 
obstruction. The levels of FSH, LH, and testosterone were within normal range 
and it seems that this patient has a deletion in AZFc associated with 
spermatogenic arrest. 
In infertile men with DAZ deletions, both meiotic arrest and the Sertoli- 
cell-only phenotypes have been described (ReiJo et al, 1995). It is possible that 
germ cell degeneration may occur secondarily. Testicular biopsies often reveal 
some tubules that show meiotic arrest and other tubules with the Sertoli-cell-only 
phenotype. It remains unclear whether these two histological phenotypes represent 
two ends of the same spectrum or whether they are the result of distinct 
genotypes. 
Several investigators have shown that some infertile men carry 
submicroscopic deletions in Yq that are not present in their fathers' or brothers' Y 
chromosome (Ma et al, 1993; Kaboyashi et al, 1994; Reijo, et al, 1995; Qureshi et 
al, 1996; Vogt et al, 1996). However, Stuppia et al (1996b) showed both a 
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proband and his father with a deletion inYqI 1, but the deletion in the proband was 
actually larger compared with that in his father as the proband's deletion also 
involved STSs sY243 and sY 269 which are located within the more proximal 
subinterval E of interval 6. They confirmed the critical role of interval 6 in the 
spermatogentic process, which suggests that deletions of subinterval F, per se, is 
not associated with infertility. An additional point of interest is that both the 
proband and his father retained RBMI and STSs sY254 and sY255, which are 
mapped within DAZ in subinterval D. The segment deleted in the proband only, 
which is likely related to infertility, lies within subinterval E, which is outside the 
DAZ region. They implied that, in oligoospermic patients at least, other genes in 
the region distal to DAZ and RBM I may be involved in the spermatogensis 
process. Moreover, they argued that some deletions should not lead necessarily to 
infertility, but these deletions make the Y chromosome more liable to a second 
mutation resulting in spermatogenesis failure, as a consequences of DNA 
instability (Stuppia et al, 1996a). 
The precise physiological function and role of RBM and DAZ gene 
families in human spermatogenesis remain unclear. The RNA molecules that are 
the targets of these RNA-binding proteins have not been identified. It is also not 
clear how deletions of one or two copies could explain infertility when there are 
multiple copies of these genes elsewhere on the Y chromosome. 
On the basis of the infertility rate among men and the percentage of 
infertile patients showing deletions of the Y chromosome, Reijo etal (1995) have 
suggested that these mutations should occur in -1 in 104 male newborns and that 
this high figure could arise by a mechanism involving repeated sequences 
flanking the gene. 
Y-chromosome deletions are relatively frequent (10%) and their 
frequency increases with the severity of the spermatogenic defect. However, Y- 
chromosome microdeletions can not be predicted on the basis of clinical findings 
or even the result of semen analyses. The role of analyses of Y-chromosome 
microdeletions in evaluating men with infertility remains to be determined. With 
the advent of intra. cytoplasmic sperm injection (ICSI) in the field of reproductive 
technology, the potential for passing on these defects to offspring is real and 
should be considered when infertile couples are counseled about this procedure 
((Pryor et al, 1997). This raises issues of informed consent and ethical concerns. 
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Substantial prevalence of Y deletions in infertile men and the potential risk of 
transmitting this genetic disorder to their offspring provide a compelling rationale 
for screening of infertile men prior to ICSI. Considering the ease of PCR-based 
STS mapping, this screening could become readily available in clinical 
cytogenetic laboratories. The couples undergoing ICSI should be counselled about 
the potential risk of transmitting this genetic disorder to offspring. In addition, 
there is a pressing need for developing mechanisms for worldwide monitoring of 
ICSI babies for genetic disorders, including Y deletions (Bhasin et al, 1997). 
Mutation detection in RBMZ gene 
If RBM is involved in human spermatogenesis and altered in a proportion 
of infertile males, then, because it is a multicopy gene family on the human Y 
chromosome (Ma et al, 1993), it is possible that deletion or rearrangement would 
be a more common route to infertility than point mutation. However, if point 
mutations do play a part, a possible region for an effective single base change 
would be the RNA-binding domain of the protein, particularly in the RNP I and 
RNP2 amino acid motifs (Prosser et al, 1996). 
To rule out the possibility of structural rearrangement or deletion of the 
RBM gene family, all DNA samples from 50 infertile and 50 normal men were 
screened by means of FISH analysis and Southern blot hybridisation. 
In situ hybridisation with MK5 and MK29 to metaphase spreads of 
infertile and normal males showed intense and multi-signals on both chromatids 
of the Y chromosome. Interphase in situ hybridisation also showed the presence 
of multiple clustered hybridisation signals. These findings confirmed that RBAf 
gene family is multicopy as reported by Maet al (1993). No deletion or structural 
rearrangement was detected in all cohorts including the patient who showed 
microdeletion in Yqll upon multiplex PCR experiments. Because theRBMI 
sequences are known to be multigenic and dispersed throughout intervals 5 and 6, 
are likely to hinder detection of small deletion, large deletions are required to 
remove all specific RBM targets in order to be detected by FISH analysis (Ma et 
al, 1993). 
DNA samples from 50 infertile and 50 normal men were digested with two 
restriction enzymes EcoRl and Taql. In the present study the resulting 
hybridisation with MK5 pattern was the same. No deletion or structural 
rearrangement was detected in all investigated individuals. Molecular deletion 
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analysis with probes from interval 6 of the Y chromosome has found evidence for 
microdeletions in some azoospermic men (Vogt et al, 1992a; Ma et al, 1993). In 
this study Southern blot analysis failed to detect microdeletions in the RBM gene 
family confirming the FISH studies and multiplex PCR experiments. 
In summary, FISH analysis and Southern blot hybridisation to DNA from 
50 infertile men and 50 controls with cDNA encoding RBMI and RBM2 
respectively revealed the presence of multicopies of the gene and no deletion or 
structural rearrangements were detected in all investigated cases. These results are 
in agreement with the multiplex PCR studies. Therefore, the possibility that 
deletion or rearrangement of RBM gene family would be the cause of infertility is 
ruled out in the cases of the present work. 
To provide proof that defects in a gene result in the disease for which it is 
a candidate remains problematic. One convincing route is to demonstrate a new 
point mutation in the gene in one or more patients with the disease. Therefore an 
attempt was done for the RBM gene family in a patient set (50 cases) with no 
visible chromosome deletions and with idiopathic defects in spermatogenesis. To 
search for mutations in the multicopy RBM genes that might be associated with 
male infertility, sequence data from the reported cDNA clones was used (Ma et al, 
1993). This gene has 12 exons, three of which encode the putative RNA binding 
domain of the protein. Two particular sequence arrays in RBM are believed to be 
potentially important for its function (Ma et al, 1993). The RNA recognition motif 
(RRM) extends from amino acid I to 87 with the two evolutionarily highly 
conserved sequences, RNP1 in exons 3 and 2 respectively. (Prosser et al, 1996) 
The so-called SRGY (Serine-Arginine-Glycine-Tyrosine) box domain extends 
from amino acids 227 to 347 (exons 7-11) and may be characteristic of human 
RBM. It has been postulated that the SRGY box acts in protein-protein interaction 
related to gene function and specificity (Prosser et al, 1996). 
With this in mind, the DNA of 50 patients with no known Y chromosome 
deletion was amplified with intronic primers specific for exons 1-12. Single strand 
conformation polymorphism (SSCP) analysis was optimised to screen exons 1.11 
and three different copies of exon 2 (B, C, D), and heteroduplex analysis (HA) 
was optimised to screen exon 12 of the RBM1 gene in all cohorts of the studied 
patients. For SSCP study, different running conditions were used. 0.5X MDETM 
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gel with 5% glycerol running at room temperature and at 4 OC were applied along 
the study. No band shift was detected upon analysis of all screened exons. 
However, in some instances, variant bands, which were interpreted as mobility 
shifts, were detected upon SSCP analysis of the PCR product from different exons 
of the RBM1 gene. In all of them, except one, reloading of the same PCR product 
on a newly prepared gel was associated by disappearance of such band. There is 
no clear explanation for this observation, but errors in sample loading (over 
loading), uneven gel running, improper gel polymerisation, and improperly 
flushed wells or combination of these may play a role in producing false results. 
Differentiation among polymorphic molecules by SSCP is not entirely predictable 
and the method can result in false negatives, ambiguous results and experimental 
artifacts (Sheffield et al, 1993). 
in one case, the abnormal band shift pattern persisted upon re-running of 
the same PCR product while it disappeared upon electrophoresis of a newly 
amplified product from the same exon from the same patient. To know the cause 
of this condition, the PCR product which showed abnormal band pattern was 
recovered from low melting point agarose gel. Then I ul aliquot was used in 
asymmetric PCR amplification reactions to generate single stranded DNA. 
Sequencing of this product revealed the misincorporation of a single base, most 
probably due to PCR error. The DNA Taq polymerase isolated from Thermus 
aquaticus currently used in most PCR studies lacks 3' to 5' proof-reading activity 
and has an error rate of approximately 1/10000 bases (Shibata 1992). In the 
previous case, such a PCR error must be produced early in the PCR amplification 
to make sufficient PCR products detectable by SSCP analysis and DNA 
sequencing. 
It was not possible to screen cDNA since testis RNA is not easily 
available, especially from patients, and break through transcription in 
lymphocytes was undetectable. 
No data has been published regarding the detection of RBMI and RBM2 
point mutations in idiopathic infertile men although several hundred cases have 
been studied and were only screened for microdeletion in Yq II particularly RBM 
and DAZ gene families. The only study for mutation analysis of RBM was done 
by Pressor et al (1996). They scanned exons 2-4 for mutation by SSCP on DNA 
from 30 normal and 60 infertile men. They found a point mutation that alters the 
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highly conserved RNPs motif (exon 2) in one infertile patient. The mutation was 
also found in his father. Whether the point mutation found in the patient and his 
father is a polymorphism or a mutation of significance remains to be determined. 
There are a number of potential reasons for this to find more mutations 
failure. The gene may be unimportant in the process of spermatogenesis although 
its conservation on the mammalian Y chromosome, testis-specific and germ line 
nuclear confined pattern argue against this (Elliot et al, 1996). Alternatively, 
point mutations may not be present or difficult to detect, or in regions of the gene 
not yet analysed in these patients. RBM is a multicopy family of genes and 
mosaicism is not easy to demonstrate. In this study it was not possible to find de 
novo point mutation that proves that the RBM gene family is involved in the 
failure of spermatogenesis in all investigated patients. However, although this 
approach has not provided proof of identify between RBM and AZF, it has given 
basic information. 
To provide proof that defects in a gene result in the disease for which it is 
a candidate remains problematic. The RBM genes provide an example of the 
difficulty of this approach, which is unfortunately the only one available at 
present. Firstly, the gene is normally expressed only in the testis, a tissue not 
readily sampled either the normal population or in patients. This means that the 
analysis of transcripts in vivo is impracticable. Secondly, the gene is not 
ectopically expressed at a detectable level. Thirdly, the gene has 12 exons, any of 
which could potentially be mutated in any patient. Fourthly, and most 
significantly, the gene or sequences related to it are multicopy and give rise to 
transcripts that vary in the number of copies of the SRGY repeat as well as in a 
multitude of bases differences. A fifth complication is that some of these changes 
represent polymorphisms. 
Several RBM sequences remain uncharacterised as yet, Until the detailed 
genomic layout of the gene family members is established, the high degree of 
similarity between family members and their dispersal throughout the distal. part 
of intervals 5 and 6 are likely to hinder detection of small deletions, and hence, 
the identification of the individual genes responsible for effects on 
spermatogenesis. 
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4.3 Conclusions and recommendations 
In conclusion, the most appropriate screening strategies for the detection 
of molecular pathology are influenced by the expected nature of the mutations, 
size and structure of the gene in question and the availability of sample (e. g. 
DNA, *fixed chromosomes or RNA). Table 4.2 summarises the sequence of events 
for mutation detection. Therefore, for each of the four groups studied, a different 
mutation strategy was chosen and optimised. The present study showed the 
importance of cytogenetic and FISH approaches in the identification of marker 
chromosomes, the precise analysis of X and Y chromosomal aberrations as well 
as the detection of low grade mosaicism. Each of these methods has its own 
advantages and drawbacks, which should be carefully considered before 
application. 
Classical cytogenetic methods provide more general information on 
karyotype structure and chromosomal rearrangements but are hardly applicable 
for identification of marker chromosomes or detection of the exact breakpoint. 
The latter might be much more easily attained with FISH, which is more rapid, 
precise, and efficient. Unlike techniques requiring DNA for analysis, in situ 
hybridisation does not require additional samples, as unstained slides or fixed cell 
pellets are usually available and =enable to analysis. Additionally, modification 
of standard FISH techniques allows the use of previously banded slides for 
immediate determining of the nature of the marker chromosome. This can be 
crucial for counselling in cases with prenatally detected markers. Most 
importantly, reliable, high quality DNA probes are easily available for 
hybridisation, allowing unequivocal determination of the origin and structure of 
the marker chromosomes. 
On the other hand, molecular approaches such as single strand 
conformational analysis (SSCP), heteroduplex analysis (HA), Chemical cleavage 
mismatch (CCM) are the most common and rapid methods for detecting minor 
sequence alterations. DNA sequencing is the most accurate method for screening 
small genes such as SRY. Multiplex PCR and Southern blot analyses are more 
applicable for genes or loci prone to deletions such as the AZF locus. These have 
proven to be a very useful approach to many diseases and are highly 
recommended methods. 
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The importance of the combined application of molecular cytogenetic and 
molecular genetic techniques can enable adequate chromosomal analysis in 
patients with marker chromosomes or with complex chromosome rearrangements 
involving the X and Y chromosomes, which can not be confirmed by standard 
cytogenetic methods. 
The strategies of using DNA as template for PCR such as SSCP, HA and 
DNA sequencing analyses were the main screening methods applied in the present 
study, and have proved to be a useful method in screening for mutations within 
the AR, SRY, and RBM1 (AZF region) genes. 
Molecular investigations indicate that mutations involving the SRY gene 
on the Y chromosome are an infrequent cause of 46, XY gonadal dysgenesis. 
These mutations have been identified in only about 10-15% of XY females. 
Accordingly the mutations in the promoter regions might be essential for gene 
expression. The existence of other sequences crucial for the regulation of the SRY 
gene lying outside the regions studied or other sex reversing gene(s) ableto 
produce indistinguishable phenotypes may be an alternative explanation. 
Molecular and FISH techniques are very useful tools in detecting and 
locating Y sequences in cytogenetically XX males. Testing new Y chromosome 
markers in XX males will make it possible to identify and narrow the breakpoints 
in each case which could help in establishing genotype phenotype correlation. 
PCR amplification of Y sequences could be effectively used in cases 
where cytogenetic analysis fails to detect the Y chromosome. Furthermore, it is 
more specific, and can be used for the precise detection of sequences responsible 
for the development of testicular tissue (SRY), or for regions implicated in the 
development of gonadoblastorna (e. g., AMGLY). This approach considerably 
improves the diagnosis if compared with the classical cytogenetic analysis and is 
recornmended as an important tool in cases of cytogenetically undetectable 
markers or in the visualization of cases of unknown origin. 
The role of analyses of Y-chromosome microdeletions in evaluating 
infertile men remains to be determined. Considering the case of PCR-based STS 
mapping, this screening could become readily available in clinical cytogenetic 
laboratories. With the advent of intra cytoplasmic sperm injection (ICSI) in the 
field of reproductive technology, the potential for passing on these defects to 
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offspring is real and should be considered when infertile couples are counseled. 
This raises issues of informed consent and ethical concerns. In addition, there is a 
pressing need for developing mechanisms for worldwide monitoring of ICSI 
babies for genetic disorders, including Y deletions. 
General screening for point mutations in the RBM gene family seems to be 
unwarranted at this time. No data has been published regarding the detection of 
RBM gene family point mutations in idiopathic infertile men. Screening for 
mutation in gene(s) involved in male infertility alone such as the DAZ gene should 
be considered. 
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Table 4.2 (a): Methods for mutation detection (Scanning methods) 
Method Advantages Limitations 
Cytogenetics Detects major alteration (>3-5 Mb) Can not detect minor 
General method for chromosome studY. alteration. 
Gives a comprehensive view of the 23 pairs Hardly applicable for marker 
of chromosome. identification or detection of 
Very simple the exact breakpoints. 
Requires highly skilled 
cytogeneticists 
FISH Detects major DNA alteration (1-3 Mb) Expensive 
Used as an adjunct to routine cytogenetic to Can not detect minor 
achieve a higher sensitivity and better alteration 
resolution of chromosome aberrations 
Simple 
Southern blot Large scale alteration (>500bp) Laborious 
hybridisation, Very sensitive Biohazard (radioactive) 
Heteroduplex Detects minor DNA alteration (I bp) Suitable for short DNA 
analysis (HA) Very simple sequences (optimal<300 bp) 
Limited sensitivity 
Does not show position of 
the change in the PCR 
product 
Single strand Detects minor DNA alteration (I bp) Suitable for short DNA 
conformation Simple sequences (optimal<200 bp) 
polymorphism Limited sensitivity 
(SSCP) analysis Does not show position of 
the change in the PCR 
product 
DNA Sequencing Detects all changes Laborious 
Mutations fully characterised 
Mismatch cleavage Detects minor DNA alteration (I bp) Toxic chemicals 
(i) Chemical High sensitivity Experimentally diff icult 
(ii) Enzymatic Can easily scan up to 1.7Kb of DNA 
DNA or RNA may be used as templates 
Shows position of change 
Denaturing Detects minor DNA alteration (I bp) Choice of primers is critical 
gradient gel High sensitivity GC-clamped primers 
electrophoresis Expensive 
(DGGE) Does not show position of 
the change 
Reverse Requires mRNA as a template to check for 
transcriptase PCR splicing errors (deletions and insertions) by 
(RT/PCR) simple gel electrophoresis. 
Long segment of peptide coding region can 
be analysed. 
Detects changes in the 
coding sequences only 
Gene may not be expressed 
in accessible specimens 
(tissue specific). 
Mutations in promoter and 
intronic splice junctions are 
not detected. 
Because the coding sequence 
is a fraction of the size of the 
gene, SSCP, HA etc, can be 
used as initial screen, 
followcd by DNA 
sequencing 
Table 4.2 (b): Methods of testing for a specific mutation 
Method Application 
Restriction enzyme digestion of PCR- Only when the mutation creates or abolishes a 
amplified DNA; check size of products on natural restriction site or one engineered by use 
gel of special PCR primers 
Molecular hybridisation of PCR-amplified General method for point mutations 
DNA to allele-specific oligonucleotides 
(ASO) on a dot-blot, slot-blot or Southern 
blot 
PCR using allele-specific primers General method for point mutations 
(ARMS test) 
Check size of expanded trinucleotide repeat Trinucleotide repeats diseases only; large 
expansions may require Southern blots, smaller 
ones can be visualized by PCR-based methods. 
Multiplex PCR Applied to loci of known sequences prone to 
deletions or duplications 
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Appendix I 
Table 1.1: PCR primers used in analysis of the AR gene. 
1A'F' GCCTGTTGAACTCTTCTGAGC 427 600C DeSellisetal(1992) 
1XR' GCTGTGAAGGTTGCTGTTCCTC 
I BT CACAGGCTACCTGGTCCTGG 415 600C DeBellisetal(1992) 
IBW CTGCCTTACACAACTCCTTGGC 
ICT GCTCCCACTTCCTCCAAGGAC 527 600C DeSellisetal(1992) 
1 C, Fr CGGGTTCTCCAGCTTGATGCG 
ID IF' CCAGAACACAGAGTGACTCTGCC 605 600C DeElellisetal(1992) 
i D'R' CCAGAACACAGAGTGACTCTGCC 
27 GCCTGCAGGTTAATGCTGAAGACC 379 600C DeSellisetal(1992) 
2'R' CCTAAGTTATTTGATAGGGCCTTGCC 
VRI TTATCAGGTCTATCAACTCTTGT 313 600C DeBellisetal(1992) 
3'R' CTGATGGCCACGTTGCCTATGAA 
47 GATAAATTCAAGTCTCTCTTCCT 360 580C DeBellisetal(1992) 
4'R' GATCCCCCTTATCTCATGCTCCC 
57 TCTTCTTCTCCAGGCTTCCGC 171 58 OC Lobaccaro et al (1993) 
5'R' CAGGAGCACTTACTCATTGAA 
VFI CTCTGGGCTTATTGGTAAACTTCC 292 580C DeSellisetal(1992) 
VR' GTCCAGGAGCTGCCTMCCCTA 
771 CMCAGATCGGATCCAGCTATCC 416 580C DeBelllsetal(1992) 
7 'RI CTCTATCAGGCTGTTCTCCCTGAT 
8'Fl GAGGCCACCTCCTTGTCAACCCTG 347 580C Dol3ellisetal(1992) 
8'R' GGAACATGTTCATGACAGACTOTACACTA 
F stands for forward and R stands for reverse primers. 
A 
Table 1.2: PCR primers used in analysis of the SR Y gene. 
Name Primer sequence (5' to 3' end) Size Reference 
XES77 CCCGAATrCGACAATGCAATCATATriCTTCTG 609bp Hawkins etal (1992) 
XES2'R' CTGTAGCGGTCCCGTTGCTGCGGTG 
XESIO IF' GGTGTTGAGGGCGGAGAAATGC 778bp Hawkins eta] (1992) 
XESIVR' GTAGCCAATGTTACCCGATTGTC 
SRY A CCATGAACGCAITCATCGTGTG 
SRY B GCCTTCCGACGAGGTCGATACT 
217 bp Zeng et al (1993) 
SRY C GAGATCAGCAAGTAGCTGGGA 
SRY D ACAACCTGTTGTCCAGTTGC 
SRY E =CAGOACAGCAGTAGAGCA 
SRY F TTGAAAGGTGCCAGAOTTCGA 
226 bp Zeng et a] (1993) 
251bp Self designed 
SRY G TGGACAAAGCTGTAGGACAATC 248 bp Self designed 
SRY H ATAGGCAGGCTCACTTCTGGA 
F'stands for forwards and'R'stands for reverse primers 
All sets of primers are annealed at 58 OC. 
B 
Table 1.3: PCR Primers used in XX male study. 
_Name 
gelion Primer sequences Size* Temp Reference 
XES7'F' SRY" CCCOAATTCOACAATGCAATCATATGCTrC 609 600C Hawkins etal (1992) 
XES2 IRI CTGTAGCGGTCCCOTTGCTGCGGTG 
MY 5.1 IF ZFY CGAATTCATACCGGCGAGAAGCCATACC 735 610C Barbosactal(1995) 
MY 6.1 'R' AAAGCTTGTAGACACATCGTTAGGG 
PART' PAR-Y CTGAGAGTGOAAGTGTCGCAG 1100 550C Barbosatta](1995) 
PAR IR' GTACTACCTTTAGAAAACTAGTATTTTCcc 
YVF' Y-cený ATGATAGAACGGAAATATG 170 540C Wittetal(1989) 
y2 IR, AGTAGAATGCAAAGGGCTCC 
F stands for forwards and 'R! stands for reverse primers. 
Size in base pairs (bp). 
Amplifies the HMO box of the SR Y gene 
b y_ centrorneric sequences ( DYZ2). 
C 
Table 14: Sets of primers used in the multiplex PCRO*. 
IA- Y-specific primer pairs of pY6H sequence family 
Y6Dl4pr DYS20S GGCTAGGTGCCAGCAAGTAGATCA GTTCTCTTCCCCTGCATCAAG 134 
Y6BaH34; DYS206 OCCCTTTOGTAAAAGCO CTGAATTrOCAACGGCTOC 910 
H6YP35pr DYS274 GGTACAr-ACTCCATCCTOGAC CTACAGOCTACCTMAGOTGo 226 
Y6HP52pr DYS239 OGAACTGGCAGGATTAOCCTTC GCTCAGAATCTGCOATCAG 258 
Y6PHc54p ND rCAGAAGAGTTCAOC GTGGAGTGCTOCATTAAAGG 166 
113- Primers pairs from DNA loci in Yq II according to to Foote et a] (1992) and Scherer et W (1991). 
Name Locus* Forward Reverse Product size (bp) 
_ 
FrIS-Ilpr ND TACCTTOGTTTTOCACCAGACOC CACCCTCTOTATATGACCTCGC 313 
sY14 SRY GAATATTCCCGCTCTCCGGA OCTOGTOCTCCATTCTTGAG 472 
Sys) DYS271 AGGCACTGGTCAGAATGAAG AATGGAAAATACAGCTCCCC 209 
SyS2 DYS272 ATCCTOCCCTTCTGAATCTC CAGTOTCCACTOATOGATcA 264 
sY84 DYS273 AGAAGGOTCTGAAAGCAGGT GCCTACTACCTOGAGO MC 326 
sY86 DYS148 GTOACACACACAGACTATOCTTC ACACACAGAGGGACAACCCT 320 
SM DYS276 TTGTAATCCAAATACATGGGC CACCCAGCCATTTGTTTTAC 123 
SY182 KALA TCAGAAGTGAAACCCTGTATO GCATGTGACTCAAAGTATAArjC 132 
sY152 KAL-V AAATCTGTAGTCTCATATCAATCTG TTACTTGATTTACCAATAAAAAor 183 
sY49 DYS279 TCATOACAGCCAGCtGTATIT MGGACATAGTTTTTTGGTCC ISO 
SY95 DYS280 TCCTACAGATGTCCAAAGTGC GATGAOTGACCCCAGAATTG 303 
sY97 DYS281 AACTTCATCAOTGTTACATCAAGO TGTGQCATMGTTATGTGG 104 
sY102 DYS198 CACTACCACATTTCCTGGTTGG CGCTGAOTCCATTCTTTGAG 218 
SY105 DYS201 AAGGGCTTCTTCTCTTCCTr AGGOAGCTTAAACTCACCOT 301 
SY109 DVF43SI AGGAGATOTCAGGACTATCAriC TCCATCCAGCTGOTCATATT 233 
sYI17 DS209 GTTGOTTCCATCCTCCATAC CAGGGAGAGAGCCTTTrACC 262 
SY127 DYS213 GOCTCACAAACOAAAAGAAA CTGCAG(3CAGTAATAAGOGA 274 
sY134 DYS224 GTCTGCCTCACCATAAAACO ACCACTGCCAAAACTTTCAA 301 
sY143 DYS231 GCAGGATGAGAAGCAGGTAG CCGTGTGCTGGAGACTAATC 311 
sY147 DYS232 iijCjCGMGATGATCCTAG TTAATATOAGAATGAGAACAGATC)T 100 
sY149 DYSI TOTCACACTOCCCTAATCCT TGOTCATGACAAAAGACGAA 132 
sYI53 DYS237 GCATCCTCATTTTATOTCCA CAACCCAAAA(3CACTGAGTA 139 
&YI57 DYS240 CTrAGGAAAAAGTGAAGCCG CCTGCTGTCAGCAAGATACA 283 
* Y-DNA locus as defined m Genome Data Base (GDB). Utunore, MD, USA, 
ND - not yet defined in GDB. 
$* Henegariu et &1 (1994). 
All acs of primers am annealed at 58T. 
D 
Table 1-5: Y-chromosomal STSs used in male infertility study" 
STS Forward Reverse Product size Mp) 
sY231 ATTGATGTGTTGCCCCAAAT AGAGTGAACTTTAAATCCCAGCC 149 
sY232 GACTCTACCACTTGGGCTCAATTT AGATGTACCCAAGOCCACTO 91 
sY233 AGTTAGTAAGCCCCAGTTATCCTCC TTTGGAAAAGGACACCTTATTAGCCA 115 
sY236 CCCCATCGGTAAACCAAATCA CCCATTGAAGT77CAAGGTOTCA 94 
sY239a CA7rCATCTTCCCTTTTGAAGG ATGCAAGTCGCAGOAAATCT 200 
sY240a TCAAATAGCAGCAATTTAATAT GCACCTGAAGAGCTOCT70 247 
sY242 ACACAGTAOCAGCWGAGTT TCTGCCACTAAACTOTAAGCTCC 233 
sY243 GTTTCTTCATAAGCAACCAAATTG CAGATTATGCCACTGCCCTT Ila 
sV245 TTACTTCCTTAAGTCAAAGCOG CTGAGACAGCAAGACCAATCC 101 
sY247& CTGGACAAAGCCTTGGAAAA CTGCATOTCAATTGTGGOAC 114 
sY248a CATTGGCATGAATGTGTATTC CTCTOGGACAAGTOTTCCTT 94 
sY249 GACAAAGGOCTGATGATTTA CATCACCTTTACTTMAAATOO 114 
sY254 b GGGTGTTACCAGAAGOCAAA GAACCGTATCTACCAAAGCAGC 350 
sY255 b OTTACAGOATTCCvGCGTGAT CTCGTCATGTGCAGCCAC 126 
sY257 AGGTTGT7rrjGCCTTGAOC TCTATOATCTGTACCCGGTGC 123 
sY262 AGCCACTGCAAGCAACAGA CCACCATCCCCCTTCTTC 100 
sY267 GAATGTGTATTCAAGGACTTCTCO TACTTCCTTCGGGGCCTCT 102 
sY273 GGTCT'TTAAAAGGTGAGTCAAATT AGACAGAGGOAACTTCAAGACC 95 
a Anneal at 62 OC; otherwise, anneal at 58 OC. b Within DAZ gene, 
"From Reijo et al (1995 
E 
Table 1.6: Primers sequences of 4 different genes involved in male germ cell development that were used 
in male infertility study **. 
Name Forw2rd Reverse Size (bp) Temp* 
RBMI ATGCACTTCAGAGATACGO CCTCTCTCCACAAAACCAACA goo 580C 
RBM2 AGAGATGCACTTCAGAGG CCTCTCTCCACAAAACCAACA goo 58*c 
DAZ GOAACTCTOCTTTGGTAGATAC TAGOTTTCAOTOTTTGOATTCCO 1300 380C 
SPGY1 MCACATACAOCCATTAAGTTTAOC ACAATTrTGATAGTCTGAACACAAGC 460 580C 
Table 11.6: Primers designed and used for PCR amplificatiorn of RBM (YRRM) gene. 
Exon Forward Reverse Size (bp ) Temp* 
2A CGGCACGACAATGGTAGAA GGGACCATGTrTCCCAAAT 113 540C 
2B AATGGTAGAAGCAGA77GTCA GATAGGGGACCATG7MG 113 56 CC 
2C CGCACGACATGGTAGAG GGGACCATATTTCCCAAAC 113 560C 
2D GTTTACAGCACAATCATCC TATGGGACCGTGTTTCAC 100 54 CC 
4 GTCTTrGCATGGAAAAGCAATA TAAAACATTACCCAGGTGCC 190 540C 
5 GAAATACAGATGATOGTGGA ATCAGGCAGCATTTACCTTG 178 540C 
6 TGAATGTTAAAGOTCCCATGT GGTTTACCCATCGTTAGTTGC 119 540C 
7 GCACACAGAAATCATCCAAGT CAGTACCTATATCCTCTAGAGG 125 600C 
8 TATGCATACAGAAATCATCG AAAAGTTACAGTACCTGTATCC 136 580C 
9 M CTGCATACAGAAATCGT CAGAAAAATTACAGTACCTATA 580C 
10 ACTCGTGCACGCAGAAATCA ACCTATATCCTCTAGAGOAATG 127 540C 
11 CAATT7AGTrATCATGATGGCT ACCCTTACCGTATCTCTGAA 105 580C 
12 AACCCTGCAGGGACCTCTCA CTACCTCTCTCCACAAAACCAA 437 580C 
* Annealing temperature. 
"From Vogt et al (1996) 
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